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Abstract 
 
Solar ultraviolet radiation (UV) comprising ≥ 95% UVA (320-400nm) and around 5% UVB 
(280-320nm), is a carcinogen. Nucleotide excision repair (NER) removes UVB-induced 
DNA lesions. Defective NER is associated with photosensitivity and an increased risk of 
sunlight-induced skin cancer. Some drugs including the immunosuppressant 
azathioprine and the fluoroquinolone antibiotics, cause photosensitivity and increase 
skin cancer risk. Azathioprine treatment results in the incorporation of 6-thioguanine (6-
TG) into DNA where it interacts with UVA radiation to generate reactive oxygen species 
(ROS). ROS generated by DNA 6-TG+UVA or fluoroquinolone+UVA damage proteins, 
including those involved in NER. This protein damage results in NER inhibition. 
Replication protein A (RPA), the human single-stranded DNA binding protein essential 
for NER is particularly susceptible to damage by ROS. I investigated RPA oxidation in 
cultured human cells and identified several oxidised forms of RPA that are generated by 
6-TG+UVA and fluoroquinolone+UVA treatments. Using cells expressing different levels 
of RPA, I examined the relationship between RPA oxidation and NER inhibition. My 
findings demonstrate that RPA is limiting for NER under oxidative stress conditions and 
that damage to RPA is the main contributor to oxidation-related NER inhibition. The 
vulnerability of NER to inhibition by oxidation links cutaneous photosensitivity, protein 
damage, and increased skin cancer risk and indicates that in addition to DNA damage 
itself, damage to DNA repair proteins may be an important factor in skin cancer risk.  
 
The oxidative stress conditions generated by photosensitiser+UVA combinations also 
favour the formation of DNA-protein crosslinks (DPCs). I developed a sensitive and 
statistically rigorous proteomics-based method to study DPCs induced by oxidizing 
treatments. This novel approach provided a detailed analysis of the DPCs associated 
with 6-TG treatment and by the UVA activation of DNA 6-TG. It also provided the first 
demonstration that UVA activation of the fluoroquinolone antibiotic ciprofloxacin induces 
extensive DPC formation. Proteomic analysis identified more than 2000 cellular proteins 
that were crosslinked to DNA by 6-TG or by 6-TG+UVA. The proteins most susceptible 
to DNA crosslinking, were involved in control of gene expression and DNA repair and/or 
replication, including RPA. The findings indicate that DPCs are a significant product of 
photochemically-induced oxidative stress and may contribute to impaired DNA repair 
and an increased risk of permanent genetic damage.  
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Chapter 1. Introduction 
1.1 Oxygen and reactive oxygen species 
Oxygen is essential for aerobic life. Paradoxically, it is also converted to reactive 
oxygen species (ROS), which can damage cellular components. As a consequence, 
cells have evolved powerful antioxidant defences and the existence of a plethora of 
these defences underlines the threat that ROS pose to cellular homeostasis. When 
the level of ROS production overwhelms antioxidant protection, cells succumb to 
oxidative stress, which can be detrimental to cellular function and is linked to cancer, 
premature aging, cardiovascular dysfunction and neurodegenerative diseases 
(Halliwell, 1998). More recently, the role of ROS in signalling and regulation of 
biological and physiological processes has been uncovered (Finkel, 2011). It has 
been shown to have a role in several cellular processes including cellular 
differentiation and tissue regeneration (reviewed in (Schieber and Chandel, 2014)). 
 
Oxygen is in a triplet ground state and contains two unpaired electrons of parallel 
spin. This is unusual as most organic molecules exist in a singlet ground state with 
paired electrons of antiparallel spin. Quantum mechanical restrictions (Pauli 
exclusion principle) dictate pairing of electrons in the same orbital with antiparallel 
spins for reactions to occur. This means that reactions between singlet and triplet 
state molecules are rare and extremely slow (Halliwell, 1991). Whilst this restriction 
is protective against reactions between ground state oxygen and cellular 
components, the triplet state enables oxygen to react rapidly with radical species.  
 
In respiring cells, molecular oxygen (O2) is reduced to water with 4 electrons (e-) at 
the end of the mitochondrial electron transport chain through cytochrome c oxidase 
(complex IV) (equation 1): 
                    
 
This mechanism is in place to restrict univalent reduction of O2 that can result in the 
formation of reactive intermediates. Leakage of single electrons may occur from 
mitochondrial complexes I-III, however, resulting in partial reduction of O2 to 
O2 + 4H+ + 4e- 2H2O                                  (1)                      
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superoxide (O2•-), hydrogen peroxide (H2O2) and hydroxyl radical (•OH) (Figure 1.1) 
(Frei, 1994). The reduction potentials in Figure 1.1 explain the affinity of each ROS 
for electrons and their tendency to be reduced. 
 
 
 
       
Reduction potential (V) 0.94 0.32 2.31 
Half-life (seconds) 10-6 10-5 10-9 
In vivo concentration (M) 10-10 10-7 10-15 
 
Figure 1.1: Univalent reduction of O2 to H2O and the characteristics of the 
intermediate products. Adapted from (Giorgio et al., 2007) 
 
 
Free radicals contain one or more unpaired electrons (designated •) that render them 
generally more reactive than non-radical molecules. Radicals can react with non-
radicals or with other radicals. The reaction between a radical and a non-radical 
generates a second radical species and reactions involving free radicals tend to be 
chain reactions (Halliwell, 1991). In order to terminate this chain reaction, a radical 
must form electron pairs with another free radical or be quenched by a free radical 
scavenger (Nordberg and Arner, 2001). 
 
1.1.1 Hydroxyl radical  
•OH is the most biologically reactive free radical. It can be produced due to exposure 
to ionising radiation, where most of the energy is absorbed by water in the cell. This 
breaks the single covalent bond between oxygen and hydrogen resulting in •H and 
•OH (Halliwell, 1991). The in vivo formation of •OH from the significantly less-reactive 
O2•- or H2O2 can also be catalysed by trace amounts of transition metals in the Haber-
Weiss and Fenton reactions (equation 2 & 3): 
 
Fe3+ +  O2•- Fe2+ +   O2 (2)
Fe2+ +  H2O2 Fe3+ +  •OH  + OH- (3)
O2 O2•- H2O2 •OH H2O 
e- e- e- e-
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Normally, iron and copper are sequestered by binding to proteins, membranes or 
chelating agents (Halliwell and Gutteridge, 1984). Under certain conditions, however, 
transition metals are released from metalloproteins. For example, O2•- can induce 
the release of iron from ferritin, a protein responsible for storing excess cellular iron 
(Biemond et al., 1984) and from [4Fe-4S] centres of dehydrases (Nordberg and 
Arner, 2001). The resulting •OH is extremely reactive and has a very short half-life 
of the order of nanoseconds. It can damage virtually any cellular molecule in its 
vicinity, limited only by its diffusion capacity (Bandyopadhyay et al., 1999). 
 
1.1.1.1 Hydroxyl radical scavengers 
Polyunsaturated fatty acids can exhibit a protective effect against •OH in diseases 
associated with free radical generation (Lipinski, 2011). This protective effect may 
reflect scavenging •OH mediated by C=C bonds. Further oxidation produces 
aldehydes and ketones - markers of oxidative stress (Lipinski, 2011). In addition, 
polyphenols, including salicylates can scavenge •OH and are protective against free 
radical injury in vivo (Kim et al., 2001; Lipinski, 2011). 
 
Bioflavonoids are natural free radical scavengers. These benzo-γ-pyran derivatives 
inhibit •OH induced DNA damage by chelating copper or iron ions (Jun et al., 2007; 
Russo et al., 2000). The effects of these bioflavonoids can depend on the 
concentration of these ions. At low cupric ion concentrations, quercetin, a 
bioflavonoid, protects DNA from ROS mediated damage whereas at high 
concentrations it is carcinogenic (Jun et al., 2007). 
 
1.1.2 Hydrogen peroxide  
H2O2 is produced through various reactions including those catalysed by glucose 
oxidase, peroxisomal oxidases, cyclooxygenase and neutrophil NADPH 
(nicotinamide adenine dinucleotide phosphate) oxidase. Xanthine oxidase produces 
both O2•- and H2O2 (Bandyopadhyay et al., 1999; Chance et al., 1979). O2•- can also 
form H2O2 spontaneously or through superoxide dismutase (SOD) (Fridovich, 1983). 
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H2O2 is not a free radical and is not particularly reactive in a transition metal-free 
environment. It is, however, membrane-permeable (facilitated by some aquaporins) 
and its relatively long half-life allows it to diffuse significantly far away from its site of 
generation (Bienert et al., 2007; Halliwell and Gutteridge, 1984). H2O2 plays an 
important role in generating more reactive ROS including •OH, as well as 
hypochlorous acid (HOCl) in the phagosomes of neutrophils (Winterbourn et al., 
2000). 
 
H2O2 is a strong two electron oxidant, but a weak one electron oxidant. It is a more 
powerful two electron oxidant than HOCl or peroxynitrite (OONO-), but is relatively 
unreactive with biological molecules because it has to overcome a high activation 
energy barrier (Winterbourn, 2013). As a one electron oxidant it has a low activation 
energy barrier and produces •OH due to its relatively weak O-O bond (Winterbourn, 
2013). H2O2 can also react with keto acids, such as pyruvate. These reactions 
generate carbon dioxide (CO2) that can react further with H2O2 to produce 
peroxymonocarbonate (HCO4-), which is ≥ 200x more reactive with thiols than H2O2 
itself (Bakhmutova-Albert et al., 2010). 
 
H2O2 has an important role in redox signalling, which most likely involves oxidation 
of protein thiols (Winterbourn, 2013). Under physiological and oncogenic conditions, 
H2O2 is involved in the transmission of growth signals, through epidermal growth 
factor, platelet derived growth factor and nerve growth factor, as well as through 
inactivation of some tyrosine and serine/threonine phosphatases (Finkel, 2000; 
Giorgio et al., 2007). 
 
1.1.2.1 Antioxidant mechanisms against hydrogen peroxide 
Catalases catalyse the breakdown of H2O2. They are found primarily in peroxisomes 
and convert H2O2 to a harmless mix of oxygen and water (equation 4) (Schrader and 
Fahimi, 2006). Catalases use NADPH (forming NADP+) to improve efficiency as well 
as for protection against inactivation by preventing H2O2 from converting catalase 
into an inactive state through altering its heme group (Kirkman et al., 1999). This 
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protection may occur through electron tunnelling between NADPH and the heme 
group of catalase.  
 
 
 
Glutathione peroxidases (GPX) and peroxiredoxins (PRX) are present in several 
cellular compartments. GPX have an active site selenocysteine. Selenolate (Se-) 
reacts with H2O2 to form selenenic acid (Se-OH), which then reacts with glutathione 
(GSH) to form selenylsulphide (Se-SG) (Nordberg and Arner, 2001). The active 
peroxidase selenolate is regenerated by reaction with a second GSH molecule. GPX 
can also react with other peroxides (ROOH) to produce alcohol as seen in equation 
(5). 
 
 
 
GSH is present in millimolar concentrations in cells and works as an antioxidant 
either via glutathione S-transferase or directly. The reaction of GSH not only protects 
protein thiols from hyperoxidation, but can also act as a regulatory post translational 
modification and alter protein structure and function (Dalle-Donne et al., 2007; 
Gallogly and Mieyal, 2007). Glutaredoxin can reduce the disulphide bonds formed 
between GSH and protein thiols. 
 
Oxidized glutathione (GSSG) is reduced to GSH by glutathione reductase (GR) and 
NADPH (reviewed in (Deponte, 2013)). GR is a flavoenzyme and consists of a 
homodimer where each subunit binds FAD (flavin adenine dinucleotide) and NADPH. 
Both subunits together form the binding pocket for GSSG. The substrates of the 
reaction are NADPH and GSSG, and the products are 2GSH. There are two 
essential cysteines involved in the reaction. Initially, there is hydride transfer from 
NADPH to FAD, forming FADH-. NADP+ is then replaced with NADPH. GR (now 
GRH2) then binds GSSG, where the SH group of one of the active site cysteines 
attacks GSSG to form an intermolecular disulphide bond. Following protonation, 
GSH can dissociate. 
2H2O2 O2 +  2H2O (4)
catalase
ROOH + 2GSH H2O + ROH + GSSG (5)
GPX
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N-acetylcysteine (NAC) is a precursor of GSH and can act as a direct scavenger of 
•OH, H2O2 and O2•-. In addition, it can supplement the available pool of intracellular 
GSH under conditions of oxidative stress when GSH levels may be low (Santus et 
al., 2014). 
 
PRX are thiol proteins (typical 2-Cys, atypical 2-Cys and 1-Cys) that react with H2O2 
or OONO- to form protein sulfenic acid and organic hydroperoxides (equation 6) 
(Trujillo et al., 2007). The subsequent disulphide bond that forms between the two 
cysteines in typical and atypical 2-Cys PRX is regenerated by thioredoxin (TRX) (Hall 
et al., 2009). TRX is recycled using thioredoxin reductase (TRXR) and NADPH (see 
Section 1.1.6). The 1-Cys PRX are restored by GSH (Winterbourn, 2013). PRX are 
particularly abundant and are thought to be the major enzyme in charge of H2O2 
disproportionation under steady state conditions. Inactivation of PRX through the 
reaction of the active site sulfenic acid with a peroxide to form sufinic acid can cause 
upregulation of catalase and GPX (Rhee et al., 2003). 
 
 
 
It is clear from the foregoing that there is redundancy in the antioxidant mechanisms 
targeting H2O2. Although catalases are restricted to peroxisomes, GPX and PRX can 
be co-localised. One of the proposed reasons for this redundancy is the requirement 
for the tight regulation of H2O2 due to its role in signalling and redox metabolism 
(Winterbourn, 2013). It is also important that antioxidant mechanisms targeting H2O2 
are co-localised with SOD, as H2O2 is a product of the dismutation reaction (see 
Section 1.1.3.1). 
 
1.1.3 Superoxide 
O2•- is formed by the acquisition of a single electron by molecular oxygen. In the cell, 
this usually occurs by leakage of an electron from complexes I and III in the electron 
transport chain. O2•- has a single negative charge and an unpaired electron.  
 
PRX-SH + H2O2 PRX-SOH + H2O          (6)
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Despite its free radical nature, O2•- is not highly reactive. It is also unable to diffuse 
through lipid membranes. The reactions of O2•- with organic molecules such as 
proteins, lipids and nucleic acids are slow compared to its rate of conversion to H2O2 
(Bielski et al., 1985). When it does react, it forms a substrate radical and hydroperoxyl 
radical (HO2•) (Sheng et al., 2014). 
 
1.1.3.1 Antioxidant mechanisms against superoxide 
There are two predominant forms of cellular SOD. CuZnSOD is located in the cytosol 
and MnSOD in the mitochondrial matrix. SOD-catalysed dismutation of O2•- is much 
more efficient than the corresponding spontaneous reaction (Nordberg and Arner, 
2001). MnSOD is induced by oxidative stress. It is an essential enzyme and mice 
lacking MnSOD exhibit severe neurodegeneration and die soon after birth (Melov et 
al., 1998). The SOD reaction is shown in equation (7). 
 
 
 
CuZnSOD overexpression in cultured mammalian cells results in higher levels of lipid 
peroxidation and hypersensitivity to oxidative stress. This can be alleviated by 
increasing catalase and GPX levels (Amstad et al., 1994). The most likely 
explanation for this behaviour is the increased production of  H2O2 by overexpressed 
CuZnSOD (Giorgio et al., 2007). These findings illustrate the importance of rigorously 
controlling H2O2 production. 
 
Superoxide reductase (SOR) is an iron metalloenzyme, which requires an external 
reductant to provide an electron in addition to two protons to produce H2O2 from one 
molecule of O2•- (equation 8) (reviewed in (Sheng et al., 2014)).  
 
 
2H+ +  2O2•- H2O2 +   O2 (7)
SOD/
spontaneous
2H+ +  O2•- + e- H2O2 (8)
SOR
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1.1.4 Singlet oxygen  
Changing the valance electron spin state of triplet ground-state oxygen converts it to 
singlet oxygen (1O2), which has electrons with paired spins in the same molecular 
orbital. 1O2 can be produced in many ways. Most commonly, it is produced through 
energy transfer from a sensitiser to ground-state O2 (Ogilby, 2010). 1O2 has a 
relatively long half-life of 1.7±1µs in H2O. This increases to around 24 µs in D2O, due 
to the higher density and stronger H-O bonds of D2O (Jiménez-Banzo et al., 2008). 
1O2 can be quenched by sodium azide (NaN3). These two properties are often used 
to infer the 1O2-dependence of reactions.  
 
1O2 can also be formed by peroxidases and the reaction of H2O2 with HOCl or OONO- 
(Di Mascio et al., 1994; Foote and Wexler, 1964). It can be produced by the reaction 
of ozone with organic and inorganic molecules, and is generated biologically by 
activated eosinophils and macrophages (Kanofsky and Sima, 1991; Kanofsky et al., 
1988; Steinbeck et al., 1993). The ability of 1O2 to oxidise target molecules can have 
beneficial effects in destroying pathogens, as well as a negative impact on healthy 
organisms. 
 
When 1O2 reacts with an organic molecule the initial product is a peroxide, which can 
then form •OH (Ogilby, 2010). When the rate constants for 1O2 reactions as well as 
the cellular abundance of the targets is taken into account, 1O2 is most reactive with 
proteins, followed by ascorbate, RNA and DNA (Davies, 2003). An interaction 
between 1O2 and its target can result in energy transfer and a return to the triplet 
oxygen state, or a chemical reaction and alteration of the target. 
 
1.1.4.1 Antioxidant mechanisms against singlet oxygen 
The carotenoids, of which lycopene and β-carotene (Figure 1.2) are the most 
important, scavenge peroxyl radicals and 1O2 and alleviate damage to cellular lipids 
by forming resonance stabilised carbon cantered radicals (Olson and Krinsky, 1995). 
Lycopene, found in many fruits and vegetables, has a large number of double bonds 
that delocalise unpaired electrons. This allows it to act as a strong 1O2 quencher. It 
has been proposed that carotenoids act as antioxidants at low oxygen conditions, 
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but at high oxygen conditions can act as pro-oxidants by forming a carotenoid-
peroxyl radical and oxidising unsaturated lipids (Valko et al., 2006).  
 
 
Figure 1.2: Chemical structures of β-carotene and lycopene (Valko et al., 2006)  
 
1.1.5 Other reactive species 
Nitric oxide (NO•), also a free radical, is similar to O2•- in its low reactivity with 
biomolecules. It can cross cell membranes and has a role in signalling and redox 
regulation (Ignarro, 1990; Wink and Mitchell, 1998). NO• is produced together with 
L-citrulline from L-arginine, O2 and NADPH by NO synthase (NOS). It acts as a type 
of radical scavenger and neutralises peroxyl and alkyl radicals to prevent lipid 
peroxidation (Rubbo et al., 2000). It can, however, react with O2•- to produce the 
highly reactive OONO-, that can nitrate aromatic amino acid residues of proteins and 
react with ceruloplasmin to release copper ions (Halliwell et al., 1997). Depending 
on the environmental conditions, OONO- can be protonated to form peroxonitrous 
acid (ONOOH). This can generate either •OH and •NO2, rearrange to nitrate (NO3) 
or react with CO2 to form the very reactive nitrosoperoxycarbonate (ONOOCO2-) 
(Pavlovic and Santaniello, 2007).   
 
Under conditions of high NO• production, it is removed from the cell by being 
conjugated to GSH to form S-nitroso-glutathione. This product is subject to cleavage 
by the TRX system (Nordberg and Arner, 2001). 
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1.1.6 Other antioxidants 
Ascorbic acid is an important antioxidant but it is unable to exhibit its antioxidant 
effect in the presence of transition metal ions (Halliwell, 1991). Its antioxidant effect 
reflects its ability to form ascorbate radicals that terminate free radical chain reactions. 
 
α-tocopherol (Toc) is a lipid soluble molecule present in cell membranes and plasma 
lipoproteins. It has an –OH group, where the hydrogen atom is donated to peroxyl 
and alkoxyl radicals formed through lipid (L) peroxidation (Halliwell, 1991). This 
reaction converts α-tocopherol into a radical, which has low reactivity with nearby 
fatty acid side chains, and terminates the chain reaction (equation 9-11). α-
tocopherol radical may be converted back into α-tocopherol using GSH and ascorbic 
acid (AA) (equation 11) (Wefers and Sies, 1988). Low plasma content of α-tocopherol 
and ascorbate is associated with higher risk of myocardial infarction, due to their 
protection against lipid peroxidation of low density lipoprotein (LDL) (Gey et al., 1987).  
 
 
 
TRX and TRXR are antioxidant oxidoreductase enzymes that together form the TRX 
system (Nordberg and Arner, 2001). TRX contains a –Cys-Gly-Pro-Cys active site 
that is essential for its function as a protein disulphide oxidoreductase (Holmgren, 
1989). TRX is particularly important for acting as an electron donor to PRXs. TRX in 
its reduced form is able to reduce disulphide bonds in proteins and is restored using 
TRXR and NADPH. TRXR contains a selenocysteine and relies on NADPH and FAD 
to reduce the oxidised disulphide of TRX (Nordberg and Arner, 2001). 
 
1.1.7 Lipid peroxidation 
Free radicals can react with virtually all biomolecules. Reactions with cell membrane 
fatty acids generate acid radicals (L•) that propagate chain reactions (equation 12) 
(Nimse and Pal, 2015). These radicals can react with oxygen to form fatty acid 
LOO• + TocH Toc• + LOOH (9)
Toc•  +  LOO• Toc-OOL (10)
Toc•  +  AAH- TocH + AA•- (11)
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peroxyl radicals (LOO•) (equation 13) and generate lipid hydroperoxides (LOOH) 
(equation 14) and aldehydes (equation 15). Aldehydes can migrate from their original 
source to cause damage in other areas in the cell (Pryor and Porter, 1990). 
 
 
 
Lipid peroxidation is particularly relevant to the generation of atherosclerosis plaques 
through oxidation of LDL in cardiovascular disease (Steinberg, 1997). 
 
1.1.8 Protein oxidation 
Proteins can be directly modified by ROS or undergo secondary oxidation by lipid 
peroxides (eg. malondialdehyde) or reactive sugars (glycation or glyoxidation 
products) (Dunlop et al., 2009). Their high cellular abundance (70% of dry mass) and 
the reactivity of their side chains enhance their vulnerability to oxidation. These 
reactions can result in a chemically heterogeneous mixture of oxidation products, 
which are determined by the type of reactive species involved, steric constrictions 
imposed by the protein such as exposure of side chains, presence of metal atoms 
and the local redox environment. Protein oxidation can result in intersubunit 
crosslinking, dissociation of subunits, exposure of hydrophobic residues, 
aggregation, changes in mechanical properties, changes in binding to cofactors and 
metal ions and fragmentation of the backbone (Prinsze et al., 1990). 
 
Certain extremophiles such as Deinococcus radiodurans exhibit resistance to cell 
killing by lethal treatments that induce both DNA and protein damage. It appears that 
this resistance is due to efficient proteome protection and preventing protein 
oxidation through non-enzymatic antioxidant protection rather than DNA protection 
(Green et al., 2011; Krisko and Radman, 2010). In addition, protein oxidation was 
identified as being responsible for elevated ultraviolet radiation (UV) induced 
LH   +   R• L•	+ RH (12)
L•		+  O2 LOO• (13)
LOO•		+  LH LOOH	+	L•	 (14)
LOOH LO•	+	LOO•	+	aldehydes (15)
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mutagenesis, highlighting the potential detrimental effect of protein oxidation on 
cellular viability (Krisko and Radman, 2013). 
 
1.1.8.1 Protein modifications caused by •OH, 1O2, H2O2 and O2•- 
•OH is extremely reactive and results in extensive damage through its ability to 
modify all amino acid side chains. This results in a complicated set of modifications. 
The most common reaction involves H-abstraction from S-H and C-H bonds of amino 
acid side chains forming thiyl and alkyl radicals, respectively (Xu and Chance, 2007). 
Carbon centred radicals can react with oxygen to form peroxyl radicals, ranging from 
hydroperoxide, hydroxide and carbonyl products (Davies, 2003; Easton, 1997). 
Radicals formed from peroxides on tryptophan, tyrosine and histidine can result in 
backbone fragmentation (Davies, 2003; Pileni et al., 1979; 1978). Due to the radical 
nature and extreme reactivity of •OH, a propagating chain reaction can occur 
whereby a single •OH can modify up to 15 amino acids (Neuzil et al., 1993). 
 
1O2 is reactive with proteins, particularly amino acids with electron rich aromatic or 
sulphur containing side chains (Davies, 2003). At physiological pH it reacts 
predominantly with histidine, tryptophan, methionine, cysteine and tyrosine in order 
of decreasing reactivity (Wilkinson et al., 1995). The reaction of free tryptophan with 
1O2 initially produces a hydroperoxide (ROOH), which can decompose through 
homolytic cleavage of the -O-O- bond to produce •OH, particularly in the presence 
of metal ions or UV light (Davies, 2003; Langlots et al., 1986). The hydroperoxide 
can also result in tryptophan ring-opening and protein:protein crosslinking or 
fragmentation. The ring opening produces N-formylkynurenine, which can further 
decompose to kynurenine. Both N-formylkynurenine and kynurenine are better 
photosensitisers than tryptophan, and can continue to cause 1O2 formation through 
sustained UV light exposure (Pileni et al., 1978; 1979; Saito et al., 1977). Initially 
tryptophan can preferentially act as a physical quenching agent, however, the 
creation of these photosensitising decomposition products can result in propagating 
damage. The main product of peptide-bound tyrosine at room temperature after 
oxidation by 1O2 is a hydroperoxide, which can also result in the formation of •OH 
and dityrosine protein:protein crosslinks (Langlots et al., 1986; Wright et al., 2002). 
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Reaction of histidine with 1O2 causes the formation of endoperoxides. These can 
undergo further reactions with another histidine, an oxidised histidine or a lysine side 
chain to form protein:protein crosslinks (Krisko and Radman, 2010; Shen et al., 1996; 
2000). Proteins which lack histidine have been shown to be less likely to form 
crosslinks (Montaner et al., 2007; Schäfer et al., 1998; Shen et al., 2000).  
 
Oxidation of aromatic amino acids changes their hydrophobicity and can contribute 
to exposure of hydrophobic regions, which can result in unfolding, aggregation and 
non-specific interactions with other proteins (Mirzaei and Regnier, 2008). The 
protein:protein crosslinks caused by oxidised aromatic amino acids can also result 
in aggregation and loss of function (Souza et al., 2000). Under conditions of severe 
oxidative stress, oxidised proteins and lipids can form an aggregated complex called 
lipofuscin, which is challenging to remove and can cause further oxidation.  
 
H2O2 does not generally react with proteins even at high concentrations (mM) 
(Halliwell and Gutteridge, 2007). It can react with and oxidise protein cysteine or 
methionine residues and low molecular weight thiols (glutathione). It can also oxidise 
proteins that have a transition metal centre and cause heme oxidation and release 
of iron, intensifying oxidative stress (Gutteridge, 1986). 
 
O2•- is not generally reactive with proteins, although it can modify the iron-sulphur 
clusters of proteins, resulting in the release of ferrous iron (Fe2+) and enzyme 
inactivation. Specific targets of this reaction include aconitase, which has an 
important role in metabolism (Halliwell and Gutteridge, 2007). 
 
1.1.8.2 Protein carbonylation 
Oxidation of protein side chains leads to the formation of aldehydes and ketones 
through protein carbonylation. Protein carbonyls cannot be repaired chemically or 
enzymatically and are therefore stable and effective markers of protein oxidation in 
cells. The level of protein carbonylation increases from one in nine to one in three 
proteins during oxidative stress (Stadtman and Levine, 2000). Lysine, arginine, 
threonine and proline are the most susceptible protein side chains for metal 
Chapter 1. Introduction 
 
28 
 
catalysed oxidation (in the presence of Fe(II), H2O2 and a reducing agent) (Requena 
et al., 2001). 1O2 can also react with aromatic amino acids and cause protein 
carbonylation. Protein carbonyls can react with lysine and arginine on the same or 
another protein, where further rearrangements may result in irreversible covalent 
crosslinking. In addition, nucleophilic side chains of cysteine, histidine and lysine can 
react with aldehydes generated by lipid peroxidation or with reactive carbonyls 
formed by reducing sugars, resulting in advanced lipoxidation/glycation end products 
(ALE/AGE) (Dalle-Donne et al., 2003). 
 
1.1.8.3 Thiol oxidation 
Thiol oxidation of cysteine can result in the formation of sufenic acid (R-S-OH), which 
can react with other thiols or glutathione to form a disulphide (R-S-S-R). Further 
oxidation of sulfenic acid leads to the formation of sulfinic acid (R-S(=O)-OH) and 
sulfonic acid (R-S(=O)2-OH), which are generally stable and irreversible and can be 
inactivating modifications. Cysteine is also able to form a zwitterionic peroxy 
intermediate that can react with another cysteine to form two molecules of R-S-
S(=O)-R (Ando and Takata, 1986; Berlett and Stadtman, 1997). Methionine oxidised 
by an oxidant [O] forms methionine sulfoxide (Dalle-Donne et al., 2003; Sysak et al., 
1977) (equation 16). Further oxidation forms methionine sulfonate (R-S(=O)2-CH3). 
 
 
 
Cysteine oxidation has been shown to result in enzyme inactivation of a range of 
proteins with active site cysteines such as glyceraldehyde-3-phosphate 
dehydrogenase, glutathione reductase, and caspases through non-radical and 
radical reactions (Hampton et al., 2002; Morgan et al., 2002; Wright et al., 2002). 
 
The reaction of weaker ROS such as H2O2 with cysteine is determined by whether 
cysteine is in its thiolate state. Stronger reactive species such as •OH, 1O2 and 
ONOO- do not require this deprotonation and are likely to form higher cysteine 
oxyacids. 
R-S-CH3 R-S(=O)-CH3 R-S(=O)2-CH3 (16)
[O] [O]
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Some protein oxidation is important for regulation of enzymatic function and occurs 
almost exclusively through thiol oxidation. Modifications can be activating or 
inactivating and alter the binding of proteins to their substrates, interacting partners 
or cofactors (Kansanen et al., 2013; Korichneva, 2005). Although cysteine is 
considered to be the main residue for redox regulation, methionine when oxidised 
can result in protein conformational changes (eg. calmodulin) (Bigelow and Squier, 
2011). The oxidation product of methionine, methionine sulfoxide, can be 
enzymatically reduced (Stadtman and Levine, 2000). 
 
1.1.9 DNA oxidation 
ROS and reactive nitrogen species (RNS) can result in >100 different types of 
oxidative DNA lesions. These include base modifications, single-strand (ss) and 
double-strand (ds) DNA breaks, DNA-protein crosslinks (DPCs) and deoxyribose 
oxidation (Dexheimer, 2013; Frei, 1994; Nordberg and Arner, 2001). Cellular DNA is 
subject to around 104 damaging oxidative reactions per day. Most of these lesions 
are removed. Persistent DNA lesions are potentially mutagenic due to erroneous 
base pairing during DNA replication. The accumulation of mutations over time 
contributes to various pathological conditions. DNA damage and repair will be 
discussed in detail in Section 1.3. 
  
1.2 Solar radiation 
Radiation from the sun enables life on Earth. Solar radiation has played a pivotal role 
in evolution. Its benefits range from a contribution to the provision of temperatures 
that support life, to being an essential component of photosynthesis. However, solar 
UV radiation also has detrimental effects on biological systems. 
 
1.2.1 The solar radiation spectrum 
The electromagnetic spectrum is divided into wavelength segments of UV, visible 
and infrared radiation. The most biologically damaging solar wavelengths lie in the 
UV region of the spectrum. For this reason, the effects of UV radiation have been 
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extensively studied and the biological effects of visible and infrared radiation are less 
well characterised. For the purpose of this thesis I will focus mainly on UV radiation. 
 
UV radiation is divided into UVA, UVB and UVC in order of decreasing wavelength 
(Figure 1.3). Oxygen produced by photosynthesis splits and recombines to form the 
stratospheric ozone layer. The ozone layer absorbs UV wavelengths less than 
310nm and effectively removes all UVC and 95% of UVB radiation from incident 
sunlight. UVA is not absorbed (de Gruijl and van der Leun, 2000). UV is required for 
the synthesis of vitamin D. It is important for regulation of hormones through 
circadian rhythm and is used in the treatment of skin disorders (Beersma and 
Gordijn, 2007).  
 
 
Figure 1.3: Solar radiation spectrum  
Adapted from (Svobodova et al., 2006) 
 
1.2.1.1 The skin anatomy 
The skin is the major target for the biological effects of solar radiation. It is the largest 
organ with many essential functions, including protection against the external 
environment. The skin has three layers: epidermis, dermis and hypodermis (Figure 
1.4). The epidermis contains squamous keratinised epithelium made up of 80% 
keratinocytes, and other cell types including melanocytes (1-2%) for pigment 
production and Langerhans immune cells (Svobodova et al., 2006). Depending on 
the location, the epidermis contains 4-5 layers of cells where the outermost layer is 
called the stratum corneum and the innermost layer is called the stratum basale. The 
innermost basal layer separates the dermis from the epidermis and is the layer of 
stem cells with the ability to migrate outwards and differentiate into keratinocytes. 
The stratum corneum contains several layers of keratinised dead cells lacking nuclei 
and other organelles. Each melanocyte in the basal layer is associated with 30-40 
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keratinocytes and one Langerhans cell. They contain melanosomes in which they 
produce the photoprotective melanin pigment that is distributed to the associated 
keratinocytes (Svobodova et al., 2006). Melanosomes persist in the various layers 
of the skin until they are shed by epidermal turnover that occurs every 4-5 weeks 
(Borovanský and Elleder, 2003). Fibroblasts are the most common cells in the dermis. 
The dermis contains collagen and elastin fibres, which gives skin its elasticity.  
 
 
Figure 1.4: Skin anatomy  
Adapted from (Svobodova et al., 2006) 
 
1.2.1.2 Sun, tanning and skin cancer 
Skin pigmentation is regulated by over 125 genes (Brenner and Hearing, 2008). Each 
individual has a genetically determined constitutive skin pigmentation. In addition, 
facultative pigmentation occurs upon exposure to external stimuli such as UV 
radiation. Upon exposure to UV, oxidation and polymerisation of melanin precursors 
in the skin causes immediate (within minutes) pigment darkening (Polefka et al., 
2012). Within an hour of exposure, UVA detection by the photoreceptor rhodopsin 
stimulates signalling that results in activation of melanin synthesis in melanosomes 
that have migrated to the outer epidermal layer (Moan et al., 2012; Natarajan et al., 
2014a; Wicks et al., 2011). Pigment darkening continues for several hours until de 
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novo melanin synthesis stimulates delayed tanning that lasts for several days 
(Yamaguchi et al., 2007). 
 
Melanin precursors are cytotoxic to melanocytes (Svobodova et al., 2006). 
Dihydroxyphenylalanine and indolic precursor autooxidation can result in the 
formation of ROS and generate products such as dihydroxyindole, which can insert 
itself between DNA bases and act as a mutagen (Svobodova et al., 2006). This DNA 
binding is enhanced by UV exposure (Hussein, 2005). Even though melanin acts in 
a protective manner against damage caused by solar radiation, melanogenesis is a 
pro-oxidative process and its activation and long term progression can be detrimental 
(Urabe et al., 1994). 
 
The hyperpigmentation that occurs in sun exposed regions of the skin through the 
accumulation of melanosomes can be shed through desquamation during the de-
tanning response (Natarajan et al., 2014a; 2014b). However, this is not specific to 
sun exposed regions but is a constitutive process that occurs in the entire skin. IFN-
γ (interferon-γ) is proposed to be responsible for acting as a transient molecular 
switch to downregulate expression of melanogenic genes and impede maturation of 
melanosomes without altering melanocyte biology. IFN-γ is a good candidate for this 
type of response as it can be produced by immune cells in the vicinity of injury from 
UV exposure. IFN-γ is also strongly associated with predisposition to 
melanomagenesis (Zaidi et al., 2011). Therefore, the de-tanning response can be 
harmful as well. 
 
UV radiation is firmly implicated in the three major types of skin cancer: basal cell 
carcinoma (BCC), squamous cell carcinoma (SCC) and melanoma. Keratinocyte-
derived BCCs are the most common, followed by SCCs (in a ratio of approximately 
4:1) (Stockfleth and Ulrich, 2009). Melanomas, which are derived from melanocytes, 
are less frequent but are the most dangerous due to their tendency to metastasize 
(de Gruijl and van der Leun, 2000). Fair skin, proximity to the equator, increasing 
altitude and increasing exposure (particularly 11am-1pm), are risk factors for UV-
mediated carcinogenesis (Diffey, 2002; Rigel, 2008). The risk of developing SCC 
increases with lifelong accumulated exposure to solar radiation (Vitasa et al., 1990). 
On the other hand, the risk of developing BCCs and cutaneous malignant melanoma 
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is more related to childhood and adolescence sun exposure and intermittent 
excessive exposure (sunburn) (Holman and Armstrong, 1984; Kricker et al., 1995). 
 
1.2.1.3 UVA 
UVA comprises 95% of solar UV radiation that reaches the earth surface. Its 
comparatively longer wavelengths enable UVA to penetrate deep into the epidermis 
and dermis. It is also 1000-fold more efficient than UVB at inducing pigment 
darkening in the epidermis (Clydesdale et al., 2001). Around 80% of UVA reaches 
the dermo-epidermal junction and around 10% can reach the hypodermis 
(Verschooten et al., 2006). On a sunny summer’s day, at midday in south-east 
England, skin is exposed to 10kJ/m2 of UVA in less than 10 minutes (Attard and 
Karran, 2012). This can result in DNA and protein damage. Extensive exposure to 
UVA can result in skin photoaging, necrosis of endothelial cells and damage to 
dermal blood vessels.  
 
UVA induces the production of ROS via interactions with endogenous cellular 
photosensitisers. UVA-induced ROS stimulate detoxification responses in 
keratinocytes and melanocytes. Activation of the mitogen activated protein kinase 
(MAPK) signalling pathways and subsequent formation of the AP-1 (activator protein-
1) transcription factor, increases scavenging enzyme levels (Natarajan et al., 2014a). 
UVA dependent activation of NF-κB and Nrf modulates inflammatory and antioxidant 
responses, respectively (Bickers and Athar, 2006). 
 
1.2.1.4 UVB 
UVB is less penetrative than UVA and mainly targets the epidermal basal cell layer 
of the skin (Svobodova et al., 2006). Around 70% of UVB is blocked by the stratum 
corneum (Svobodova et al., 2006). Proteins and DNA absorb maximally in the UVC 
and UVB regions of the spectrum, with absorbance maxima around 280nm and 260-
265nm, respectively. High energy UVB and UVC photons cause significant DNA 
damage. The two most common DNA modifications are cyclobutane-pyrimidine 
dimers (CPDs) and pyrimidine-pyrimidone (6,4) photoproducts (6,4 Py:Py) that occur 
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between adjacent pyrimidine residues (Brash, 1988). These photoproducts are 
removed by nucleotide excision repair (NER). Mutations at persistent dipyrimidine 
photoproducts are implicated in skin cancer development.  
 
UVB induces ROS and RNS. UVB can also modify endogenous photosensitisers and 
alter their absorption, which can make them more or less vulnerable to UVB or UVA 
radiation and 1O2 production. 1O2 is generated by irradiation of vitamin B molecules 
and unsaturated fatty acids can change their absorption spectra, increase 1O2 
production and can cause lipid peroxidation (Regensburger et al., 2012). This 
production of ROS and RNS also depletes skin antioxidants, which decreases the 
skin’s protection against free radical damage. 
 
1.2.1.5 Ageing 
UV stimulates cytokine release into the dermal microenvironment. This results in 
inflammation and the production of ROS. Recruited immune cells secrete elastases 
and proteases, which in turn upregulate matrix metalloproteases (MMPs). The result 
of this cascade is matrix degradation (Cavarra et al., 2002). Fibroblast AP-1 also 
increases MMP production that stimulates collagen breakdown. Concomitantly, 
TGF-! downregulates Type 1 procollagen expression. Collagen depletion following 
repeated UV injury can result in a visible solar scar (Helfrich et al., 2008; Schroeder 
and Krutmann, 2010). Oxidative stress can also induce higher elastin levels in dermal 
fibroblasts which may contribute to the elastolytic changes characteristic to 
photoaged dermis (Svobodova et al., 2006). Daily sub-erythemic UVA exposure for 
one month is sufficient to cause sufficient damage to dermal collagen and elastin to 
be apparent as photoaging (Matsumura and Ananthaswamy, 2004). 
 
1.2.1.6 Immunosuppression 
UVA (360-380nm) and UVB (around 300nm) can be immunosuppressive. This may 
exacerbate the development of skin cancers (Damian et al., 2011; Halliday et al., 
2011). It can also cause UV-induced expression of latent viruses (HSV and HPV) 
(Norval, 2006). The likely advantage of this immunosuppression is in preventing an 
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immune response against neo-antigens produced by UV-mediated modifications of 
skin cell molecules (de Gruijl and van der Leun, 2000). UVA and UVB can also act 
in a synergistic way, whereby UVA can sensitise cultured human cells to UVB 
mediated killing and enhance UVB mediated immune suppression (Kuchel et al., 
2002; Tyrrell et al., 1984). UV radiation is therefore particularly dangerous. It is a 
complete carcinogen that not only initiates carcinogenesis by mutation, but also acts 
as a cancer promoter by dampening the immune response (Bickers and Athar, 2006). 
 
1.2.1.7 Signalling 
Keratinocytes, fibroblasts, melanocytes and Langerhans cells express the aryl 
hydrocarbon receptor (AhR) - a cytosolic ligand-activated transcription factor (Abel 
and Haarmann-Stemmann, 2010). Tryptophan absorbs UVB and the resulting 
photoproduct, 6-formylindolo[3,2-b]carbazole (FICZ), activates AhR signalling. AhR-
activated signalling is a part of the UV stress response (Fritsche et al., 2007). Upon 
ligand binding, AhR translocates to the nucleus and activates the expression of 
genes containing a xenobiotic response element. These include genes involved in 
oxidative stress, skin tanning response, circadian rhythm and inflammation (Abel and 
Haarmann-Stemmann, 2010; Agostinis et al., 2007; Jux et al., 2011; Oberg et al., 
2005). FICZ is discussed further in Chapter 4. 
 
1.2.1.8 Visible light 
Visible wavelengths account for around 50% of the total solar spectrum and nearly 
20% of visible light can penetrate the hypodermis (Svobodova and Vostalova, 2010). 
Studies of ex vivo skin explants exposed to UVA, UVB and visible light have shown 
that the relative contribution to ROS generation was around 46%, 4% and 50% 
respectively (Zastrow et al., 2009). Visible light also induces inflammatory cytokines 
and MMPs. Cellular photosensitisers for visible light include β-carotene (464 nm), 
porphyrins (400–410 nm), bilirubin (420–490 nm), melanin, and its precursors (300–
700 nm) (Mahmoud et al., 2008). Visible light exposure also oxidises DNA bases but 
does not induce CPD or 6,4 Py:Py formation (Dupont et al., 2013). Overall, it is 
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responsible for <10% of the DNA damage caused by solar radiation (Dupont et al., 
2013). 
 
1.2.1.9 Infrared radiation 
Infrared radiation is split into ranges of infrared A (700–1400nm), B (1400–3000nm) 
and C (3000nm–1mm). Infrared B and C interact with thermosensitive receptor 
molecules in tissues. Vibrational energy from infrared B and C generates heat and 
provides the sensation of warmth in sunlight-exposed skin (Svobodova and 
Vostalova, 2010). Infrared A makes up 30% of infrared radiation and more than half 
of incident infrared A can reach the dermis and 10% the hypodermis (Svobodova 
and Vostalova, 2010). Infrared radiation can be a source of free radicals and 
generate ROS, albeit with around a quarter of the potency of UV (Darvin et al., 2011; 
Zastrow et al., 2009). Infrared is not strongly absorbed by melanin and other skin 
chromophores, including DNA. It does contribute to photoaging, may promote 
carcinogenesis and has a detrimental effect on mitochondrial integrity (Krutmann and 
Schroeder, 2009; Schroeder et al., 2008; Zastrow et al., 2009). The last point may 
be due to the disruption of the electron transport chain and ROS production following 
infrared absorption by cytochrome c oxidase (Krutmann and Schroeder, 2009). 
 
1.2.2 Types of photosensitising reactions 
UV photons can be directly absorbed by cellular chromophores such as DNA. The 
absorbed energy causes chemical reactions that result in damaged bases. In a 
second mechanism, endogenous or exogenous photosensitisers absorb UV photons 
and attain a singlet excited state. The excited photosensitiser can lose the energy as 
heat, emit fluorescence or undergo intersystem crossing to generate a relatively 
long-lived (micro/milliseconds compared to nanoseconds) triplet excited state. The 
triplet state allows efficient transfer of charge or energy to other molecules. Energy 
transfer to molecular oxygen generates 1O2 (Figure 1.5). 
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Figure 1.5: Photosensitisation reaction and production of singlet oxygen 
UVA exposure converting endogenous photosensitiser from singlet (S0) to excited singlet 
state (S1) to triplet state (T1) via intersystem crossing (ISC). The triplet state can transfer 
energy to triplet oxygen to form singlet oxygen, which exhibits luminescence at 1270nm. 
 
Cellular UV chromophores include nucleic acids, NADH/NADPH, carotenoids, 
melanin precursors, collagen crosslinks, ALE/AGE, as well as amino acid side chains 
and prosthetic groups such as flavins and heme (Lamore et al., 2010; Wondrak et 
al., 2003). 
 
Photosensitisers absorb UV radiation to generate an excited state, which can react 
with a substrate to produce a radical or radical ion in the sensitiser and substrate 
(Davies, 2003). The sensitiser can then undergo another reaction with O2 to form 
O2•-. This is known as Type I photosensitisation. Type II photosensitisation occurs 
when energy is transferred from an excited chromophore to ground state triplet 
oxygen to form 1O2. 1O2 can then result in protein oxidation. A less common reaction 
involves O2•- formation that can dismutate to H2O2, which can form •OH in the 
presence of iron and copper as mentioned previously (Svobodova et al., 2006). 
These two types of reactions are summarised in Figure 1.6. 
 
In general, cells are not exposed to UV light wavelengths below 290nm. Most amino 
acid side chains absorb at wavelengths around 230nm (Davies, 2003). In addition, 
the peptide bond (-C(=O)-NH-) displays weak absorbance at 210-220nm. The 
formation of 1O2 by protein absorption of solar UV is therefore limited. The aromatic 
amino acids (tryptophan in particular) do absorb longer wavelengths and are more 
effective in their ability to form 1O2.  
Endogenous 
photosensitiser
S1
S0
T1UVA 
ISC Tripletoxygen
Singlet
oxygen
1270 nm
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Figure 1.6: Photosensitiser mediated ROS formation 
Sen, photosensitiser; Sen*, excited photosensitiser, R, DNA base or aromatic amino 
acid; Me+, metal cation. Adapted from (Svobodova et al., 2006). 
 
1.2.3 Photosensitisers and their mechanism of photosensitisation 
Photosensitising drugs predispose individuals to phototoxic effects. A drug that is 
absorbed into the skin either locally or in the systemic circulation can absorb UVA 
and result in phototoxic reactions. 
 
Many commonly-prescribed drugs are photosensitizers. The work I describe in this 
thesis concerns the properties of three photosensitizers: 6-thioguanine (6-TG, a 
metabolite of the immunosuppressant azathioprine) and the antibiotics ciprofloxacin 
and ofloxacin (Figure 1.7). All three drugs are on the 2015 WHO Model List of 
Essential Medicines. Ciprofloxacin and the active enantiomer of ofloxacin 
(levofloxacin) are the most widely-prescribed fluoroquinolones in the United Kingdom 
(www.hscic.gov.uk). 
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UV R O2
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6-Thioguanine 
 
Ciprofloxacin 
 
Ofloxacin 
Figure 1.7: Chemical structures of azathioprine, 6-thioguanine, ciprofloxacin and 
ofloxacin 
 
1.2.3.1 6-Thioguanine 
Thiopurines 6-mercaptopurine (6-MP), 6-TG and azathioprine are 
immunosuppressants that are also used in the treatment of cancer and inflammatory 
disorders (Elion, 1989). More specifically, they are used in the treatment of acute 
leukaemia in children and are prescribed for colitis, psoriasis and rheumatoid arthritis 
(Attard and Karran, 2012). For many years, azathioprine was the standard 
immunosuppressant to prevent graft rejection in organ transplant patients. Although 
it has been to some degree superseded by a new generation of 
immunosuppressants, azathioprine remains the main immunosuppressant drug for 
many transplant patients. It is increasingly prescribed for chronic inflammatory 
disorders such as colitis. In fact, azathioprine prescriptions have been increasing 
steadily in the past five years in England, with 866,200 prescriptions dispensed in 
2015 (NHS Digital, Prescription Cost Analysis). Azathioprine, 6-MP and 6-TG are 
prodrugs that are metabolised into deoxythioGTP (Figure 1.8), which can be used as 
a substrate for DNA replication. Since thiopurines act systemically and are taken 
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continuously, the DNA of patients taking these drugs contains measurable levels of 
6-TG. 
 
 
Figure 1.8: Thiopurine metabolism (Karran, 2006) 
Following transporter mediated uptake, 6-MP and 6-TG are converted by hypoxanthine 
phosphoribosyltransferase (HPRT) to thioinosine and thioguanosine monophosphate, 
TIMP and TGMP, respectively. TIMP and TGMP are substrates for thiopurine 
methyltransferase (TPMT), which forms S-methylmercaptopurine (me6-MP, meTIMP) or 
S-methylthioguanine (me6-TG, meTGMP). This methylation prevents further metabolism 
and incorporation into DNA. meTIMP also inhibits de novo purine synthesis. While TGMP 
is converted directly to deoxynucleoside triphosphate by deoxynucleotide kinases 
followed by reductases, TIMP requires inosine monophosphate dehydrogenase (IMPD) 
to form thioxanthine monophosphate and is then converted to thioguanosine 
monophosphate (TGMP) by guanine monophosphate synthetase (GMPS). 
Deoxythioguanine-5’-triphosphate (dthioGTP) can be incorporated into DNA by 
replicative DNA polymerases. 
 
 
The therapeutic mechanism of thiopurines is still not fully elucidated. They are 
selectively toxic towards rapidly proliferating leukaemia cells and activated T cells 
involved in graft rejection. One suggested mechanism is via meTIMP-mediated 
inhibition of phosphoribosylpyrophosphate amidotransferase. This is the first enzyme 
in de novo purine biosynthesis and it has been proposed that proliferating cells are 
likely to be particularly susceptible to the resulting purine starvation (Bökkerink et al., 
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1993). meTIMP is not formed through 6-TG metabolism, however, and its toxicity 
clearly implies the existence of an alternative pathway, most likely related to its 
incorporation into DNA. 
 
Around 0.01-0.03% of the DNA guanine in circulating peripheral blood lymphocytes 
and skin of azathioprine patients is replaced by 6-TG (Cuffari et al., 2004). Unlike the 
oxygen atoms of canonical DNA bases, the thiol group of DNA 6-TG is susceptible 
to chemical methylation - most likely by the cellular methyl group donor S-
adenosylmethionine (Swann et al., 1996). Its methylation product (6-meTG) pairs 
with thymine during replication and the resulting base pairs are processed by the 
mismatch repair (MMR) system that corrects replication errors. This processing is 
incomplete and results in the formation of ssDNA breaks (SSB), cell cycle arrest and 
cell death (Karran, 2001; Swann et al., 1996; Yan et al., 2003). 6-TG cytotoxicity is 
partly MMR-independent, as MMR-deficient cells are sensitive to high 6-TG 
concentrations (Karran et al., 2003). 
 
Organ transplant patients have high rates of malignancy. Cancer is the reported 
cause of death in 25% of kidney transplant patients 10 years after transplantation 
(Bustami et al., 2004). Although immunosuppression probably plays a part in this 
susceptibility, comparison with cancer incidence among HIV infected individuals 
suggests that additional factor(s) influence malignancy in transplant patients (Grulich 
et al., 2007). Whereas cancers with a known viral aetiology are significantly 
overrepresented in both HIV positive and transplant patients, skin cancer is by far 
the most common malignancy among the latter but not the former group. The 
frequency of SCCs in organ transplant patients is around 100-fold higher than the 
population average (Euvrard et al., 2003). SCCs account for 90% of the skin cancers 
in these patients, reversing the normal BCC:SCC ratio. This is not specific to 
thiopurine use in organ transplant patients. The ongoing and past use of thiopurines 
for the treatment of inflammatory bowel disease is associated with an increased risk 
of developing non-melanoma skin cancer even prior to the age of 50 years (Long et 
al., 2010; Peyrin-Biroulet et al., 2011; Setshedi et al., 2012). 
 
Sun exposure is clearly a factor in transplant associated skin cancer. Tumours 
develop almost exclusively on sun-exposed regions of the body. They are more 
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frequent in geographical regions with the most sunshine.  In Australia, the cumulative 
risk of non-melanoma skin cancer 10 years after receiving a transplant is 50%, 
compared to 10% in the Netherlands (Hartevelt et al., 1990; Ramsay et al., 2002). 
Facial tumours in British and French organ transplant patients occur preferentially on 
the right and left sides of the face, respectively, consistent with glass filtered UV 
exposure during driving (predominantly UVA as UVB is blocked by glass) (Atkar et 
al., 2013). The likely involvement of UVA in the effects of azathioprine is 
strengthened by the observation that azathioprine patients exhibit increased 
sensitivity to erythema and photochemical damage when exposed to UVA but not 
UVB (Hofbauer et al., 2012; Perrett et al., 2008).  
 
Canonical DNA bases absorb maximally in the UVC region of the spectrum. The 
substitution of the guanine oxygen atom with sulphur in 6-TG shifts its absorption 
maximum to the UVA wavelength of 340nm (O'Donovan et al., 2005). DNA 6-TG is 
a Type I and Type II UVA photosensitiser and a source of 1O2 (Hemmens and Moore, 
1986). UVA and DNA 6-TG have synergistic toxicity and mutagenicity (Attard and 
Karran, 2012). Therefore, UVA activation of normally harmless levels of skin DNA 6-
TG is potentially dangerous. 
 
Several consequences of the synergism between DNA and UVA have been reported. 
DNA 6-TG has a low oxidation potential and is readily oxidised to guanine sulfinate 
(GSO2) and guanine sulfonate (GSO3). These bulky DNA lesions remain in DNA for 
over 24 hours after irradiation (Karran, 2006). They block DNA and RNA 
polymerases and require an error-prone DNA polymerase for bypass, entailing a 
potential risk of mutation (Brem et al., 2009; Zhang et al., 2007). DNA 6-TG and UVA-
mediated replication and transcription inhibition triggers a cell cycle checkpoint 
response through ATR (ataxia telangiectasia and Rad3 related) and Chk1 
(checkpoint kinase 1) phosphorylation (Brem et al., 2010; 2009; Zhang et al., 2007). 
DNA 6-TG and UVA also induces collateral DNA damage in the form of DNA 8-oxo-
dG (8-oxo-7,8-dihydro-2‘-deoxyguanosine), some of which is derived from the 
oxidized dNTP pool (Cooke et al., 2008).  
 
UVA activation of DNA 6-TG increases the vulnerability of DNA near the replication 
fork to breakage. Cells deficient in homologous recombination (HR), the pathway that 
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repairs DNA double strand breaks (DSB) during S phase, are hypersensitive to UVA-
activated DNA 6-TG. Consistent with a particular S phase sensitivity, cells with a 
deficiency in non-homologous end joining (NHEJ) which repairs DSBs outside of S 
phase are not hypersensitive to UVA-activated DNA 6-TG (Brem et al., 2010). 
 
6-TG also causes interstrand crosslinks (ICL) between DNA 6-TG and canonical 
DNA bases in a UVA-dependent and -independent manner (Brem and Karran, 2012). 
This reaction is the consequence of 6-TG mediated antioxidant depletion and the 
presence of DNA embedded 6-TG that serves as a target for ROS-mediated 
crosslinking (Brem and Karran, 2012). Cells defective in the Fanconi anaemia (FA) 
pathway (see Section 1.2.3.5), which processes ICLs by HR, are sensitive to both 6-
TG and to UVA-activated DNA 6-TG.  
 
UVA-activated DNA 6-TG causes protein damage. 1O2 mainly targets tryptophan, 
histidine, methionine, cysteine and tyrosine in vitro, and carbonyls are formed 
through oxidation of aromatic amino acids (Oleinick et al., 2009; Silvester et al., 
1998). The subunits of the homotrimeric PCNA (proliferating cell nuclear antigen) 
complex become crosslinked via a His-Lys covalent bond in cells treated with 6-TG 
and UVA (Montaner et al., 2007). 6-TG mediated damage impairs proteins from 
various DNA repair pathways, including non-homologous end joining (NHEJ) by 
protein-protein crosslinking of Ku70 and Ku 80, base excision repair (BER) of 8-oxo-
G by oxidation of OGG1 and MYH, and nucleotide excision repair (NER) (Gueranger 
et al., 2014). Ku was originally identified as an oxidised protein in a screen for protein 
carbonyls and Ku80 was shown to contain sulfenic acid, suggesting that the same 
protein can be oxidised in several ways (Leonard et al., 2009). 
 
1.2.3.2 Ciprofloxacin 
The first developed quinolone antibiotic, nalidixic acid, did not have a wide clinical 
use. In contrast, the fluoroquinolones that have a fluorine in the 6-position, are the 
most widely prescribed family of antibiotics. They have an improved half-life, 
absorption and antibacterial efficacy (Domagala, 1994). Fluoroquinolones prevent 
bacterial growth by inhibiting DNA gyrase and topoisomerase IV, which have crucial 
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roles in replication (Higgins et al., 2003; Maxwell, 1992). UVA and UVB 
photosensitising activity is a side effect of several fluoroquinolones and their 
photoactivation generates ROS (Hooper and Wolfson, 1985). 
 
Absorbance of UVA and UVB radiation by ciprofloxacin results in the production of 
1O2 along with O2•-, H2O2 and •OH. In the presence of DNA these cause SSB and 
cyclobutadithymine (T<>T) CPDs through Type I and Type II photosensitised 
reactions (Agrawal et al., 2007; Lhiaubet-Vallet et al., 2007; Spratt et al., 1999). 
Cultured rat epithelial cells exhibit a significant increase in DNA 8-oxo-dG when 
treated with lomefloxacin or ciprofloxacin in combination with UVA (Rosen et al., 
1997). Production of DNA 8-oxo-dG and SSB by UVA-activated ciprofloxacin is 
suppressed by NaN3 (1O2 scavenger) and N-tert-butyl-α-phenylnitrone (BPN, radical 
scavenger) and is amplified by D2O, implicating 1O2 and radicals in their formation 
(Spratt et al., 1999).  
 
1.2.3.3 Ofloxacin 
The fluoroquinolone ofloxacin is a racemic mixture of 50% levofloxacin (the 
biologically active component) and the R-enantiomer dextrofloxacin. The usage of 
ofloxacin is increasing worldwide for the treatment of urinary tract infections (Dwivedi 
et al., 2014). Ofloxacin produces 1O2 , O2•- and •OH when exposed to UVA, UVB or 
sunlight (Ray et al., 2006; Viola et al., 2004). Cellular damage caused by UVA-
activated ofloxacin includes oxidation of pyrimidine and purine bases through both 
Type I and Type II mechanisms (Dwivedi et al., 2014; Lhiaubet-Vallet et al., 2003). 
 
The S-stereoisomer of ofloxacin, levofloxacin, is more damaging to cellular 
macromolecules than ofloxacin (Lhiaubet-Vallet et al., 2003). It decreases HaCaT 
cell viability, induces micronuclei and lipid peroxidation and causes G2/M cell cycle 
arrest (Dwivedi et al., 2012). UVA-activated ofloxacin can destroy the actin filament 
network and cause the release of cytochrome c, caspase-3 activation and apoptosis 
(Ouédraogo et al., 1999). These effects are quenched by antioxidants DABCO (1,4-
diazabicyclo[2.2.2]octane), NaN3, D-mannitol and N-acetyl cysteine (NAC) (Dwivedi 
et al., 2012).  
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Ofloxacin forms T<>T CPDs much less efficiently than ciprofloxacin. Neither induces 
6,4 Py:Pys (Peacock et al., 2014; Sauvaigo et al., 2001). Consistent with this 
difference, UVA-activated ciprofloxacin blocks replication more efficiently than 
ofloxacin (Peacock et al., 2014). Both treatments cause extensive protein 
carbonylation, PCNA protein-protein crosslinking and inhibit NER (Peacock et al., 
2014). 
 
UVA-activated ciprofloxacin and ofloxacin induce benign skin tumours and a few 
cases of SCCs and solar keratosis in Skh-1 hairless mice (Mäkinen et al., 1997). 
UVA-activated ciprofloxacin depletes antigen presenting Langerhans cells and 
suppresses local but not systemic immunity in mice (Sun et al., 2001). In the 
treatment of ocular infections, ofloxacin and ciprofloxacin cause phototoxic reactions 
resulting in decreased viability of lens epithelial cells and photopolymerisation of α-
crystallin (Zhao et al., 2010). 
 
Photodegradation also compromises the antibiotic efficacy of ofloxacin and reduces 
its ability to bind DNA gyrase (Singh et al., 2016). Although short term treatment with 
fluoroquinolones is unlikely to significantly increase skin cancer risk, their long term 
prophylactic use by immunosuppressed organ transplant patients may be more of a 
cause for concern (Green et al., 2011). 
 
1.3 DNA damage and repair 
Since the ~1013 cells in the human body sustain tens of thousands of DNA lesions of 
various types every day, they have evolved highly coordinated strategies to cope 
with DNA damage. These are known collectively as the DNA damage response 
(DDR) (Jackson and Bartek, 2009). DDR can trigger DNA repair, cell cycle arrest or 
cell death pathways. The genetic conditions xeroderma pigmentosum (XP), ataxia-
telangiectasia and FA are all defective in different aspects of DDR. 
 
Hydrolytic reactions are a source of endogenous DNA damage. Spontaneous 
hydrolysis of the N-glycosyl bond between DNA bases and deoxyribose, generates 
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an AP (apurinic/apyrimidinic) site (Lindahl, 1993). Around 10,000 AP sites are 
created per cell per day (Lindahl and Nyberg, 1972). AP sites are themselves 
vulnerable to hydrolysis, producing DNA strand breaks (Sugiyama et al., 1994). 
 
Deamination of exocyclic amino groups is another source of spontaneous DNA base 
damage. Deamination of cytosine to uracil occurs around 100-500 times per cell per 
day (Krokan et al., 2002). Deamination of adenine and guanine to hypoxanthine and 
xanthine, respectively, occurs at slower rates (Kow, 2002). 
 
DNA modification by endogenous alkylating agents targets the O and N atoms of 
nucleobases. These reactions can be stimulated by methyl donor S-
adenosylmethionine, nitrosated amines and methyl radicals formed through lipid 
peroxidation (Dexheimer, 2013). 
 
Mismatches, insertions and deletions are introduced by polymerase errors during 
DNA replication, at a rate ranging from 10-4 to 10-6 (McCulloch and Kunkel, 2008). 
These misincorporations are normally removed by their 3’-5’ exonuclease activity, 
lowering the error rate to 10-8, which means one mutation for 100 million base pairs 
replicated without the involvement of repair enzymes. Other types of endogenous 
DNA damage include incorrect incorporation of non-canonical nucleosides such as 
8-oxo-dG and dU, erroneous DNA repair and abortive topoisomerase activity 
resulting in a covalent crosslink with DNA (Bridges, 2005; McClendon and Osheroff, 
2007; Pourquier and Pommier, 2001; Shimizu et al., 2003). 
 
Exogenous sources of DNA damage include UV radiation as well as ionising 
radiation from natural (cosmic and gamma radiation) and artificial sources (X-ray and 
radiotherapy), which can result in DSBs and ROS mediated DNA lesions 
(Dexheimer, 2013). 
 
1.3.1 UVB mediated DNA damage 
Nucleic acids absorb UVB. In skin, aromatic amino acids in the stratum corneum 
absorb a significant amount of UVB to protect DNA in living skin cells (Hussein, 2005). 
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UVB induces CPDs and 6,4 Py:Pys (Figure 1.9), which account for the vast majority 
of UVB mediated photoproducts in double-stranded DNA (dsDNA). All four possible 
CPDs, T<>T, C<>T, T<>C and C<>C have been identified in irradiated naked and 
cellular DNA. The cyclobutadithymine (T<>T) is the most common UVB-induced 
photoproduct (Cadet et al., 2005).  
 
 
Figure 1.9: UVB mediated DNA damage (Svobodova et al., 2006) 
Formation of (A) cyclobutane pyrimidine dimers and (B) 6,4 pyrimidine-pyrimidone 
photoproducts upon UVB absorption. 
 
 
For UVB, the ratio between CPDs and 6,4 Py:Pys is around 4:1 (Douki and Cadet, 
2001; Perdiz et al., 2000). In mammalian cells and explanted human skin the T<>T 
CPD to 6,4 T:T ratio is 10:1 (Douki and Cadet, 2001; Douki et al., 2003b; Mouret et 
al., 2006). The yield of T<>C CPDs is comparable to that of 6,4 T:C (1:1.1).  
 
Failure to remove these DNA lesions can result in mutation. Because 6,4 Py:Pys 
induce a more severe structural distortion, they are repaired more efficiently than 
CPDs (see section 1.3.3.4). As CPD repair is less efficient, these lesions are likely 
to be the main contributor to mutations in human cells. Mutation analysis indicates 
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that T<>C and C<>C CPDs are the most mutagenic, and CàT transitions in 
bipyrimidine sites and CCàTT tandem mutations are the predominant mutations in 
skin tumours (Ichihashi et al., 2009; Ikehata et al., 2003; Reid and Loeb, 1993; 
Skinner and Turker, 2008). 
 
UV also causes mutations in mitochondrial DNA, including the 4977bp common 
deletion and/or 3895bp deletion. Mitochondrial DNA is particularly susceptible to 
damage owing to the absence of histones and only minimal protection from DNA 
repair (Reimann et al., 2008). 
 
1.3.2 UVA mediated DNA damage 
UVA induces CPDs in cellular DNA (Tyrrell, 1973). Importantly, it is also a source of 
ROS including 1O2. Guanine has the lowest ionisation potential of the canonical DNA 
bases and the most susceptible to both Type I and Type II oxidation, followed by 
adenine and pyrimidines (Svobodova et al., 2006). 
 
Following a type I reaction, in which an excited chromophore carries out a one 
electron oxidation of DNA, a radical cation intermediate is generated, which can 
undergo hydration or deprotonation (Svobodova et al., 2006). Guanine is the main 
target of this type of oxidation. Hydration of a guanine radical cation results in a 
radical intermediate, which under reducing conditions forms 2,6-diamino-4-hydroxy-
5-formamidoguanine (FapyGuanine) through a ring opening reaction. Under 
oxidising conditions or in the presence of molecular oxygen, it forms 8-oxo-7,8-
dihydroguanine (8-oxo-G) or 8-oxo-dG as seen in Figure 1.10 (Svobodova et al., 
2006). UVB can also result in the formation of 8-oxo-dG, but the yield of this product 
is 2-3 orders of magnitude lower than the amount of CPDs or 6,4 Py:Pys generated 
(Kielbassa et al., 1997). 
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Figure 1.10: DNA oxidation products (Malayappan et al., 2007) 
Oxidised guanine forming 8-oxo-7,8-dihydroguanine (8-oxo-G), 2,6-diamino-4-hydroxy-
5-formamidoguanine (FapyGuanine) and 8-oxo-7,8-dihydro-2’deoxyguanosine (8-oxo-
dG). 
 
1O2 has a strong affinity for molecules with double bonds. Following Type II reactions, 
1O2 generates endoperoxides through a cycloaddition reaction of the imidazole ring. 
The 8-hydroxyperoxyguanine produced by this reaction decomposes to 8-oxo-dG 
(Pattison and Davies, 2006; Svobodova et al., 2006). Nucleobase damage by UVA 
occurs more frequently than the formation of SSB and DPCs (Melnikova and 
Ananthaswamy, 2005). On its own 1O2 is not able to cleave the DNA backbone. 
However, 8-oxo-dG is 100-fold more reactive with 1O2 than guanosine and its 
secondary oxidation can promote the formation of SSBs as well as UVA mediated 
formation of •OH (Cadet et al., 2012). UVA-mediated •OH formation is likely to be 
responsible for around a quarter of 8-oxo-dG produced, subject to the wavelength of 
incident UVA and cell type (Svobodova et al., 2006). 
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Surprisingly, UVA irradiation of human skin induces more CPDs than 8-oxo-dG (9:1 
ratio) (Courdavault et al., 2004; Douki et al., 2003a; Mouret et al., 2006). This ratio 
depends on the cell type. Melanocytes incur higher levels of oxidative stress, which 
reduces the ratio to 1.4:1 (Ikehata et al., 2008; Kappes et al., 2006). Studies have 
shown that ketone compounds in UVA irradiated cells cause DNA triplet transfer 
photosensitisation, and result in the formation of a majority of CPDs (90%) as T<>T 
followed by T<>C and C<>T (Douki et al., 2003b; Sauvaigo et al., 2001). 
 
1.3.3 DNA repair pathways 
1.3.3.1 Base excision repair (BER) 
BER is initiated by lesion-specific DNA glycosylases. Enzymes targeting uracil in ss 
and dsDNA, alkylated purines and oxidised, ring-fragmented or saturated 
pyrimidines have been characterized (Jacobs and Schär, 2012).  
 
DNA glycosylases (Table 1.1) flip the target base to an extra-helical position to 
facilitate cleavage of the N-glycosyl bond, which generates an AP site (Huffman et 
al., 2005; Lindahl, 1974). Monofunctional DNA glycosylases have glycosylase 
activity only (e.g., UNG) and generate an AP-site. AP sites created by 
monofunctional glycosylases can be processed by AP endonuclease 1 (APE1), 
which hydrolyses the phosphodiester backbone 5’ of the AP site generating a SSB 
with a 3’-OH and 5’-deoxyribose phosphate (Hitomi et al., 2007). All uracil removing 
DNA glycosylases are monofunctional, while most glycosylases specialised in the 
removal of oxidised bases (eg. NTHL1, NEIL1-3) are bifunctional (Krokan and 
Bjørås, 2013). Bifunctional glycosylases have both glycosylase and lyase activity, 
which enables them to cleave the DNA strand (Jacobs and Schär, 2012). Their 
cleavage product, however, differs from that of APE1. 
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Table 1.1: Mammalian DNA glycosylases and their substrates  
U, uracil; A, adenine; T, thymine; C, cytosine; G, guanine; ss, single stranded; ds, double 
stranded; hm, hydroxymethyl; FU, fluorouracil; ε, etheno; fC, formylcytosine; 5-caC, 5-
carboxylcytosine; 8-oxo-G, 8-oxo-7,8-dihydroguanine; Tg, thymine glycol; Fapy, 2,6-
diamino-4-hydroxy-5-N-methylformamidopyrimidine; me, methyl; h, hydroxyl. Adapted 
from (Jacobs and Schär, 2012). 
 
Type of base 
lesion 
Name Physiological 
substrates 
Mono or Bi 
functional 
Uracil in 
ssDNA and 
dsDNA 
Uracil-N glycosylase (UNG) U, 5-FU (ss and ds 
DNA) 
Mono 
Single-strand-specific 
monofunctional uracil DNA 
glycosylase 1 (SMUG1) 
U, 5-hmU, 5-FU (ss and 
ds DNA) 
Mono 
Pyrimidine 
derivatives in 
mismatches 
Methyl-binding domain 
glycosylase 4 (MBD4) 
T, U, 5-FU, εC, opposite 
G (dsDNA) 
Mono 
Thymine DNA glycosylase (TDG) T, U, 5-FU, εC, 5-hmU, 
5-fC, 5-caC, opposite G 
(dsDNA) 
Mono 
Oxidative 
base damage 
8-oxo-G DNA glycosylase 1 
(OGG1) 
8-oxo-G, Fapy, opposite 
C (dsDNA) 
Bi 
MutY homolog DNA glycosylase 
(MYH) 
A opposite 8-oxo-G, C 
or G, 2-hA opposite G 
(dsDNA) 
Mono 
Alkylated 
purines 
Methylpurine glycosylase (MPG) 3-meA, 7-meG, 3-meG, 
hypoxanthine, εA (ss 
and dsDNA) 
Mono 
Oxidized, 
ring-
fragmented 
or -saturated 
pyrimidines 
Endonuclease III-like 1 (NTHL1) Tg, FapyG, 5-hC, 5-hU 
(dsDNA) 
Bi 
Endonuclease VIII-like 
glycosylase 1 (NEIL1) 
Tg, FapyG, FapyA, 8-
oxo-G, 5-hU, 5-hC (ss 
and dsDNA) 
Bi 
Endonuclease VIII-like 
glycosylase 2 (NEIL2) 
As NTHL1 and NEIL1 Bi 
Endonuclease VIII-like 
glycosylase 3 (NEIL3) 
FapyG, FapyA (prefers 
ssDNA) 
Bi 
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The ends that are generated need to be modified to 3’-OH and 5’-phosphate to permit 
ligation to complete repair. Removal of damaged bases by a bifunctional DNA 
glycosylase results in an unsaturated hydroxyaldehyde at the 3’ end and a 
5’phosphate, or 3’ phosphate and 5’ phosphate ends (Svilar et al., 2011). The 3’ end 
of the former is processed by APE1 to form a 3’ OH end, and the 3’ end of the latter 
is processed by polynucleotide kinase/phosphatase (PNKP), which is a bifunctional 
enzyme with 5’ kinase and 3’ phosphatase activities. 
 
Two BER pathways are characterized as short and long patch. In short patch BER 
(80-90% of all BER), AP site repair involves replacement of a single nucleotide by 
DNA polymerase β, which also removes the 5’-deoxyribose phosphate generated by 
APE1 (Beard and Wilson, 2006). DNA ligase I or DNA ligase III and XRCC1 ligate 
the DNA ends to complete repair. Long patch BER is initiated when the terminus 
created by APE1 or lyase cannot be removed by DNA polymerase β. In this case 
elongation from the 3’-OH by DNA polymerase/PCNA displaces the 5’-blocking 
lesion in a flap structure. The flap is then removed by FEN1 (flap endonuclease-1) 
and the nick is sealed by DNA ligase I.   
 
DNA glycosylase OGG1 (8-oxo-G DNA glycosylase I) removes miscoding 8-oxo-G 
from dsDNA (Jacobs and Schär, 2012). MYH (MutY homolog DNA glycosylase) is 
unique in that it works during replication to remove adenine bases misincorporated 
opposite a template 8-oxo-dG. The removal of adenine and replacement with 
cytosine prevents the GàT transversion mutations that are the hallmark of oxidation 
damage to DNA (Besaratinia et al., 2004). In addition, formation of 8-oxo-G in the 
nucleotide pool results in hydrolysis by MTH to avoid the misincorporation of oxidised 
guanine opposite adenine in the template strand. 
 
1.3.3.2 Mismatch repair (MMR) 
MMR prevents mutation by correcting mispairs that have evaded proofreading by 
replicative polymerases. By removing the small loops that occur through polymerase 
slippage during replication of repetitive sequences, MMR also prevents 
insertion/deletion mutations (Kroutil et al., 1996). 
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MMR has three stages: recognition of mismatches, excision of the newly-synthesized 
strand containing the error and a resynthesis step in which the gap left by excision 
is filled (reviewed in (Kunkel and Erie, 2015)). Human mismatch recognition is 
initiated by MutSα, a heterodimer of the hMSH2 and hMSH6 proteins that recognises 
single base mismatches (eg. T:G) and small loops of one or two nucleotides. MutSβ, 
a hMSH2 and hMSH3 heterodimer, recognises larger insertion/deletion loops and 
one or two base insertion/deletion mismatches. In the majority (90%) of cases, 
excision is initiated by MutLα, (hMLH1 and hPMS2). MutSα binds the mismatch and 
its ATP activated state interacts with the MutLα heterodimer (Friedhoff et al., 2016). 
PCNA is then loaded by replication factor C (RFC), which activates the PCNA and 
ATP-dependent endonuclease activity of MutLα and allows it to generate a single-
stranded incision (Kadyrov et al., 2006). Strand incision allows access of 
exonuclease 1 (Exo1) that degrades the error-containing strand in a 5’ to 3’ direction 
(Tran et al., 2004). The gap that this creates is filled by DNA polymerase δ, PCNA 
and replication protein A (RPA), followed by DNA ligase I mediated ligation. 
 
1.3.3.3 Double-strand break repair 
DSBs are particularly hazardous and a single unrepaired DSB can result in cell death 
(Jeggo and Löbrich, 2007). In human cells, DSBs are repaired by homologous 
recombination (HR) and non-homologous end joining (NHEJ). HR uses the genetic 
information from the undamaged sister chromatid as a template for repair and is 
generally error-free. NHEJ ligates the two ends of the DSB in a way that requires 
limited or no sequence homology, making it a more error-prone mechanism (Raynard 
et al., 2008). NHEJ is utilised in all phases of the cell cycle, while HR takes place in 
late S and G2 phases. A very brief overview of the two processes is outlined below 
and in Figure 1.11. 
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Figure 1.11: Repair of double strand breaks 
Double strand breaks (DSBs) are repaired through homologous recombination (HR) and 
non-homologous end joining (NHEJ) in mammalian cells. From the formation of the 
displacement (D-loop) the HR pathway branches in two, synthesis-dependent strand 
annealing (SDSA) and double strand break repair (DSBR). A non-crossover outcome 
results from SDSA without a change in the template DNA, while DSBR can also result in 
a crossover.  
 
Homologous recombination follows three stages: presynapsis, synapsis and 
postsynapsis. The heterotrimeric MRN complex (Mre11 3’ to 5’ endo/exonuclease-
Rad50-Nbs1), along with CtIP, instigate a 5’-end resection to generate 3’-overhangs 
on both sides of the DSB. This also requires the collective involvement of the BLM 
helicase and Exo1 exonuclease. The exposed ssDNA generated by the resection is 
protected by ssDNA binding protein RPA. The Rad51 recombinase then replaces 
RPA in a reaction that activates ATM and histone γH2A.X phosphorylation (Lukas et 
al., 2011). This nucleoprotein filament initiates a homology search of the sister 
chromatid to generate a template for repair. The DNA is then synthesised by DNA 
polymerase η from the 3’ end of the invading strand (McIlwraith et al., 2005). The 
nicks are ligated by DNA ligase I, resulting in the formation of a Holliday junction. 
This structure can be resolved through dissolution by BLM-TopIIIα, GEN1/Yen1 or 
Slx1/Slx4 mediated symmetrical cleavage or endonuclease Mus81/Eme1 mediated 
asymmetrical cleavage (Ip et al., 2008; Mimitou and Symington, 2009; Seki et al., 
2006). 
 
DSB
NHEJ
DSB recognition and processing
Ligation
HR
SDSA
DNA resection
Formation of D-loop and invasion
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Strand displacement
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Second end capture and
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Binding of the Ku70/Ku80 heterodimer to both termini of a DSB instigates recruitment 
of DNA-PKcs, the catalytic subunit of DNA-dependent protein kinase, to initiate 
NHEJ (Walker et al., 2001). Autophosphorylation of the DNA end-associated DNA-
PKcs tethers the broken ends to facilitate ligation (DeFazio et al., 2002). DSB 
frequently require modification before ligation by DNA ligase IV/XRCC4/XLF 
(Ahnesorg et al., 2006). Overhanging terminal ssDNA can be converted to dsDNA 
by DNA polymerase (Pol μ and Pol λ) or removed through resection by Artemis 
(Lieber et al., 2008). Artemis is specific to NHEJ and has both a DNA-PK 
independent 5’ to 3’ exonuclease activity and a DNA-PK phosphorylation dependent 
endonuclease activity (Jeggo and O'Neill, 2002). BER enzymes APE1, Tdp1 and 
PNKP, as well as exonucleases Exo1 and WRN may also participate in end 
modification process (Chappell et al., 2002; Perry et al., 2006). Since end processing 
can result in a gain or loss or mispairing of nucleotides, NHEJ is a more error-prone 
process than HR.  
 
1.3.3.4 Nucleotide excision repair (NER) 
NER occurs through two partly-overlapping pathways. Global genome NER (GG-
NER) is initiated by the interaction between a DNA repair protein complex and a 
helix-distorting DNA lesion. Transcription coupled NER (TC-NER) is triggered by 
RNA polymerase II stalling at a lesion on the template strand during transcription. 
Both pathways are outlined in Figure 1.12. 
 
Lesion recognition in GG-NER is performed by a complex of the xeroderma 
pigmentosum complementation group C protein (XPC) with the RAD23B and centrin 
2 (CETN2) proteins (Nishi et al., 2005). The XPC/RAD23B/CETN2 complex 
recognizes a wide spectrum of DNA lesions. Studies in fission yeast led to the 
development of a model in which XPC binds the ssDNA exposed by disrupted base 
pairing through inserting its C-terminal double β-hairpin between the dsDNA and 
ssDNA (Min and Pavletich, 2007). 
 
By comparison to other lesions, including 6,4 Py:PYs, CPDs are surprisingly poor 
substrates for recognition by XPC/RAD23B/CETN2 (Reardon and Sancar, 2003). 
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Their recognition is facilitated by the UV-DDB (ultraviolet radiation-DNA damage-
binding protein) complex. This comprises the DDB1 and DDB2 proteins which bind 
UV-induced DNA lesions. UV-DDB binds the CRL complex (cullin 4A (CUL4A), 
regulator of cullins 1 (ROC1) E3 ubiquitin ligase) and DDB1 links the CRL complex 
and DDB2 (Marteijn et al., 2014). It is generally thought that DDB2-generated kinks 
in the DNA to allow XPC to bind the exposed ssDNA lesion (Scrima et al., 2008).  
 
Following XPC binding, TFIIH (transcription initiation factor IIH) complex is recruited 
to the lesion. TFIIH can switch between its roles in transcription and repair by 
dissociating from the trimeric CAK transcription subcomplex (CDK-activating kinase) 
upon binding to XPC (Coin et al., 2008). Two of the ten TFIIH subunits are helicases 
encoded by the XPB and XPD genes (also ERCC3 and ERCC2, respectively) with 
complementary polarities.  The ATPase activity of XPB is important for the 
DNA/TFIIH association. The 5’ to 3’ helicase activity of XPD is essential for NER 
(Coin et al., 2007). The XPD helicase detects helicase-blocking damage and verifies 
the presence of lesions. It contains an Fe-S cluster that may be important in this 
verification process (Mathieu et al., 2013; Sugasawa et al., 2009). The XPA protein, 
not a part of TFIIH, is also involved in lesion verification (Camenisch et al., 2006). 
 
Lesion excision is carried out by structure specific endonucleases XPF-ERCC1 and 
XPG (ERCC5), which cleave DNA 5’ and 3’ of the damaged site, respectively 
(Fagbemi et al., 2011). XPA interacts with nearly all NER proteins and is particularly 
important in recruiting XPF-ERCC1 (Tsodikov et al., 2007). RPA, an interacting 
partner of XPA, protects ssDNA from endonucleases and assists in the correct 
orientation of XPF-ERCC1 and XPG (de Laat et al., 1998). XPG needs to be present 
to allow XPF-ERCC1 mediated 5’ incision. Once this 5’ incision takes place, DNA 
synthesis can begin. The synchronisation of excision/resynthesis by RPA and XPG 
counteracts the accumulation of 22-35 nucleotide ssDNA gaps and onset of DNA 
damage signalling (Mocquet et al., 2008; Overmeer et al., 2011). The gap is filled by 
the coordinated action of PCNA and RFC, together with DNA Pol ε and DNA ligase 
I in replicating cells or DNA Pol κ/δ and XRCC1–DNA ligase III in non-replicating 
cells (Moser et al., 2007; Ogi et al., 2010). 
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UV induced lesions during S phase causing stalled replication forks and long 
stretches of RPA bound ssDNA result in ATRIP (ATR-interacting protein), TOPBP1 
(topoisomerase 2-binding protein 1) and 9-1-1 complex binding to RPA (Bartek and 
Lukas, 2007). This results in ATR activation and γH2A.X phosphorylation. NER 
intermediates with a single bound RPA heterotrimer may not be sufficient to generate 
ATR signalling (MacDougall et al., 2007). When there is a shortage of NER factors 
during high damage load, when two NER reactions collide, when repair synthesis is 
inhibited or when 3’ incision does not take place, Exo1 (5’-3’) can be recruited instead 
of XPG and generate longer regions of ssDNA (Sertic et al., 2011). This can form a 
ssDNA gap of up to 1kb that is covered by RPA, which can cause a reaction similar 
to DSB signalling and recruit ATRIP/ATR and phosphorylate γH2A.X. 
 
Despite the help provided by UV-DDB, the removal of CPDs is still relatively 
inefficient. Persistent CPDs interfere with replication and transcription. Stalled 
replication forks can result in DSBs and activate cell cycle checkpoints. During 
replication, alternative DNA polymerases or template switching can be used for 
lesion bypass. To date RNA polymerases with the ability to carry out transcriptional 
lesion bypass of helix distorting adducts have not been identified.  
 
The TC-NER pathway removes transcription-blocking DNA lesions and is initiated by 
stalled RNA polymerase II. Transcription stalling induces recruitment of Cockayne 
syndrome proteins CSA (Cockayne syndrome WD repeat protein A) and CSB 
(Cockayne syndrome protein B). The lesion is made available for repair by RNA 
polymerase II backtracking. Additional factors involved in TC-NER initiation include: 
UV-stimulated scaffold protein A (UVSSA), ubiquitin-specific-processing protease 7 
(USP7), XPA-binding protein 2 (XAB2) and high mobility group nucleosome-binding 
domain-containing protein 1 (HMGN1) (Marteijn et al., 2014). Cockayne syndrome is 
a severe neurodevelopmental disorder with symptoms that include photosensitivity, 
growth abnormalities, premature aging and likely death within the first decade of life 
(Brooks, 2013). Around 80% of Cockayne syndrome cases occur due to mutations 
in CSB, which not only has a role in TC-NER but also BER, mitochondrial function 
and transcriptional regulation (Brooks, 2013). It has been proposed that the 
neurodevelopmental problems occur as a result of imperfect gene regulation as 
opposed to DNA repair defects (reviewed in (Brooks, 2013), (Wang et al., 2016)). 
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CSB also has an important role in regulating transcriptional response to UV 
irradiation (Proietti-De-Santis et al., 2006). 
 
In the context of chromatin, DNA needs to be made accessible to NER repair factors 
through histone tail modifications and histones need to be shifted along DNA by ATP-
dependent chromatin remodelling enzymes (Schärer, 2013). This chromatin 
rearrangement during NER led to the proposal of the “access-repair-restore” model 
(Smerdon, 1991; Smerdon and Lieberman, 1978). There are several candidates for 
chromatin remodelling in NER, such as the SWI/SNF family of proteins, but the exact 
mechanism by which this occurs is not clear (Zhao et al., 2009). 
 
Mutations in NER cause xeroderma pigmentosum (XP), an inherited disorder 
characterized by UV-sensitivity, susceptibility to UV mutagenesis and skin cancer 
predisposition. There is significant clinical heterogeneity in XP. Patients who have 
defects in exclusively GG-NER proteins XPC and XPE have >1000-fold increase risk 
of sun-related skin cancer, skin hypo/hyper pigmentation and a substantially 
increased risk of developing internal tumours (Marteijn et al., 2014). Mutations in 
proteins that are involved in both TC and GG-NER can exhibit additional symptoms. 
XPD mutations can range from XP to a combination of XP and Cockayne syndrome, 
as well as Cerebro-oculo-facio-skeletal syndrome (COFS). Mutations in genes 
encoding XPD, XPB and TTDA can result in trichothiodystrophy, a disorder of 
sulphur metabolism that displays similar symptoms to Cockayne syndrome with the 
addition of brittle hair and nails and scaly skin (Kraemer et al., 2007). These 
overlapping symptoms reflect effects on transcription and gene expression during 
hair, nail and skin differentiation. XPF-ERCC1 is involved in NER, interstrand 
crosslink repair (ICL) and DSB repair. As a consequence, XPF or ERCC1 mutations 
can result in XP, severe Cockayne syndrome, COFS and/or FA features (Jaspers et 
al., 2007; Kashiyama et al., 2013). 
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Figure 1.12: Outline of nucleotide 
excision repair (Marteijn et al., 2014) 
In GG-NER (global genome nucleotide 
excision repair), XPC in complex with 
RAD23 homologue B (RAD23B) and 
centrin 2 (CETN2) recognise helix 
distorting lesions (left, 1) and are aided 
by UV–DDB (ultraviolet (UV) radiation–
DNA damage-binding protein) complex 
(left, 2). Upon XPC binding, RAD23B 
dissociates (left, 3). UV-stimulated 
scaffold protein A (UVSSA), ubiquitin-
specific-processing protease 7 (USP7) 
and Cockayne syndrome protein CSB 
transiently interact with RNA Pol II 
throughout transcription elongation 
(right, 1). This interaction is stabilised 
by RNA Pol II stalling at a lesion (right, 
2), which initiates TC-NER 
(transcription-coupled NER). This 
forms Cockayne syndrome WD repeat 
protein CSA–CSB complex. There is 
some backtracking by RNA Pol II to 
reveal the lesion (right, 3). At this point 
the two pathways both recruit the TFIIH 
(transcription initiation factor IIH) 
complex, where upon binding the CAK 
(CDK-activating kinase) subcomplex 
dissociates from TFIIH (4). XPG is a 
structure specific endonuclease that is 
recruited to the pre-incision complex. 
TFIIH helicase activity (XPD) exposes 
the lesion further and contributes to 
lesion verification, along with XPB and 
XPA. Single stranded DNA binding 
protein replication protein A (RPA) 
binds and protects the undamaged 
strand. XPF-ERCC1 structure specific 
endonuclease is recruited by XPA and 
RPA to 5’ of the lesion (5). Following 
incision by XPF-ERCC1 the process is 
no longer reversible and is followed by 
XPG incision of the damaged DNA at 
the 3’ end, producing a 22-30 
nucleotide excision product (6). 
Proliferating cell nuclear antigen 
(PCNA) is recruited, followed by DNA 
Pol δ, DNA Pol κ or DNA Pol ε for DNA 
synthesis (7) and the nick is sealed by 
DNA ligase I or III (8). 
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1.3.3.5 Interstrand crosslink repair (ICL) 
ICLs inhibit DNA separation. As a consequence, they block replication and 
transcription and are highly toxic. They are induced by a range of chemotherapeutic 
drugs, particularly those used in the treatment of leukaemias. The repair of ICLs is 
defective in Fanconi anaemia (FA), a rare genetic disorder that causes reduced 
fertility, congenital abnormalities, bone marrow failure and increased predisposition 
to haematological and squamous cell cancers (Deans and West, 2011). FA cells are 
extremely sensitive to the toxic effects of ICL-inducing agents. Following exposure 
they exhibit high levels of chromosome breakage and fusion of the broken arms of 
non-homologous chromosomes (radial chromosomes) (Deans and West, 2011). 
These radial chromosomes are considered a hallmark of ineffectively processed 
ICLs. The FA pathway contains 19 gene products (Ceccaldi et al., 2016). Seven FA 
gene products (FANCA, FANCB, FANCC, FANCE, FANCF, FANCG and FANCL) 
form a multiprotein assembly known as the FA core complex. Most of the mutations 
identified in FA patients are FANCA (65%), FANCC (15%) or FANCG (10%) (Fanconi 
Anaemia Mutation Database). Patients with BRCA2/FANCD1 or PALB2/FANCN 
mutations have increased susceptibility to cancer development and particularly 
medulloblastoma in the case of FANCD1. 
 
The FANCM protein recognises ICLs during S phase (Niedernhofer, 2007). 
Subsequent recruitment of the FA core complex results in the monoubiquitination of 
FANCD2-FANCI – a process that depends on the simultaneous presence of all FA 
complex components. Although the consequences of these protein modifications 
have not been fully clarified, a proposed mechanism suggests that 
monoubiquitination stabilises the otherwise transient interaction of FANCD2-FANCI 
with damaged DNA (Deans and West, 2011).  
 
Subsequent processing of the ICL involves proteins from HR, NER and translesion 
synthesis (TLS) pathways. A variety of nucleases and polymerases are recruited to 
the damaged region. Multiple nuclease recruitment may reflect different types of ICLs 
(different levels of DNA distortion) or different requirements depending on the cell 
cycle phase.  
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HR factors are recruited to the damaged area to stabilise the fork. Fanconi 
associated nuclease (FAN1) can interact with monoubiquitinated FANCD2 and can 
degrade ssDNA or dsDNA through its 5’-3’ exonuclease and 5’-flap endonuclease 
activity. The coordinated action of the recruited FAN1 and MUS81-EME1 3’-flap 
endonuclease allows unhooking of the ICL (Deans and West, 2011). Once the 
translesion polymerase is recruited, the replicative polymerase stalls to allow the 
exchange to the translesion polymerase (Zhuang et al., 2008). Although there are 
several translesion polymerases, REV1 and Pol ζ seem to be essential for ICL repair 
and are error-prone and mutagenic (Räschle et al., 2008). After sufficient extension 
past the lesion, the replicative polymerase is reinstated (Huang et al., 2006). The 
translesion synthesised area will still be a substrate for DNA repair. Once the FA 
complex dissociates, deubiquitinating enzyme ubiquitin-specific peptidase 1 (USP1) 
can deactivate the pathway. Exposure of ssDNA during these processes results in 
RPA binding to ssDNA and the stimulation of cell cycle checkpoints by ATR-Chk1 
signalling cascade.  
 
1.3.3.6 Translesion synthesis (TLS) 
Genomic DNA is normally replicated by DNA polymerase α, δ and ε, where Polα 
initiates DNA synthesis with an RNA primer, while DNA Polδ and ε elongate the 
primers. Polδ and ε are high fidelity enzymes that have 3’-5’ exonuclease activity to 
remove base substitution errors (McCulloch and Kunkel, 2008). Replicative DNA 
polymerases have limited ability in replicating opposite damaged bases and 
therefore are exchanged with translesion bypass polymerases (Schmitt et al., 2009). 
TLS polymerases include Y-family polymerases POLη, POLι, POLκ and REV1, and 
B-family polymerase POLζ (Waters et al., 2009). None of these have proofreading 
exonuclease activity.  
 
A deficiency in POLη results in XP-V and increased risk of SCCs (Masutani et al., 
1999). Polη is able to bypass T<>T CPDs, the most common lesion caused by UV 
radiation, exhibiting high efficiency and fidelity. The mutation results in loss of specific 
contacts made by Polη with T<>T (Silverstein et al., 2010). This results in DSB 
formation where replication forks stall and collapse at sites of UV radiation induced 
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damage on the template strand (Limoli et al., 2002). Polη does not exhibit as high 
fidelity when bypassing 6,4 T:T and generally incorporates one G (Szüts et al., 2008). 
POLι is better at inserting the correct bases across from this lesion, however, it is 
extremely mutagenic when faced with T<>T or undamaged DNA (Johnson et al., 
2000). REV1 is also involved in bypass of UV-mediated damage in cells and may 
have a role in interacting with monoubiquitinated PCNA and Y-family polymerases 
to regulate DNA polymerase switching (Jansen et al., 2009) 
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Chapter 2. Materials & Methods 
2.1 Chemicals and reagents 
All chemicals and reagents were obtained from Sigma-Aldrich, unless otherwise 
stated.  
 
Standard solutions of 1M Tris-HCl, 0.5M Ethylenediaminetetraacetic acid (EDTA), 
1M MgCl2, 5M NaCl, 10x Tris-Borate-EDTA (TBE), phosphate-buffered saline (PBS), 
10x tris-buffered saline (TBS) and 20x saline sodium citrate (SSC) were sourced 
from The Francis Crick Institute Central Services. 
 
2.2 Cell culture 
2.2.1 Cell maintenance 
DMEM (Dulbecco's Modified Eagle Medium) and RPMI (Roswell Park Memorial 
Institute) 1640 Medium were obtained from Thermo-Fisher (Gibco™). Penicillin and 
streptomycin (Pen/Strep), were obtained from The Francis Crick Institute Central 
Services. Foetal Calf Serum (FCS) and Dialysed FCS were obtained from Thermo-
Fisher. Sterile plastic equipment was obtained from Becton Dickinson, Corning and 
Fisher Scientific.  
 
The cell lines and cell culture conditions are specified in Table 2.1. RPA16 and 
RPA21 cells were grown in medium containing G418 (200µg/ml), which was 
removed during experiments. All cells were grown at 37°C in a humidified 
atmosphere containing 5 or 10% CO2. Cells were counted using a haemocytometer 
or Cellometer® Auto T4 (Nexcelom Bioscience). 
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Table 2.1: Cell lines used and their individual cell culture methods 
 
Cell Line 
 
Organism 
 
Cell Type 
 
Cell Culture Method 
 
HeLa 
 
Human 
 
Epithelial 
DMEM 
10% FCS, Pen/Strep, 10% CO2 
 
U2OS 
 
Human 
 
Epithelial 
DMEM 
10% FCS, Pen/Strep, 10% CO2 
 
RPA16 
 
Human 
 
Epithelial 
DMEM 
10% FCS, Pen/Strep, 10% CO2, 
G418 
 
RPA21 
 
Human 
 
Epithelial 
DMEM 
10% FCS, Pen/Strep, 10% CO2, 
G418 
GM8339 Human Fibroblast DMEM 
10% FCS, Pen/Strep, 5% CO2 
 
CCRF-CEM 
 
Human 
 
T leukemic 
lymphoblast 
RIPA 1640 
10% Dialysed FCS, Pen/Strep, 
5% CO2 
GM03467 
Lesch-
Nyhan 
 
Human 
 
Fibroblast 
DMEM 
15% FCS, Pen/Strep, 5% CO2 
 
2.2.2 Drug treatments 
6-thioguanine (6-TG): Stock solution of 1mM 6-TG dissolved in 0.1mM NaOH was 
filter sterilised. It was added to cells at around 50% confluency. Cells were incubated 
with 6-TG for 24 hours for all experiments, except when measuring 6-TG 
incorporation where the incubation was 48 hours. 
 
Ciprofloxacin and ofloxacin: Stock solution of 50mM fluoroquinolone dissolved in 
0.1mM NaOH was filter sterilised. Cells were treated in medium (with FCS) for 1 hour 
at 37°C. 
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6-formylindolo[3,2-b]carbazole (FICZ): FICZ was purchased from Enzo (Plymouth 
Meeting, PA). Stock solution of 200µM dissolved in dimethyl sulfoxide (DMSO) was 
filter sterilised. Cells were treated in medium (with FCS) for 2 hours at 37°C. 
 
For irradiation, treated cells were rinsed in PBS and adherent cells irradiated through 
a thin layer of PBS (5 ml per 100mm dish). 
 
2.2.3 Antioxidant treatments 
Antioxidants ascorbic acid (1M stock, in water), N-acetyl cysteine (200mM stock, in 
water) and allopurinol (200mM stock, in 0.1M NaOH) were present throughout 6-
TG treatment. 
 
2.2.4 UVA irradiation 
Cells were irradiated in PBS using a UVH 253 lamp (UV Light Technology Limited) 
with a low range cut off at 320nm, high range cut off at 400nm and maximum 
emission at 365nm. The standard dose rate was 0.1kJ/m2/s measured using a UVA 
dosimeter (UV Light Technology Limited). The irradiation chamber includes a 
temperature control unit that maintains a temperature range of 10-15°C during 
irradiation. 
 
2.2.5 UVC irradiation 
UVC irradiation (254nm) was performed using a Stratalinker UV Crosslinker 
(Stratagene). The machine was calibrated to deliver 10J/m2/s. For experiments with 
combined UVA and UVC irradiation, drug treatment preceded UVA, which preceded 
UVC irradiation.  
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2.3 Biochemical techniques 
2.3.1 CM-H2DCFDA (5-(and-6)-chloromethyl-2’,7’-dichlorodihydrofluorescein 
diacetate, acetyl ester) assay 
Treated cells (8x106) were washed with PBS and resuspended in 1.5ml PBS. CM-
H2DCFDA (Thermo Fisher) was added at a final concentration of 7.5μM and the cells 
incubated at 37°C for 20 minutes. They were transferred to 100mm dishes and UVA 
irradiated. Following washing and resuspension in PBS, FACS (fluorescence-
activated cell sorting) analysis was carried out using a Beckton Dickinson FACScan. 
The fluorescence intensity and frequency distribution data were collected and 
analysed using BD CellQuest™ Pro v3.3 software. 
 
2.3.2 Cell extracts 
2.3.2.1 RIPA and non-denaturing extracts 
Cells (generally 8x106) were suspended in three pellet volumes of extraction buffer, 
either RIPA (Radioimmunoprecipitation assay) buffer or non-denaturing buffer (Table 
2.2 for chemicals and concentrations). Following 20 minutes on ice, cells were 
disrupted by vortexing. Extracts were centrifuged at 20,000g for 20 minutes. 
 
Pellets were discarded and supernatant protein concentrations were measured by 
Bradford assay (Bio-Rad).  Supernatants were stored in aliquots at -80°C. 
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Table 2.2: Components of the radioimmunoprecipitation assay (RIPA) and non-
denaturing lysis buffers 
RIPA buffer Non-denaturing lysis buffer 
Chemical Final 
Concentration 
Chemical Final 
Concentration 
Tris-HCl (pH 7.5) 50mM Tris-HCl (pH 7.5) 20mM 
NaCl 150mM NaCl 137mM 
Sodium Dodecyl 
Sulphate (SDS) 
0.1% Glycerol 10% 
Sodium 
Deoxycholate 
0.5% Nonidet P-40 (NP-
40) 
1% 
Triton x100 1% EDTA 2mM 
cOmplete 
Protease Inhibitor 
Cocktail Tablets 
1 tablet cOmplete 
Protease Inhibitor 
Cocktail Tablets 
1 tablet 
 
 
2.3.2.2 Benzonase treatment 
Benzonase treatment of RIPA extracts was as follows: MgCl2 and benzonase were 
added to reach a final concentration of 2mM and 2.5U/μl, respectively. Digestion was 
allowed to proceed for 15 min at room temperature. Digested extracts were then 
centrifuged at 20,000g for 20 min. 
 
Sodium deoxycholate has a negative impact on benzonase activity but benzonase 
retains 60% activity at 0.5% concentration of sodium deoxycholate. SDS partially 
inactivates benzonase. Therefore, high benzonase concentrations were used to 
allow benzonase to retain its activity. 
 
2.3.3 Polyacrylamide gel electrophoresis (PAGE) 
10-well, 10% polyacrylamide NuPAGE® Bis-Tris Precast Gels (Life Techonologies, 
Thermo Fisher) were electrophoresed in X-cell SureLock Mini Cells. Cell extracts 
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(20μg protein) were mixed with loading buffer (β-Mercaptoethanol (1%), Dithiothreitol 
(DTT, 20mM), Bromophenol blue (0.004%), Glycerol (6%), SDS (2%), Tris-HCl (50 
mM, pH 7.5)). Extracts were heated for 10 minutes at 95°C. Each gel was run with 
Amersham ECL Full-Range Rainbow Molecular Weight Markers (GE Healthcare Life 
Sciences). 
 
2.3.4 Immunoblot 
Following protein gel electrophoresis, proteins were transferred to PVDF 
(polyvinylidene difluoride) membranes (Immobilon-P, Milipore) overnight at 4°C 
using a Bio-Rad wet transfer apparatus. After transfer, membranes were washed at 
room temperature with water and TBS-T (TBS+0.1% Tween 20). Membranes were 
blocked for 1 hour with 10% (w/v) non-fat powdered milk in TBS-T. They were then 
incubated for 2 hours at room temperature with primary antibodies (Table 2.3 for 
dilutions and suppliers) diluted in 5% milk in TBS-T. After washing with TBS-T, 
membranes were incubated with the appropriate secondary antibody (Table 2.3 for 
dilutions and suppliers) at 1:5000. Proteins were visualised using Amersham ECL 
Western Blotting Detection Reagent (GE Healthcare Lifesciences) and Amersham 
Hyperfilm ECL (GE Healthcare Lifesciences). 
 
Table 2.3: The antibodies used in this work, their suppliers and dilutions- all 
dilutions in 5% milk in TBS-T (TBS+0.1% Tween 20); HRP, horseradish peroxidase 
Antibody Supplier Dilution 
XPA Abcam 1:1000 
XPD Abcam 1:1000 
RPA14 Abcam 1:1000 
RPA32 Abcam 1:1000 
RPA70 Abcam 1:1000 
β-Tubulin Abcam 1:1000 
PCNA Santa Cruz 1:1000 
MSH2 Santa Cruz 1:500 
Goat Anti-Mouse HRP Bio-Rad 1:5000 
Goat Anti-Rabbit HRP Bio-Rad 1:5000 
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2.3.5 Electrophoretic mobility shift assay (EMSA) 
2.3.5.1 32P labelling of oligonucleotides  
A 51 nucleotide oligonucleotide 
(5’GGGGACCACTTTGTACAAGAAAGCTGGGTCTCACATCAATGCACTTCTCCT
3’) (0.2pmol/μl) was mixed with T4 Kinase Buffer, T4 polynucleotide kinase (2U/μl 
final concentration) (both New England Biolabs), and 3μl g-[32P]-ATP (Amersham 
Pharmacia) in a final volume of 10μl. Following incubation for 40 min at 37°C, the 
labelled oligonucleotide was recovered using a G50 spin column (Amersham 
Pharmacia) and stored at 4°C. 
 
2.3.5.2 RPA-DNA binding and PAGE  
Cell extracts (25μg) were incubated in a total volume 20μl containing 2μl g32P-
labelled oligonucleotide (80fmol) and 1μl Poly(dA-dT) for 30 minutes at 37°C. For the 
supershift analysis, anti-RPA32 antibody was also present (1:50 dilution). Following 
incubation, 4μl of loading buffer (50mM Tris-HCl pH8, 10% glycerol, 2mM EDTA, 
bromophenol blue) was added to each sample. Samples were electrophoresed at 
80V on 12.5% polyacrylamide gels in 0.5x TBE. Gels were fixed in 10% glycerol for 
30 minutes and dried. They were then exposed to a Storage Phosphor Screen and 
imaged using a Typhoon scanner (both GE Healthcare Lifesciences). 
 
2.3.6 Immunoprecipitation 
Anti-RPA32 antibody (1:50 dilution) in TBS-T was combined with 1.5mg 
Dynabeads® Magnetic Beads (Thermo Fisher) and incubated with constant rotation 
for 10 min at room temperature. Beads were recovered and unbound antibody was 
removed by extensive washing with TBS-T.  
 
Extracts (500μg protein) in 200μl TBS-T were incubated with coated beads for 30 
minutes at room temperature with rotation. The supernatant protein was retained. 
Following extensive washing with TBS-T, beads were transferred to a new tube in 
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TBS-T, heated for 10 minutes at 95°C and the released protein was analysed by gel 
electrophoresis and immunoblotting (see Sections 2.3.3 and 2.3.4).   
 
2.3.7 Cell viability assay 
Treated cells were diluted in medium and 1000 cells were added per well into a 96-
well plate. Each cell treatment was plated in triplicate. Once the untreated cells 
reached 70% confluency (4 days), 10μl tetrazolium MTT reagent (3-(4,5-
dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide) was added to each well and 
incubated for 4 hours at 37°C. Excess MTT reagent was removed and replaced with 
100μl DMSO to dissolve the formazan generated by metabolically active cells. The 
dissolved formazan was quantified by absorbance at 540nm. 
 
2.3.8 6-TG incorporation  
6-TG was measured as previously described (Zhang et al., 2007). Cells were grown 
for 48 hours in 6-TG containing medium. DNA was purified from cells using the 
Wizard® Genomic DNA Purification Kit (Promega), with an additional overnight 
proteinase K digestion step. The DNA concentration was measured by NanoDrop. 
Purified DNA was denatured and digested with Nuclease P1 at 50°C for 1 hour. The 
pH was adjusted to pH 8.0 and two units of shrimp alkaline phosphatase (SAP) and 
10x SAP buffer were added to a total volume of 120μl. Digestion was continued for 
a further hour at 37°C.  
 
6-TG was analysed by high-performance liquid chromatography (HPLC) on a Waters 
dC18 (Atlantis 3µm, 150 × 2.1mm) column using a Waters 2695 Alliance system 
equipped with a photodiode array and Waters 474 dual monochromator fluorescence 
detector. Absorbance at both 280 and 342nm were measured to detect guanine and 
6-TG, respectively. 6-TG eluted around one minute after guanine. The percentage 
substitution of G by 6-TG was calculated from the areas under the respective peaks 
using standard curves.  
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2.3.9 Enzyme-linked immunosorbent assay (ELISA) 
6,4 pyrimidine-pyrimidone (6,4 Py:Py) induction and persistence in cellular DNA can 
be detected by ELISA. The experiment was performed according to instructions 
specified by Cosmo Bio Co. The ELISA was conducted in 96-well plates, which were 
coated in protamine sulphate (0.003% in distilled water, dried overnight).  
 
Genomic DNA was extracted from treated cells using QiaAMP DNA Mini Kit (Qiagen) 
and quantified using a NanoDrop spectrophotometer (NanoDrop Technologies). 
DNA was diluted in PBS at 4μg/ml, heated to 100°C for 10 minutes and left on ice 
for 15 minutes. 200ng denatured DNA was added to triplicate wells in 96-well plates. 
Plates were dried overnight at 37°C without the lid to allow evaporation and washed 
with PBS-T (0.05% Tween-20 in PBS). 
 
The summary of this experiment is presented in  
Figure 2.1. 150μl/well of 2% FCS in PBS was distributed for blocking and incubated and 
then washed off. All incubations were performed for 30 minutes at 37°C. All washes were 
performed 5x with 150μl/well PBS-T. 100μl/well of anti-6,4 Py:Py antibody (diluted in 
PBS at 1:1500, Cosmo Bio Co) was added, incubated and washed off. Each well was 
then incubated with 100μl/well F(ab')2-Goat anti-Mouse IgG (H+L) Secondary Antibody 
(Biotin conjugate, Thermo Fisher, 1:2000 dilution), and washed off. 100μl/well of 
Peroxidase-Streptavidin conjugate (1:10,000 dilution) was added, incubated and 
washed off. 150μl/well of citrate phosphate buffer (5.1g citric acid monohydrate and 7.3g 
Na2HPO4 in 1000ml distilled water, pH5) was added. This buffer was kept on the plate 
until a mixture of 8mg o-Phenylene diamine, 4μl hydrogen peroxide and 20ml citrate 
phosphate buffer was prepared. 100μl/well of this solution was added and checked 
regularly for the yellow colour to appear. Once a discernible difference between different 
treatments could be seen, the reaction was stopped with 50μl/well 2M H2SO4. The 
absorbance was measured at 492nm in a plate reader.  
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Figure 2.1: Summary of 6,4 pyrimidine-pyrimidone detection by ELISA 
The experimental instructions were specified by Cosmo Bio Co. 
 
2.3.10 Protein sulfenate derivatisation and detection 
RIPA cell lysates were incubated with 1mM biotin-1,3-cyclopentanedione (BP-1) 
probe (Kera-FAST) and N-ethylmaleimide (20mM) – the latter to block free thiols. 
BP-1 contains a sulfenate reactive group linked to biotin (Qian et al., 2011). The 
proteins were precipitated by the addition of four volumes of acetone. The precipitate 
was dissolved in 2% SDS and the protein concentration measured using the BCA 
assay (Thermo Scientiﬁc). BP-1-reacted proteins were enriched by binding to M280 
Streptavidin Dynabeads (Invitrogen) at 4°C overnight. Beads were then washed 
three times with 4 volumes of 0.1% SDS to remove non-specifically associated 
protein. Washed beads were then resuspended sequentially in, 2M Urea, 1M NaCl, 
0.1% SDS/10mM DTT, and PBS (for 30 minutes each). The beads were then boiled 
(95°C) in PAGE loading buffer (see Section 2.3.3) and detached proteins analysed 
by western blotting (see Section 2.3.4).  
 
Block with 2% FCS 
30 mins, 37°C 
Anti-6,4 Py:Py 
antibody 
30 mins, 37°C 
5 X PBS-T 
5 X PBS-T 
F(ab')2-Goat anti-Mouse IgG 
(H+L) Secondary Antibody 
 (Biotin Conjugate) 
30 mins, 37°C 
5 X PBS-T 
Peroxidase-Streptavidin 
conjugate  
30 mins, 37°C 
5 X PBS-T 
Citrate phosphate buffer 
wash 
o-Phenylene diamine and 
hydrogen peroxide in citrate 
phosphate buffer 
Measure absorbance at 
492nm 
2M H2SO4 
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2.4 Mass spectrometry (MS) 
2.4.1 Cells and UV irradiation 
For SILAC (stable isotope labelling by amino acids in cell culture) experiments, 
CCRF-CEM cells were grown in SILAC RPMI 1640 Medium (Thermo Fisher) 
supplemented with 10% dialysed FCS and a combination of either 100 mg/L light 
(14N, 12C) or heavy (15N, 13C) lysine and arginine (CK Isotopes). After growth for 7 
days in this medium, light or heavy labelling of proteins was confirmed by MS. 
 
CCRF-CEM cells were incubated for 24 hours with 6-TG or 1 hour with ciprofloxacin, 
and UVA irradiated in PBS.  
 
For hydroxyurea (HU) treatment, the medium was supplemented with 3 mM HU for 
6 hours prior to 6-TG addition and throughout growth in 6-TG. DNA was extracted 
and 6-TG incorporation was quantified (see Section 2.3.8). ROS levels were 
determined by FACS using the CM-H2DCFDA assay (Thermo Fisher) as in Section 
2.3.1. 
 
2.4.2 Sample preparation 
2.4.2.1 Chromatin preparation 
Following treatment, 106 isotopically-labelled control and/or treated cells were mixed 
and resuspended in 200µl Buffer 1 (Table 2.4 for chemicals and concentrations). 
Nuclei were harvested by centrifugation at 10,000g for 20 minutes at 4°C. 
 
Chromatin was released from the nuclear pellet by resuspension in 200µl Buffer 2 
(Table 2.4) and harvested by centrifugation at 10,000g for 20 minutes at 4°C. The 
chromatin pellet was then washed three times with four volumes of the same high-
salt buffer and extensively sheared by passage through 19G, 25G and 27G needles 
(20 times per needle). The DNA concentration was measured by NanoDrop. 10μg 
DNA was applied to a HyBond-N+ membrane using a slot blot apparatus (GE 
Healthcare) and crosslinked to the membrane by UVC irradiation from a Stratalinker 
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(Stratagene). Membranes were then washed sequentially with 2xSSC, 8M urea and 
water. Membrane areas containing chromatin were excised with sterile scalpels 
(Swann Morton).  
 
Table 2.4: Components of Buffer 1 and Buffer 2 for chromatin extract preparation 
 
Buffer 1 
 
Buffer 2 
Chemical Final 
Concentration 
Chemical Final 
Concentration 
Tris-HCl pH7.4 10mM Sodium phosphate pH 
7.4 
25mM 
MgCl2 2.5mM MgCl2 5mM 
NP-40 0.5% NaCl 500mM 
DTT 1mM EDTA 1mM 
 
cOmplete 
Protease 
Inhibitor Cocktail 
Tablets 
 
1 tablet 
Triton-X 0.5% 
DTT 1mM 
Glycerol 10% 
cOmplete 
Protease Inhibitor 
Cocktail Tablets 
1 tablet 
 
Further sample preparation for MS analysis was carried out by my collaborator Karin 
Barnouin. Excised membrane samples were treated with 10mM DTT at 50°C for 30 
minutes and then alkylated with 55mM iodoacetamide for 30 min at room 
temperature in the dark. Alkylation was stopped by the addition of 10mM DTT and 
further incubation for 10 minutes at room temperature. The membrane fragments 
were washed three times with 10mM triethylammonium bicarbonate (TEAB) and 
immersed in trypsin (12.5ng/ul) for overnight digestion at 37°C. DTT, iodoacetamide 
and trypsin were all prepared in 10mM TEAB.  
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2.4.2.2 RIPA extract 
DNA-free whole cell RIPA extracts (Table 2.2, 20µg of protein) were separated by 
SDS-PAGE (see Section 2.3.3) until the dye front had migrated 1-2cm into the gel. 
The gel was stained with Coomassie protein stain (Instant Blue, Expedeon). Gel 
bands were excised and trypsin digested using a Perkin Elmer Janus liquid handling 
system. 
 
2.4.2.3 Immunoblotting 
Chromatin extracts were applied to HyBond-N+ membranes that were blocked for 1 
hour with 10% (w/v) non-fat powdered milk in TBS-T. They were then incubated for 
2 hours at room temperature with primary antibodies for MSH2, MSH6, PCNA and 
RPA70 (Table 2.3, dilutions and suppliers) in 5% milk in TBS-T. Following washing 
with TBS-T, they were incubated with the appropriate HRP secondary antibody 
(1:5000). Immunoreactive proteins were detected using Amersham ECL Western 
Blotting Detection Reagent (GE Healthcare Lifesciences) and visualised using 
Amersham Hyperfilm ECL (GE Healthcare Lifesciences). 
 
2.4.3 MS and analysis 
MS was performed by my collaborator K. Barnouin. Tryptic peptides were analysed 
by LC-MS using an Ultimate 3000 uHPLC system, which was connected to either a 
Q-Exactive or Orbitrap Velos Pro mass spectrometer (Thermo Fisher Scientific). 
Acquisition was in data-dependent mode. The data were searched against human 
Uniprot (UniProt KB2012_08 taxonomy human 9606 canonical with contaminants 
20120921) using the Andromeda search engine and MaxQuant (version 1.3.0.5) 
(Cox and Mann, 2008). A false discovery rate of 0.1% was used to generate protein 
identification tables. The data were uploaded into Perseus version 1.4.0.11 
(MaxQuant) for statistical analyses. K. Barnouin also used the data visualization 
package ggplot2 (Wickham, 2009). I used Prism 6.0 to generate all of the scatterplots 
presented in Chapter 5 of this thesis.  
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Chapter 3. Oxidative damage to proteins caused by 
6-TG+UVA 
3.1 Introduction 
Previous studies have shown that antioxidant defences of cultured human cells are 
not sufficient to prevent the extensive protein damage caused by 6-thioguanine (6-
TG) photoactivation (Gueranger et al., 2014; 2011; Montaner et al., 2007). 
Photoactivation of DNA-6-TG compromises DNA break joining, base excision repair 
(BER) and nucleotide excision repair (NER). In vitro DNA repair assays, which 
monitor excision of a platinum-DNA adduct by extracts prepared from treated cells 
(Lainé et al., 2006), implicated protein oxidation in DNA repair inhibition (Gueranger 
et al., 2014; Peacock et al., 2014). The use of purified NER proteins to complement 
repair–deficient extracts indicated that replication protein A (RPA) might be a target 
for inactivation by photoactivated DNA 6-TG. In this chapter, I describe my findings 
that confirm that RPA is indeed susceptible to oxidative damage. 
 
3.1.1 Replication protein A  
The use of genetic information encoded in DNA, requires unwinding of duplex DNA 
and exposure of single stranded DNA (ssDNA). In this state DNA is highly vulnerable 
to damage, as well as to the formation of spontaneous duplex DNA. ssDNA binding 
proteins exist in bacteria, archaea and eukaryotes, and all contain the oligonucleotide 
binding (OB) fold for ssDNA binding and oligomerisation (Flynn and Zou, 2010).  
 
RPA is the primary eukaryotic ssDNA binding protein. It is required for all aspects of 
DNA metabolism that involves a ssDNA intermediate. These include DNA replication, 
recombination, repair, telomere maintenance and DNA damage response. RPA is a 
heterotrimer of 70, 32 and 14kDa subunits (RPA70, RPA32 and RPA14, 
respectively)  that are encoded by three separate genes (Wold, 1997). RPA70 is the 
major DNA binding subunit and has four domains (Figure 3.1). The domains include 
an N-terminal regulatory, protein–protein interaction domain (amino acids 1–110, 
DBD-F) and three DNA binding domains (DBD): DBD-A (amino acids 181–290), 
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DBD-B (amino acids 301–422), and DBD-C (amino acids 436–616) (Liu and Huang, 
2016). RPA32 contains the DBD-D domain and DBD-E is present in RPA14 (Brill 
and Bastin-Shanower, 1998). The trimerisation occurs through interactions between 
domains DBD-C, D and E (Bochkareva et al., 2002). RPA32 contains an additional 
C-terminal winged helix domain for RPA interaction with other proteins and an N-
terminal domain which becomes phosphorylated after DNA damage (Binz et al., 
2004; Oakley and Patrick, 2010). DBD-E has a very weak interaction with DNA and 
mainly participates in trimerisation (Bochkarev et al., 1999). 
 
 
Figure 3.1: Structure and binding of RPA (Chen and Wold, 2014) 
(A) RPA binding to ssDNA by DNA binding domains (DBD) A-F, also showing the winged 
helix domain (wh) and the phosphorylation domain (Pd). Longer ssDNA binding (30nt) 
involves DBD-D. (B) The structure of Ustilago maydis RPA bound to ssDNA (black). 
RPA1 (RPA70, green), RPA2 (RPA32, blue) and RPA3 (RPA14, red) (Fan and Pavletich, 
2012). 
 
RPA binds ssDNA 1000-fold more efficiently (nM affinity) than to dsDNA. It binds 
preferentially to longer ssDNA sequences and prefers polypyrimidine sequences to 
polypurines (Kim et al., 1994). The proposed dynamic binding mechanism involves 
an initial weak binding step by DBD-A and DBD-B to an 10-20 nucleotide segment. 
Subsequent conformational changes allow binding of DBD-C, which in turn permits 
DBD-D access for binding to ssDNA substrates of 28-30 nucleotides (Bastin-
Shanower and Brill, 2001). 
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The long linker connecting the DBD-F protein interaction and DNA binding DBD-A 
domains confers some structural and dynamic autonomy on these functions and 
binding of ssDNA does not affect the protein interactions of RPA (Brosey et al., 2015). 
The DNA binding domains (A and B) are connected by a short linker reflecting the 
high degree of coordination required for the initial binding of ssDNA. The combination 
increases binding affinity by around a 100-fold compared to each separate domain. 
 
The binding of RPA to DNA appears to depend on free RPA concentration. It was 
shown that Saccharomyces cerevisiae RPA remains tightly associated with ssDNA 
in the absence of free RPA (Gibb et al., 2014). When free RPA becomes present in 
solution, RPA undergoes dissociation from DNA and exhibits rapid exchange 
between free and bound RPA, which may occur through a partially dissociated 
intermediate. This may allow other proteins to replace RPA. Gourdin et al. have 
shown that RPA exhibits differential binding to ssDNA under different conditions. 
They speculate that transient RPA binding to DNA during replication and the pre-
incision steps of RPA prevents checkpoint activation (Gourdin et al., 2014). RPA 
binding during replication stress or in the post-incision steps of NER is more stable 
and can activate ATR (ataxia telangiectasia and Rad3 related) and ATRIP (ATR-
interacting protein). 
 
A critical step of NER involves RPA70 binding the N-terminal region of XPA 
(xeroderma pigmentosum group A), while RPA32 binds its central region (Saijo et 
al., 2011). These interactions allow the recruitment of the XPF-ERCC1 and XPG 
endonucleases. XPG interacts with RPA directly (Saijo et al., 1996). RPA interacts 
with uracil-DNA glycosylase (UNG) and also facilitates long patch BER (DeMott et 
al., 1998; Nagelhus et al., 1997). Exonuclease 1-mediated excision during MMR is 
stimulated by RPA, which also protects the ssDNA generated by the excision 
(Genschel and Modrich, 2003). RPA has an important role in protecting ssDNA and 
removing secondary structures formed by ssDNA in homologous recombination (HR) 
and interacts with RAD51 and 52 (San Filippo et al., 2008). 
 
Some genotoxic treatments may disrupt the interaction between RPA and XPA that 
is required for NER (Jiang et al., 2012). This disruption can occur through RPA32 
hyperphosphorylation, which can promote the interaction of RPA with other factors 
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(Deng et al., 2009; Shi et al., 2010). The association of RPA with ssDNA is more 
favourable than its binding to XPA and there is some overlap in the XPA interaction 
site and the DNA binding site of RPA70 (Daughdrill et al., 2003). ssDNA at collapsed 
DNA replication forks will sequester RPA and prevent it from binding XPA. The 
presence of a common surface of RPA involved in interacting with UNG2 (BER), 
Rad52 (HR) and XPA also results in competition between the different repair 
pathways for RPA (Mer et al., 2000). In the case of ultraviolet radiation (UV) and 
NER, it is proposed that at low DNA damage levels and few double strand breaks 
(DSBs), RPA associates with XPA for NER. At higher levels of DNA damage, DSBs 
at stalled DNA replication forks will compete with XPA, potentially aided by RPA 
hyperphosphorylation and sequester RPA (Wu et al., 2005). Consistent with this 
model, in the absence of translesion polymerase Polζ or in cells treated with 
hydroxyurea, persistently arrested replication forks sequester RPA (Tsaalbi-Shtylik 
et al., 2014). This is accompanied by inhibition of NER in trans. Therefore, free RPA 
levels have a significant regulatory role in the cell. Persistent fork stalling and the 
absence of free RPA can result in cell death (Tsaalbi-Shtylik et al., 2014).  
 
Loss of any of the RPA subunits is lethal and non-lethal mutations result in genomic 
instability (Chen and Wold, 2014). Depletion of RPA can result in spontaneous DNA 
damage and G2/M checkpoint activation through ATM (ataxia telangiectasia 
mutated) (Halliwell, 1991; Haring et al., 2010; Santocanale et al., 1995). It has also 
been shown that depletion of RPA70 results in genome instability, activates the 
Fanconi anaemia (FA) pathway through chromatin association of the FA core 
complex and causes FANCD2 ubiquitination through ATR (Jang et al., 2016). 
Haploinsufficiency of RPA in mice results in lymphoid tumours and shortened life 
span (Hass et al., 2010; Wang et al., 2005). 
 
Replication fork stalling during replication stress increases the levels of exposed 
ssDNA. Under normal conditions, RPA stabilisation of stalled forks and activation of 
ATR, resolves the stalled fork and allows continuation of replication. Toledo et al. 
showed that replication stress-induced depletion of RPA can cause exposed ssDNA 
to convert to DSBs (Toledo et al., 2013). This results in replication catastrophe and 
cell death. Overexpression of RPA enables cells to tolerate higher levels of 
replication stress. The activation of ATR by RPA and cell cycle arrest prevents new 
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origin activation and therefore inhibits further generation of ssDNA to alleviate RPA 
exhaustion. 
 
3.1.2 Antioxidant allopurinol 
Allopurinol is a xanthine oxidase inhibitor (Elion et al., 1966). It is also an antioxidant 
and prevents radiation-induced lipid peroxidation by •OH, ClO2 and HOCl (Das et al., 
1987; England et al., 1986; Moorhouse et al., 1987). Allopurinol protects against 6-
thioguanine (6-TG) toxicity by acting as a reactive oxygen species (ROS) scavenger 
and improving cell viability at high (mM) allopurinol concentrations (Brem and Karran, 
2012). It also confers significant protection against the inflammatory effects of 
fluoroquinolone+UVA combinations in mice (Wagai and Tawara, 1991). 
 
3.1.3 Aims 
My aims at the outset were to investigate: 
- Proteins affected by 6-TG+UVA treatment, 
- The impact of antioxidants on ROS production and protein damage, 
- The impairment of RPA by 6-TG+UVA and ciprofloxacin+UVA treatments. 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 3. Oxidative damage to proteins caused by 6-TG+UVA 
 
81 
 
3.2 Results 
3.2.1 Production of intracellular ROS by 6-TG+UVA 
I initially examined the production of ROS in cells treated with UVA, 6-TG and 
combined 6-TG and UVA using the CM-H2DCFDA probe. CM-H2DCFDA passively 
diffuses into cells where it undergoes cleavage by intracellular esterases and 
reaction with proteins that increase its retention in the cell. Oxidation by intracellular 
ROS then converts the reduced fluorescein derivative to its oxidised fluorescent form 
that is trapped inside the cell and can be detected by fluorescence-activated cell 
sorting (FACS) (Figure 3.2).  
 
 
 
 
Figure 3.2: The fluorescence spectra of CM-H2DCFDA (Thermo Fisher) 
Following passive diffusion into cells, the reaction of CM-H2DCFDA with ROS results in 
the production of the fluorescent form of the probe, which exhibits excitation (blue) at 
around 492-495nm and emission (red) at around 517-527nm.  
 
 
 
To examine ROS production by 6-TG+UVA, HeLa cells were grown in the presence 
of 6-TG for 24 hours to allow 6-TG incorporation into DNA. They were then incubated 
with CM-H2DCFDA and irradiated with UVA. The fluorescence intensity and 
frequency distribution was determined by FACS analysis. In addition, I examined the 
effect of allopurinol on ROS levels.  
 
 
 
Chapter 3. Oxidative damage to proteins caused by 6-TG+UVA 
 
82 
 
Figure 3.3  (A) shows that:  
- Allopurinol has a small effect on steady-state ROS in untreated cells, 
- A low dose of UVA induces detectable ROS, 
- Allopurinol measurably reduces the ROS induced by UVA but does not fully 
restore it to background level. 
 
Figure 3.3 (B) confirms previous findings that treatment with 6-TG+UVA results in a 
highly significant increase in ROS levels in comparison to UVA alone (O'Donovan et 
al., 2005). The FACS signal for this combination is close to the maximum detection 
capacity of this assay. Allopurinol afforded significant protection against ROS 
induced by 6-TG+UVA, but did not restore untreated steady state levels. 
 
 
A 
 
B 
 
Figure 3.3:  FACS analysis of intracellular ROS  
HeLa cells were treated with 6-TG and incubated for 20 minutes with 7.5μM CM-
H2DCFDA. They were then irradiated with UVA, washed and resuspended in PBS for 
FACS analysis. The fluorescence intensity (FL1-H log 10) vs frequency distribution 
(counts) is shown. 1μM 6-TG for 24 hours, 1mM allopurinol for 24 hours, 20kJ/m2 UVA. 
 
 
 
 
No treatment 
UVA  
Allopurinol 
Allopurinol+UVA 
 
No treatment 
6-TG 
6-TG+UVA  
6-TG+Allopurinol 
6-TG+UVA+Allopurinol 
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3.2.2 Protein damage to NER proteins  
I investigated the effect of 6-TG+UVA and allopurinol treatment on proteins of the 
NER pathway. Immunoblotting of cell extracts indicated that 6-TG+UVA treatment 
caused a decrease in the recovery of XPD, XPA and RPA, three essential NER 
proteins (Figure 3.4). Neither UVA nor 6-TG alone affected the extractable amounts 
of these proteins. The addition of the antioxidant allopurinol restored levels of both 
XPA and RPA70 but not XPD. This loss could be due to various forms of protein 
oxidation that results in precipitation as well as loss via the formation of DNA-protein 
crosslinks.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4:  Effects of 6-TG+UVA and allopurinol on NER proteins 
HeLa cells were treated with 1μM 6-TG for 24 hours, 1mM allopurinol for 24 hours and 
20kJ/m2 UVA as indicated. Extracts (20μg) were analysed by western blotting and 
probed with antibodies against XPD, XPA, RPA70 and β-tubulin as specified. 
 
 
Previous findings from our laboratory had indicated that protein oxidation, and in 
particular RPA damage, is associated with NER inhibition in cells treated with 6-
TG+UVA (Gueranger et al., 2014; Peacock et al., 2014). As treatment with 6-
TG+UVA inhibits DNA replication and causes replication fork stalling, I examined 
whether recruitment of RPA to exposed ssDNA at stalled replication forks 
(chromatinisation) might decrease RPA70 levels recovered in the low-salt RIPA 
extracts. I treated cells with 6-TG+UVA, with and without benzonase digestion and 
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tested RPA70 levels over time. Benzonase digests DNA to completion and releases 
bound proteins. Figure 3.5 shows that following UVC treatment, an efficient inducer 
of replication arrest, RPA70 recovery was visibly diminished after 30 minutes. 
Benzonase digestion largely restored pre-treatment levels, consistent with the 
expected recruitment of RPA70 to newly-exposed regions of ssDNA. 6-TG+UVA 
treatment also resulted in RPA chromatinisation, although to a lesser extent than 
UVC. RPA70 recovery was diminished immediately after treatment and continued to 
decline slowly over time.  
 
 
 
Figure 3.5:  Chromatinisation of RPA with UVC and 6-TG+UVA treatment 
Cells were treated with 1μM 6-TG for 24 hours and irradiated with 10J/m2 UVC and 
20kJ/m2 UVA and treated with benzonase where indicated. Extracts prepared at 0, 30 
and 60 minutes after treatment were analysed by western blotting (20μg) and probed 
with antibodies against RPA70 and β-tubulin as specified. 
 
 
To examine the impact of 6-TG+UVA treatment on RPA function, I carried out an 
electrophoretic mobility shift assay (EMSA). Extracts of HeLa cells were incubated 
with a [32P] end-labelled 51-mer oligonucleotide and the products analysed by 
polyacrylamide gel electrophoresis (PAGE). Figure 3.6 (A and B) shows that RPA 
binding to ssDNA can be detected by reduced oligonucleotide mobility (*). The 
supershift assay (**) in which an antibody against RPA32 was included in the 
incubations, confirms that binding is by RPA. RPA binding activity was lower in 
extracts of cells treated with both UVA and 6-TG although neither alone had a 
substantial effect. UVC treatment also causes a decrease in RPA binding most likely 
reflecting RPA recruitment to sites of DNA damage and exposed ssDNA regions. 
The decrease in RPA binding is, however, more pronounced in extracts from cells 
treated with combined 6-TG+UVA despite the similar levels of chromatinisation of 
RPA after UVC (Figure 3.5) .  
 
0 30 60 
-benzo +benzo
0 30 60 
Time after 6-TG+UVA treatment  
RPA70
0 30 60 
-benzo +benzo
0 30 60 
No treatment
0 30 60 
-benzo +benzo
0 30 60 
Time after UVC treatment
β-Tubulin
Chapter 3. Oxidative damage to proteins caused by 6-TG+UVA 
 
85 
 
I conclude that RPA recruitment to chromatin can only partly explain the considerable 
loss of RPA activity and NER inhibition in extracts from 6-TG+UVA treated cells. I 
therefore examined other potential contributors to loss of NER activity.  
 
 
A 
 
B 
 
C 
 
Figure 3.6: The effect of 6-TG+UVA on RPA binding to ssDNA and XPA 
Extracts (25μg) prepared from HeLa cells treated with 1μM 6-TG for 24 hours and 
irradiated with 10J/m2 UVC and 20kJ/m2 UVA, as indicated (A) were incubated with a 
51nt [32P] end-labelled oligonucleotide. Products were separated on a 12.5% 
polyacrylamide gel and imaged using a phosphor screen. For the supershift assay, the 
extracts were supplemented with anti-RPA32 antibody. *DNA:RPA, 
**DNA:RPA:Antibody. (B) Band intensities for representative example were measured 
using ImageJ software. (C) Immunoprecipitation (IP). Extracts enriched for XPA using 
protein A dynabeads bound to anti-XPA antibody (Ab) were analysed by western blotting 
and probing with anti-RPA70 Ab. WCE, whole cell extract. 
 
 
Efficient NER requires an interaction between RPA and XPA (Saijo et al., 2011). I 
therefore conducted an immunoprecipitation assay (IP), in which anti-XPA antibodies 
were used to enrich HeLa cell extracts for XPA. By probing with an anti-RPA70 
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antibody, I tested for the interaction between the two proteins. An interaction between 
XPA and RPA70 was detected in both untreated and UVC-treated extracts (Figure 
3.6 (C)). UVC slightly reduced the amount of XPA detected – possibly reflecting RPA 
recruitment to stalled replication forks. In contrast, 6-TG+UVA abolished the 
RPA:XPA interaction. This could be due to chromatinisation, however, at 0.5μM 6-
TG, chromatinisation is limited (Figure 3.7 (A)) yet it still abolishes RPA:XPA binding. 
Therefore, the lack of interaction may be due to RPA, XPA or both proteins being 
damaged and unable to interact with each other. These findings also support the 
conclusion that, in addition to chromatinisation, damage to RPA or its interacting 
proteins, induced by 6-TG+UVA contributes to loss of ssDNA binding and inhibition 
of NER. 
 
 
3.2.3 RPA32 modification by 6-TG+UVA 
I also examined the effect of 6-TG+UVA on the smaller RPA subunits, RPA32 and 
RPA14. The western blots shown in Figure 3.7 (A) confirm the 6-TG and UVA-
dependent reduction in recovery of RPA70. They also demonstrate a concomitant 6-
TG+UVA-dependent decrease in the yield of RPA14. More strikingly, they reveal 
modifications of RPA32 that generate prominent bands at around 100 and 45-50kDa. 
To examine whether these new RPA32 species were simply a consequence of 
damaging and lethal treatments, I investigated the effects on RPA32 of high doses 
of ionising radiation (IR), UVC and hydroxyurea (HU). Figure 3.7 (B) shows that none 
of these treatments induced detectable RPA32 modification. Allopurinol, but not N-
acetylcysteine (NAC) or ascorbic acid (AA), provided some protection against RPA32 
modification (Figure 3.7 (C)).  
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A 
 
B 
 
 
 
 
 
 
 
 
 
C 
 
 
Figure 3.7: Crosslinking of RPA32 
(A) Extracts from HeLa cells treated with 6-TG for 24 hours at the indicated concentration 
and 20kJ/m2 UVA. (B) Extracts treated with 1μM 6-TG, 20kJ/m2 UVA, 3mM hydroxyurea 
for 3 hours, 20Gy ionising radiation (IR), 100J/m2 UVC. (C) as in (A) with the addition of 
1mM allopurinol (Allo), ascorbic acid (AA) and N-acetylcysteine (NAC) as specified. The 
extracts were analysed by western blot (20μg) using antibodies against RPA70, 32 and 
14. Unmodified RPA32 serves as the loading control. 
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3.2.4 RPA32 modification by ciprofloxacin and UVA 
Since the findings with antioxidants were equivocal, I investigated the role of ROS in 
RPA32 modification by a different approach. The fluoroquinolone antibiotic 
ciprofloxacin is also a UVA photosensitizer that generates ROS that are detected by 
the CM-H2DCFDA assay (Figure 3.8 (A)). Ciprofloxacin on its own results in a modest 
increase in intracellular ROS, while the combined treatment of ciprofloxacin and UVA 
result in a significant increase in intracellular ROS in a concentration dependent 
manner. Figure 3.8 (B) shows that ciprofloxacin+UVA (Cip+UVA) generates modified 
RPA32 species that are closely similar to those produced by 6-TG+UVA. 
 
 
A 
 
 
B 
 
 
Figure 3.8: ROS production and RPA32 modification by ciprofloxacin+UVA 
(A) HeLa cells were treated with ciprofloxacin for 1 hour and incubated for 20 minutes 
with 7.5μM CM-H2DCFDA. They were then irradiated with 20kJ/m2 UVA, washed and 
resuspended in PBS for FACS analysis. The fluorescence intensity (FL1-H log 10) vs 
frequency distribution (counts) is shown. (B) Extracts were prepared from HeLa cells 
treated with ciprofloxacin for 1 hour and irradiated with 20kJ/m2 UVA. Extracts (20μg) 
were analysed by western blotting with antibodies against RPA32. Unmodified RPA32 
serves as the loading control. 
 
 
 
 
No treatment 
500μM Ciprofloxacin 
1mM Ciprofloxacin 
500μM Ciprofloxacin+UVA 
1mM Ciprofloxacin+UVA 
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In summary, 6-TG+UVA results in reduced RPA70 recovery and impedes ssDNA 
binding and potentially interaction with XPA, necessary for NER. RPA32 is also 
damaged by 6-TG+UVA and Cip+UVA treatments. This damage is most likely 
through the formation of protein-protein crosslinks formed in a ROS dependent 
manner. This RPA32 modification was investigated further in Chapter 4. 
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Chapter 4. Photosensitiser+UVA mediated damage 
to RPA 
4.1 Introduction 
Following the results of the previous chapter, the damaging effects of 
photosensitising treatments on replication protein A (RPA) were further investigated. 
In addition to the existing photosensitisers used, I studied the effects of an 
endogenous photosensitiser that is described below, as well as examining the way 
in which oxidised proteins are removed from the cell.  
 
In this chapter, I describe the protective effects of RPA overexpression against the 
damaging effects of photosensitising treatments, forms of oxidised RPA and their 
removal, as well as the surprising finding that this abundant and essential protein is 
limiting for nucleotide excision repair (NER). 
   
4.1.1 Formylindolo[3,2-b]carbazole (FICZ) 
 
 
Figure 4.1: Chemical structure of tryptophan and 6-formylindolo[3,2-b]carbazole 
(FICZ) (Oberg et al., 2005) 
 
Along with various established endogenous photosensitisers of ultraviolet radiation 
(UV), exposure of these chromophores to solar UV and the resulting production of 
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reactive oxygen species (ROS) can cause the formation of other photosensitisers in 
human skin. The L-tryptophan-derived photoproduct FICZ (Figure 4.1) exhibits 
nanomolar photodynamic activity through photoexcitation by UVA or blue light 
irradiation (Park et al., 2015). Combined FICZ and UVA treatment was shown to 
induce oxidative and proteotoxic stress response genes in keratinocytes, impair 
mitochondrial transmembrane potential and form ROS that result in protein peroxides 
(Park et al., 2015). The ROS generated by FICZ and UVA include singlet oxygen 
(1O2) and superoxide (O2•-). Oxidation of a target protein by FICZ and UVA was also 
observed and the oxidation was inhibited through the presence of 1O2 quencher 
sodium azide (NaN3) (Park et al., 2015). It also resulted in a decrease in cell viability 
via caspase 3 activation, which was prevented by NaN3. 
 
4.1.2 Degradation of oxidised proteins 
Oxidatively damaged proteins are targeted for proteolytic degradation to their 
constitutive amino acids. The limited efficiency of this process results in accumulation 
of misfolded and oxidised proteins over time in cells (especially post-mitotic cells) 
and tissues resulting in age-related diseases including atherosclerosis, 
neurodegeneration and cataractogenesis (Dunlop et al., 2009). Oxidatively damaged 
proteins are degraded by either the proteasome or through lysosomal pathways. 
 
4.1.2.1 Proteasomal degradation 
The proteasome has several isoforms but each isoform contains the catalytic core 
subunit, the 20S subunit. The different substrate specificities of its catalytically active 
subunits result in the cleavage of 10-15% of the peptide bonds in proteins, the 
remainder of which is carried out by cytosolic exo- and endo-peptidases (Reits et al., 
2004). The 20S proteasome associates with one or two of the regulatory 19S 
(PA700) particles to form the 26S proteasome, which is ATP and ubiquitin dependent 
(Dunlop et al., 2009). The role of the 19S particle is to bind polyubiquitinated proteins, 
remove the ubiquitin and transport the particle into the 20S core (Strickland et al., 
2000). The 20S proteasome can also degrade proteins without the conjugation of 
ubiquitin (Jariel-Encontre et al., 2008).  
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It appears that degradation of oxidatively damaged proteins does not require ATP or 
polyubiquitination, as shown by (1) lack of effect of inhibition of ubiquitination on 
degradation of oxidised proteins, (2) low efficiency of 26S degradation of oxidised 
proteins, (3) disassembly of the 26S proteasome and release of 19S and (4) 
inactivation of the ubiquitinating system under oxidative stress (Davies, 2001; 
Reinheckel et al., 1998; Shang and Taylor, 1995). Instead of ubiquitination, the 
exposure of hydrophobic structures appears to be responsible for proteasomal 
substrate recognition (Lasch et al., 2001). The ability of the proteasome to degrade 
oxidised proteins decreases with increasing amount of oxidative modification as 
proteins need to be unfolded in order to fit through the narrow catalytic core. When 
heavily oxidised aggregates or lipofuscin (oxidised fatty acids, protein, sugar and 
metal) are formed, they are not only resistant but also inhibitory to proteases (Jung 
et al., 2014). 
 
4.1.2.2 Lysosomal degradation 
The lysosome contains hydrolytic enzymes called cathepsins, involved in the 
degradation of extra and intracellular proteins, in addition to their role in the recycling 
of organelles such as proteasomes and mitochondria. Autophagy, which can be 
induced by starvation, involves nonspecific degradation of portions of the cytosol 
including proteins, mitochondria and proteasomes. The fusion of increasingly mature 
vacuoles form the autolysosome or autophagolysosome to degrade the components 
of the cargo (Kurz et al., 2008).  
 
The proposed method of degradation for oxidised proteins is a cooperation between 
the proteasome and endosomal-lysosomal pathways, whereby the heavily modified 
proteins switch from the proteasomal to the lysosomal pathway of degradation 
(Rodgers et al., 2002). This was demonstrated through a study by Kaganovich et al. 
where misfolded and ubiquitinated proteins move to proteasome rich perinuclear 
sites and severely aggregated proteins are found in autophagic vacuoles 
(Kaganovich et al., 2008). 
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4.1.3 Aims 
My aims at the outset were to investigate: 
- The damage caused to RPA by ciprofloxacin, ofloxacin, 6-thioguanine (6-TG) 
and FICZ in combination with UVA, and the impact of RPA overexpression on 
cell survival and DNA damage repair, 
- The removal of severely oxidised, cross-linked proteins formed by 
photosensitiser and UVA treatment. 
 
The results presented in this chapter have been published in the Journal of 
Investigative Dermatology (Guven et al., 2015). 
 
4.2 Results 
4.2.1 The RPA overexpressing U2OS cell line, RPA21 
To investigate whether damage to RPA has relevance in living cells, I used the 
U2OS-RPA21 cell line (RPA21) that overexpresses all three RPA subunits. In these 
U2OS derived cells (kindly provided by Drs. J. Lucas and L.Toledo (Toledo et al., 
2013)), RPA is expressed using 2-A peptide technology, a schematic representation 
of which is shown in Figure 4.2 (Kim et al., 2011; Ryan et al., 1991). The proteins are 
translated from a single, in-frame cDNA that contains 2A-peptide sequences from 
P2A porcine viruses between the ORFs (open reading frames) encoding each RPA 
subunit. The RPA14 ORF is also in-frame with AcGFP (green fluorescent protein). 
During translation, ribosomes skip the synthesis of the peptide bond between glycine 
and proline at the C-terminus of the 2A sequence, resulting in cleavage and 
generating the separate subunits of RPA in stoichiometric amounts (Donnelly et al., 
2001). Part of the 2A sequence is retained in each subunit resulting in a slight mobility 
shift on SDS-PAGE. 
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Figure 4.2: Schematic representation of the cDNA used for RPA overexpression in 
the RPA21 cell line  
The three proteins are expressed from a single, in-frame cDNA. 2A-peptide sequences 
from P2A porcine viruses separate the ORFs encoding each of the subunits. The RPA14 
ORF is also in-frame with AcGFP to generate a fusion protein. During translation, 
ribosomes skip the synthesis of the peptide bond between glycine and proline at the C-
terminus of the 2A sequence, resulting in cleavage and generating the separate subunits 
of RPA in stoichiometric amounts (Toledo et al., 2013). 
 
 
I carried out a western blot analysis to estimate the level of overexpression of the 
RPA subunits (Figure 4.3). This confirmed an approximately two-fold overexpression 
of RPA70 and RPA32. Expression of the endogenous U2OS RPA14 was unchanged 
and the presence of the RPA14-AcGFP fusion protein encoded by the construct was 
also confirmed. Longer exposure of the blots revealed a high molecular weight 
immunoreactive species of RPA32. The nature of this protein will be discussed in 
Section 4.2.6. 
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Figure 4.3: RPA overexpression in RPA21 cells 
Extracts (20μg protein) from U2OS and RPA21 cells were analysed by western blots 
probed with antibodies against RPA70, 32, 14 and β-tubulin as indicated. 
 
 
 
4.2.2 The effect of RPA overexpression on survival following photosensitised 
UVA treatment 
Similar to ciprofloxacin, another fluoroquinolone, ofloxacin, also produces ROS when 
combined with UVA, detectable by the CM-H2DCFDA assay. Ofloxacin appears to 
require double the dose of ciprofloxacin in combination with UVA to reach the same 
levels of ROS production as can be seen in Figure 4.4. Both drugs at this particular 
dosage produce lower levels of intracellular ROS than 6-TG+UVA. 
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Figure 4.4: ROS production by ciprofloxacin, ofloxacin and 6-TG 
U2OS cells were treated with ciprofloxacin (1 hour, 250μM), ofloxacin (1 hour, 500μM) 
or 6-TG (24 hours, 3μM) and incubated for 20 minutes with 7.5μM CM-H2DCFDA. The 
cells were then irradiated with 20kJ/m2 UVA and were washed and resuspended in PBS 
for subsequent FACS analysis. The fluorescence intensity (FL1-H log 10) vs frequency 
distribution (counts) is shown. 
 
 
Initially, I tested whether RPA overexpression affected the survival of cells exposed 
to 6-TG, ciprofloxacin or ofloxacin in combination with UVA. MTT survival assays 
were performed to compare the survival of the RPA overexpressing RPA21 cells to 
that of the parental U2OS cells. 
 
Figure 4.5 (A) shows the toxicity of ciprofloxacin+UVA (Cip+UVA) in the two cell lines. 
Individually, neither UVA nor ciprofloxacin caused a significant decrease in viability 
in either U2OS or RPA21 cells. In combination with UVA, however, ciprofloxacin 
induced a concentration-dependent decrease in viability in both cell lines. RPA21 
cells were considerably more resistant to Cip+UVA than U2OS cells. At 200μM 
ciprofloxacin, less than 2% of UVA irradiated U2OS cells were viable whereas 
approximately 70% of RPA21 cells survived the same treatment (p=0.007, paired t-
test). 
 
As demonstrated in Figure 4.4, ofloxacin requires over double the dose of 
ciprofloxacin to generate similar levels of ROS. Therefore, relatively higher doses of 
ofloxacin were used to study its effect on survival. Ofloxacin+UVA (Oflx+UVA) 
treatment was also differentially toxic towards U2OS and RPA21 cells (Figure 4.5 
(B)), although the difference between the two cell lines was more modest than that 
No treatment 
Ofloxacin+UVA 
Ciprofloxacin+UVA 
6-TG+UVA 
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for Cip+UVA.  At 500μM ofloxacin, the viabilities of irradiated U2OS and RPA21 cells 
were 50% and 85% respectively (p=0.0165, paired t-test). As expected, ofloxacin 
alone was not detectably toxic in either cell line. 
 
U2OS and RPA21 cells incorporate 6-TG into DNA at different rates. Accordingly, 
viability comparisons were carried out in cells treated with different 6-TG 
concentrations to compensate for this difference.  HPLC analysis of DNA 6-TG was 
performed in each experiment to ensure similar levels of incorporation were achieved. 
RPA21 cells were more resistant to 6-TG+UVA than U2OS (Figure 4.5 (C)). 
Following treatment with a low 6-TG concentration and the highest UVA dose, U2OS 
cells exhibited approximately 50% viability, compared to 85% for RPA21 cells. At the 
higher concentration, this becomes approximately 30 and 70% for U2OS and RPA21 
cells, respectively. These findings demonstrate that 6-TG+UVA is less toxic in 
RPA21 cells than in U2OS cells. 
 
My findings reveal that RPA21 cells are more resistant to the three different 
photosensitiser+UVA combinations than their U2OS parent cells. They indicate that 
even a modest overexpression of RPA confers resistance to the toxicity of these 
treatments. 
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Figure 4.5: MTT survival assays for RPA21 and U2OS cells treated with UVA 
combined with ciprofloxacin, ofloxacin or 6-TG 
(A) Viability of cells treated with ciprofloxacin (Cip) (1 hour) and UVA (20kJ/m2). Mean 
values from 3 experiments. (B) Viability of cells treated with ofloxacin (Oflx) (1 hour) and 
UVA (20kJ/m2). Mean values from 3 experiments. (C) Viability of cells treated with 6-TG 
(24 hours) and UVA (20kJ/m2). Mean values from 2 experiments. Low concentration of 
6-TG, 0.1μM (0.06% DNA 6-TG incorporation) and 0.2μM (0.07% incorporation), for 
U2OS and RPA21 respectively.  High concentration of 6-TG, 0.25μM (0.12% 
incorporation) and 0.5μM (0.15% incorporation), for U2OS and RPA21 respectively.    
 
 
No
 tr
ea
tm
en
t
UV
A
30
0µ
M 
Ci
p
10
0µ
M 
Ci
p +
 U
VA
20
0µ
M 
Ci
p +
 U
VA
30
0µ
M 
Ci
p +
 U
VA
0
50
100
Treatment
Vi
ab
ili
ty
 (%
)
U2OS
RPA21
No
 tr
ea
tm
en
t
UV
A
10
00
µM
 O
flx
 
25
0µ
M 
Of
lx 
+ U
VA
50
0µ
M 
Of
lx 
+ U
VA
10
00
µM
 O
flx
 + 
UV
A
0
50
100
Vi
ab
ili
ty
 (%
)
Treatment
U2OS
RPA21
No
 tr
ea
tm
en
t
20
kJ
/m
2  U
VA
6-T
G 
(Lo
w)
6-T
G 
(Lo
w)
 + 
5k
J/m
2   U
VA
6-T
G 
(Lo
w)
 + 
10
kJ
/m
2   U
VA
6-T
G 
(Lo
w)
 + 
20
kJ
/m
2   U
VA
6-T
G 
(H
igh
) +
 5k
J/m
2   U
VA
6-T
G 
(H
igh
) +
 10
kJ
/m
2   U
VA
6-T
G 
(H
igh
) +
 20
kJ
/m
2   U
VA
0
50
100
Treatment
Vi
ab
ili
ty
 (%
)
U2OS 
RPA21 
Chapter 4. Photosensitiser+UVA mediated damage to RPA 
 
99 
 
4.2.3 The effect of RPA overexpression on photosensitiser+UVA induced 
inhibition of NER 
Treatment of HeLa or CCRF-CEM cells with 6-TG+UVA inhibits NER (Gueranger et 
al., 2014; Peacock et al., 2014). I investigated NER inhibition by this treatment, and 
by the other photosensitiser+UVA combinations in U2OS and RPA21 cells. 
 
U2OS and RPA21 cells were treated with 6-TG for 24 hours (3 and 9μM, 
respectively) to produce DNA incorporation that was determined by HPLC analysis 
to be 0.85% and 0.86%. They were irradiated with 20kJ/m2 UVA and then 
immediately with 10 J/m2 UVC to induce canonical NER substrates. Genomic DNA 
was isolated at different times after irradiation and the efficiency of NER was 
determined by measuring the remaining UVC-induced 6,4 pyrimidine-pyrimidone 
photoproducts (6,4 Py:Py) by ELISA.  
 
Figure 4.6 (A) shows the effect of 6-TG+UVA on 6,4 Py:Py repair. Excision of 6,4 
Py:Pys in untreated cells is rapid and they are removed with a half-life of 1-2 hours 
by both U2OS and RPA21 cells. Repair is effectively complete by 3 hours post-
irradiation. As expected, 6-TG+UVA treatment inhibited NER by U2OS cells and they 
removed only approximately 15% of the initial 6,4 Py:Py, in 3 hours. RPA 
overexpression in RPA21 cells significantly improved NER efficiency and they 
repaired 55% of these lesions in 3 hours (p=0.012, paired t-test).  
 
Figure 4.6 (B) confirms the inhibition of NER by Cip+UVA (Peacock et al., 2014). At 
3 hours post irradiation, U2OS cells treated with 500μM Cip+UVA had repaired 
around 10% of their 6,4 Py:Py whereas for RPA21 cells, this figure was 45% 
(p=0.027, paired t-test).  
 
Figure 4.6 (C) shows that treatment with Oflx+UVA also inhibited 6,4 Py:Py excision 
in U2OS cells and that this inhibition was partially reversed in RPA21 cells, (p=0.026, 
paired t-test).    
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These findings confirm the significant inhibition of NER by photosensitizer+UVA 
combinations. They indicate further that a modest overexpression of RPA can 
significantly reverse this inhibition.  
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C 
 
 
Figure 4.6: RPA overexpression and photosensitiser mediated inhibition of 6,4 
Py:Py repair by NER 
U2OS and RPA21 cells were treated with (A) 6-TG (24 hours, 3 and 9μM 6-TG for 
0.85 and 0.86% incorporation, respectively), (B) ciprofloxacin (Cip, 500μM, 1 hour) 
and (C) ofloxacin (Oflx, 1mM, 1 hour). Cells were irradiated with 20kJ/m2 UVA and 
then immediately with 10 J/m2 UVC. Genomic DNA was extracted at the indicated 
times after irradiation and 6,4 Py:Pys were measured by ELISA. The 6,4 Py:Py levels 
recorded immediately after irradiation were set to 100%. Each treatment result is the 
mean of three independent experiments. The results for untreated U2OS and RPA21 
are the mean of 11 independent experiments and were used in all three graphs. 
 
4.2.4 The effect of RPA overexpression on UVA-mediated NER inhibition 
While these experiments were being carried out, work in the laboratory established 
that high doses of UVA also inhibit NER in the absence of an exogenous 
photosensitiser (McAdam et al., 2016). I therefore examined the effect of RPA 
overexpression on UVA-mediated NER inhibition. U2OS and RPA21 cells were 
irradiated with 200 kJ/m2 UVA, immediately followed by 10 J/m2 UVC. Genomic DNA 
was isolated at different times after irradiation and the removal of 6,4 Py:Pys was 
measured by ELISA. 
 
Figure 4.7 (A), confirms UVA-induced inhibition of NER in U2OS cells in which 
around 50% of the initial 6,4 Py:Pys remain at 3 hours post irradiation. In contrast 
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RPA21 cells repair around 80% at this time (p=0.038, paired t-test). Thus, RPA 
overexpression enables U2OS cells to partially overcome NER inhibition induced by 
high dose UVA. 
 
Reviewing the historical control data for NER by U2OS and RPA21 cells exposed to 
UVC alone, I noticed that RPA21 cells generally repaired 6,4 Py:Pys more efficiently 
than U2OS. The composite data from 11 independent experiments are presented in 
Figure 4.7 (B). The difference was small but statistically significant (p=0.01, paired t-
test). It appears from these data that a small increase in RPA expression can 
enhance the basal NER rate. 
 
Figure 4.7 (C) analyses the difference between the two cell lines in a different format. 
It is a plot of the rate of 6,4 Py:Py removal as a function of initial 6,4 Py:Py load 
(6.4x105 6,4 Py:Pys induced by a UVC dose of 20J/m2) (Perdiz et al., 2000). The 
Lineweaver-Burk plot has the reciprocal of the velocity of the reaction on the y-axis, 
which in this case is the rate of 6,4 Py:Py removal. On the x-axis it has the reciprocal 
of the substrate concentration, which in this case is the number of 6,4 Py:Pys. The 
y-intercept is 1/Vmax (maximum velocity) of NER for 6,4 Py:Py removal, while the x-
intercept is -1/Km, which is the concentration of 6,4 Py:Pys at half the Vmax. From the 
fitted equations it appears that a two-fold higher RPA level is associated with a three-
fold increase in the efficiency of NER (Vmax=3333 and 10000 for U2OS and RPA21 
respectively). In agreement with this, NER in U2OS cells reaches half of its Vmax at a 
third of the concentration of 6,4 Py:Py compared to RPA21 (Km= 5.2x105 and 1.5x106 
for U2OS and RPA21 respectively). This observation suggests that RPA levels are 
limiting for NER – at least in U2OS cells. This limitation becomes more important and 
potentially lethal under oxidative conditions. 
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A
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C  
 
Figure 4.7: The effect of RPA overexpression on UVA-mediated inhibition of NER 
and NER efficiency 
U2OS and RPA21 cells were treated with (A) 200kJ/m2 UVA and 10 J/m2 UVC, or (B) 
UVC only. Genomic DNA was extracted after the indicated times and 6,4 Py:Pys were 
measured by ELISA. The 6,4 Py:Py levels immediately after irradiation were set to 100%. 
Data are means of (A) 4 independent or (B) 11 independent experiments. (C) The rates 
of 6,4 Py:Py removal were determined for different amounts of 6,4 Py:Pys. The line of 
best fit was drawn to determine the Km and Vmax for the removal of 6,4 Py:Pys using a 
Lineweaver-Burk plot. 
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To investigate the effects of RPA expression on survival, I examined the viability of 
U2OS and RPA21 cells following irradiation by UVC, UVA or UVC+UVA. The results 
shown in Figure 4.8 indicate that the higher level of RPA in RPA21 cells does not 
confer a significantly increased protection against killing by UVC and there were no 
measurable differences in viability between U2OS and RPA21 cells irradiated with 
up to 8 J/m2 UVC. On the other hand, RPA21 cells were generally more resistant to 
lethal UVA doses and their increased RPA expression protected against killing by 
UVA either alone or in combination with a low dose of UVC.  
 
I conclude that although RPA is not limiting for survival of U2OS cells following UVC 
irradiation up to 8 J/m2, when DNA damage is induced under more oxidative 
conditions, RPA levels are a major determinant of cell survival. 
 
 
 
 
Figure 4.8: MTT survival assay for RPA21 and U2OS cells treated with UVA, UVC 
and UVA+UVC 
Viability of UVA (doses in kJ/m2) and UVC (doses in J/m2) irradiated U2OS and RPA21 
cells. Mean values from two experiments. 
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4.2.5 RPA chromatinisation by ciprofloxacin  
In chapter 3, I explained that RPA is chromatinised due to exposed ssDNA caused 
by 6-TG+UVA mediated replication blocking lesions. When activated by UVA, 
ciprofloxacin can induce the formation of T<>T CPDs, that can also block replication, 
sequester RPA and impede NER (Lhiaubet-Vallet et al., 2009). Figure 4.9 (A) shows 
this chromatinisation with Cip+UVA treatment in U2OS and RPA21 cells. Since 
RPA21 has a larger quantity of RPA available in the cell, the proportion that is 
chromatinised is much smaller in comparison to the total. 
 
On the other hand, Oflx+UVA is a very poor source of CPDs and therefore has no 
visible effect on RPA recovery from either cell line (Figure 4.9 (B)) (Peacock et al., 
2014). The DDB2 component of DDB1:DDB2 (DNA damage binding 1: DNA damage 
binding 2) is another indicator of NER substrates. It is chromatinised with 6-TG+UVA 
and Cip+UVA, but not with Oflx+UVA (Guven et al., 2015). Therefore, Oflx+UVA is 
unlikely to result in NER substrates.  
 
A                                                      B 
 
 
 
Figure 4.9: Chromatinisation of RPA70 with ciprofloxacin and ofloxacin  
RIPA extracts were prepared from HeLa cells treated with (A) ciprofloxacin (Cip) or (B) 
ofloxacin (Oflx) for 1 hour and irradiated with 20kJ/m2 UVA. The extracts were analysed 
by western blot (20μg) using antibodies against RPA70 and β-tubulin. 
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Oflx+UVA mediated NER inhibition and cell death are prevented by RPA 
overexpression. I have shown that this is not because RPA is chromatinised and is 
unavailable for NER. Therefore, I decided to investigate oxidative RPA damage. 
4.2.6 RPA inter-subunit crosslinking in U2OS and RPA21 cells 
I demonstrated in the previous chapter that a fraction of RPA32 in 6-TG+UVA-treated 
HeLa cells is converted to higher molecular weight forms that are consistent with the 
formation of inter-subunit crosslinks. I decided to investigate this crosslinking further 
in U2OS and RPA21 cells. In particular, I examined whether the other 
photosensitizers, ciprofloxacin and ofloxacin, damage RPA in a similar manner. 
 
It is important to point out that the RPA32 antibody recognises several polypeptides 
in extracts of RPA21 cells. These species are not treatment-related. They can be 
most clearly seen in Figure 4.10 (A). The prominent band at around 100kDa, I believe 
is the product of incomplete cleavage at the P2A site between RPA70 and RPA32 
(102kDa). There is also a low, but detectable level of what appears to be the full 
length, fusion polypeptide (AcGFP-RPA14-RPA70-RPA32) at 143 kDa. To 
distinguish these endogenous forms from the treatment-generated crosslinked 
RPA32, the latter are designated with *, ** and ***. 
 
Western blotting of extracts from Cip+UVA treated U2OS and RPA21 cells (Figure 
4.10 (A)) revealed a 100kDa RPA32-containing species that appeared to be identical 
to that previously observed in HeLa cells treated with 6-TG+UVA and Cip+UVA 
(Figure 3.7 (A) and Figure 3.8 (B), respectively). In this case, there is a second band 
between 70-100kDa (**), which is most likely a product of AcGFP-RPA14 
crosslinking to RPA32. A third band (***) migrating between 40-50kDa may represent 
an additional crosslinked species comprising RPA32 and endogenous RPA14, as 
seen previously in Figure 3.8 (B).  
 
Oflx+UVA also induced RPA32 crosslinking and the same products were observed 
in Figure 4.10 (B). The higher level of RPA in the RPA21 cells was reflected in the 
reproducibly more extensive crosslinking compared to U2OS cells. 
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Figure 4.10: RPA32 complexes formed by Cip+UVA and Oflx+UVA treatments in 
U2OS and RPA21 cells 
Cell extracts (20μg) were analysed by western blotting and probed with anti-RPA32 
antibody. (A) Ciprofloxacin+20kJ/m2 UVA (B) ofloxacin+20kJ/m2 UVA. Extracts from (C) 
U2OS or (D) RPA21 cells treated with hydroxyurea (HU, 3mM, 3 hours), ionising 
radiation (IR, 20Gy), UVC (100J/m2) or with 6-TG +/- 1mM allopurinol as indicated. DNA 
6-TG substitution was 0.83 and 0.71% for U2OS and RPA21, respectively. RPA32 
complexes are indicated with (*, ** and ***). Molecular weight markers are indicated. 
Unmodified RPA32 serves as the loading control. 
 
Consistent with my findings with 6-TG+UVA treated HeLa cells, the crosslinked 
RPA32 complexes were not detected after exposure to hydroxyurea, or high dose 
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ionising radiation or UVC (Figure 4.10 (C and D)) confirming that their formation is 
not due to extensive DNA damage or replication arrest and is not cell type specific. 
In addition, allopurinol partially suppressed the formation of crosslinked RPA32 
complexes (Figure 4.10 (C and D)) consistent with the involvement of ROS in their 
formation. 
 
HeLa and U2OS are tumour-derived cell lines. To investigate whether RPA32 was 
crosslinked in non-tumour cells, I examined RPA in extracts of untransformed 
GM8339 human fibroblasts treated with Cip+UVA or Oflx+UVA. The results are 
shown in Figure 4.11. Western blot analysis confirmed RPA32 crosslinking is not 
specific to transformed cells. The same (*) designation as Figure 4.10 was used to 
mark the bands representing crosslinks. 
 
 
 
 
Figure 4.11: Formation of crosslinked RPA32 in untransformed GM8339 cells 
Extracts (20μg) prepared from GM8339 cells treated with ciprofloxacin (1 hour), ofloxacin 
(1 hour) and UVA as indicated, were analysed by western blotting and probed with anti-
RPA32 antibody. Unmodified RPA32 serves as the loading control. RPA32 complexes 
are indicated with (* and ***). 
 
 
To investigate whether RPA32 is in fact crosslinked covalently to RPA70, I 
immunoprecipitated RPA from RPA21 extracts and analysed the precipitated 
* 
 
 
*** 
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material by western blotting for RPA70. The RPA overexpressing cells were used for 
these experiments to increase the chances of detecting any crosslinked proteins. 
The results are shown in Figure 4.12. Input is simply the extract and the supernatant 
(sup) are the proteins that remain after RPA32 immunodepletion. The eluate should 
contain RPA32 plus any crosslinked complexes. Figure 4.12 (30-second exposure) 
shows that RPA70-immunoreactive material of approximately 100 kDa is 
immunoprecipitated along with RPA32, consistent with Cip+UVA induced 
RPA32:RPA70 crosslinking. It is also possible to see the RPA70-RPA32 
unprocessed polypeptide in the eluate from untreated RPA21 cells. This is not 
resolved from the crosslinked species in treated cells. 
 
 
 
Figure 4.12: Immunoprecipitation of RPA32:RPA70 from ciprofloxacin+UVA 
treated RPA21 cells 
Anti-RPA32 antibodies were used with protein A dynabeads to immunoprecipitate RPA 
from extracts of ciprofloxacin+UVA (0.5mM ciprofloxacin, 20kJ/m2 UVA) treated RPA21 
cells. The eluates from protein A beads were analysed by western blotting with an anti-
RPA70 probe. The lower panels represent longer exposure of areas 1 and 2 above. 
Molecular weight markers are indicated. 
 
 
Chapter 4. Photosensitiser+UVA mediated damage to RPA 
 
110 
 
4.2.7 The fate of inter-subunit crosslinked proteins 
In addition to RPA crosslinking, 6-TG+UVA also causes crosslinking of the subunits 
of PCNA (proliferating cell nuclear antigen), DNA replication and repair trimer 
(Montaner et al., 2007). I investigated whether PCNA is also vulnerable to 
crosslinking by Oflx+UVA and Cip+UVA. I also addressed the subsequent fate of the 
crosslinked complexes. Figure 4.13 (A and B) shows that both Oflx+UVA and 
Cip+UVA cause PCNA crosslinking (PCNA*) in U2OS and RPA21 cells.  
 
The levels of Cip+UVA-mediated PCNA and RPA protein-protein crosslinks were 
diminished three hours post-irradiation and disappeared almost completely from 
U2OS and RPA21 cells within 24 hours (Figure 4.13 (B)). To investigate a possible 
role for the proteasome in this disappearance, I pre-incubated cells with the 
proteasome inhibitors MG-132 and lactacystin for two hours before treatment with 
Cip+UVA. 
 
Figure 4.13 (C), shows that MG-132 and lactacystin completely abrogated the 
removal of *PCNA indicating that that the proteasome is responsible for its 
degradation. On the other hand, although the degradation of crosslinked RPA was 
slowed, it was incompletely inhibited suggesting that its removal is partly 
proteasome-independent.  
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With MG-132 and lactacystin 
 
Figure 4.13: PCNA and RPA protein-protein crosslinking and removal of 
crosslinked proteins 
Extracts (20μg) from U2OS and RPA21 cells were analysed by western blotting for 
RPA32, PCNA and β-tubulin. Molecular weight markers are indicated. (A) Cells were 
treated with ofloxacin (Oflx) for 1 hour and UVA (20kJ/m2). (B) Cells were treated with 
500μM ciprofloxacin (Cip) for 1 hour and irradiated with UVA (20kJ/m2). (C) Cells were 
treated with proteasome inhibitors MG-132 (5μg/ml) and lactacystin (10μM) for 2 hours, 
followed by 500μM Cip for 1 hour and irradiated with UVA (20kJ/m2). Crosslinked species 
are denoted by (*). 
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4.2.8 RPA cysteine sulfenates 
In order to examine whether cysteine thiols (-SH) are oxidised to cysteine sulfenate 
(Cys-SOH), I selectively derivatised protein sulfenates in RPA21 extracts with a 
probe, BP-1 (biotin-1,3-cyclopentanedione). This probe contains a sulfenate-reactive 
group attached to biotin (Qian et al., 2011). The derivatised proteins are then 
recovered by affinity binding to streptavidin. I used the RPA21 cell line as higher 
levels of RPA facilitated detection of cysteine sulfenates.  
 
Figure 4.14 (A and B) shows that oxidized forms of RPA32 that contain cysteine 
sulfenate are present in RPA21 cells treated with Oflx+UVA or Cip+UVA under 
conditions that induce RPA32:RPA70 crosslinking. A small amount of BP-1-
derivatised RPA32 was reproducibly detected in untreated RPA21 cells and the level 
was increased by Oflx+UVA or Cip+UVA treatment. It appears that at least in the 
RPA overexpressing cells, there is a detectable steady state level of oxidized RPA 
under normal growth conditions. The oxidative stress induced by ciprofloxacin or 
ofloxacin in combination with UVA significantly increases RPA cysteine thiol 
oxidation. 
.  
Interestingly, the longer exposure western blot of the eluate from BP-1 derivatized 
Oflx+UVA treated cells revealed that along with oxidized uncomplexed RPA32, 
cysteine sulfenate is also detectable in the crosslinked RPA32:RPA70 complex 
(Figure 4.14 (B)). Since this complex accounts for a very small fraction of the total 
RPA32, detection of cysteine sulfenate suggests that the crosslinked RPA32 is 
heavily oxidized. 
 
Thus, oxidation of cysteine residues to sulfenates is another potential contributor to 
RPA inactivation and NER inhibition in oxidative stress conditions. 
 
 
Chapter 4. Photosensitiser+UVA mediated damage to RPA 
 
113 
 
A 
B 
 
 
 
Figure 4.14:  BP-1 derivatisation of RPA32 cysteine sulfenates 
(A) RPA21 cells were treated with 500μM ofloxacin (Ofl) for 1 hour and UVA (20kJ/m2). 
(B) RPA21 cells were treated with 250μM ciprofloxacin (Cip) for 1 hour and irradiated 
with UVA (20kJ/m2). Extracts were prepared and cysteine sulfenates were derivatised 
with the BP-1 probe. Derivatised proteins were recovered by binding and elution from 
streptavidin beads (Eluate). Input = samples prior to streptavidin enrichment. Analysis 
was by western blotting for RPA32. 
 
 
 
 
 
Longer 
exposure 
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4.2.9 FICZ mediated RPA and PCNA crosslinking  
During the final stages of my experimental work on RPA, it was reported that FICZ, 
a UVB photoproduct of the amino acid tryptophan, is an endogenous cellular UVA 
chromophore. FICZ, a UVA/visible photosensitiser, causes oxidative stress and 
oxidative damage to DNA at nanomolar concentrations (Park et al., 2015). I 
examined whether photoactivation of FICZ causes protein oxidation, specifically, 
inter-subunit crosslinking of PCNA and RPA.  
 
Western blot analysis indicated that treatment of U2OS cells with FICZ induces UVA-
dependent crosslinking of PCNA (Figure 4.15 (A)). A low level of RPA32 crosslinking 
was also apparent in the RPA overexpressing RPA21 cells (Figure 4.15 (B)). 
FICZ+UVA appeared to be less effective in RPA crosslinking in comparison to other 
photosensitising treatments. 
 
These results show that UVA activation of a defined endogenous UVA chromophore 
also causes significant protein oxidation and damaging modifications to essential 
DNA repair/replication proteins.  
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Figure 4.15: FICZ+UVA mediated crosslinking of PCNA and RPA 
Extracts (20μg) from U2OS and RPA21 cells treated with FICZ (1 hour) and UVA were 
analysed by western blotting for (A) PCNA and (B) RPA32. Crosslinks are indicated with 
(*). 
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4.2.10 ROS levels and RPA overexpression 
My findings presented so far suggest that RPA is particularly susceptible to oxidative 
damage. To investigate the possible source of oxidised RPA32 in untreated RPA21 
cells, I measured their steady-state ROS levels using the CM-H2DCFDA assay. 
These measurements reproducibly indicated a considerably higher constitutive ROS 
level compared to U2OS cells.  
  
To examine further the relationship between RPA overexpression and increased 
ROS, I used a second cell line RPA16 (also provided by Drs. J. Lucas and L.Toledo, 
(Toledo et al., 2013)). RPA expression in the RPA16 cell line is intermediate between 
that of U2OS and RPA21. This was confirmed by western blotting (Figure 4.16 (A)).  
 
Figure 4.16 (B) shows the CM-H2DCFDA assays for the untreated cells. U2OS cells 
had the lowest ROS level and RPA21 cells had the highest. ROS levels in RPA16 
cells were reproducibly intermediate between these two extremes. RPA16 appears 
to be more similar to RPA21 than to U2OS but this is exaggerated by the logarithmic 
scale. These differentials were maintained following UVA irradiation (Figure 4.16 (C)). 
This agrees with the hypothesis that levels of RPA expression influence intracellular 
ROS. 
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Figure 4.16: Comparison of ROS levels between U2OS, RPA16 and RPA21 cells 
(A) RIPA extracts were prepared from U2OS, RPA16 and RPA21 cells (treated with 6-
TG for 24 hours and 20kJ/m2 UVA) and analysed by western blotting for RPA70 and β-
tubulin. 6-TG incorporations were 1.424, 1.330 and 1.556% for U2OS, RPA16 and 
RPA21, respectively. For ROS measurements cells were (B) left untreated or (C) 
irradiated with UVA (20kJ/m2). They were incubated for 20 minutes with 7.5μM CM-
H2DCFDA prior to UVA irradiation and were washed and resuspended in PBS for 
subsequent FACS analysis. The fluorescence intensity (FL1-H log 10) vs frequency 
distribution (counts) is shown. 
 
 
Excess ROS reflects the saturation of the cell’s antioxidant capacity. Glutathione 
(GSH) is a non-protein thiol that provides reducing equivalents to important 
antioxidant enzymes, as well as scavenging free radicals itself. It is central to cellular 
antioxidant defences. I measured GSH levels in U2OS, RPA16 and RPA21 cells 
using the Trevigen glutathione assay kit. The assay uses glutathione reductase to 
reduce oxidised glutathione (GSSG) present in cell extracts to GSH (Figure 4.17). 
GSH then reacts with DTNB (5,5’-dithiobis-2-nitrobenzoic acid), to produce 5-thio-2-
nitrobenzoic acid (TNB), that can be detected by its absorbance at 405 or 414 nm. 
U2OS-no treatment 
RPA16-no treatment 
RPA21-no treatment 
U2OS-UVA 
RPA16-UVA 
RPA21-UVA 
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The reaction also produces a mixed disulphide, GSTNB, that is also reduced by 
glutathione reductase to TNB and GSH. GSH levels are therefore proportional to 
TNB produced. An important additional feature of the assay is the specific 
measurement of GSSG. This involves an additional reaction with 4-vinylpyridine to 
selectively block all free SH groups, including that of GSH. Unfortunately, despite 
several attempts I was unable to measure GSSG as 4-vinylpyridine mediated 
blocking of free thiols appeared to be ineffective. 
 
The total glutathione levels for U2OS, RPA16 and RPA21 were 4653, 3674 and 3429 
pmol respectively (averages from four independent determinations). Interestingly, 
the increasing RPA levels exhibit a negative correlation with the amount of GSH in 
the cell.  
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Figure 4.17: The Trevigen glutathione assay 
The assay uses glutathione reductase to convert oxidised glutathione (GSSG) to its 
reduced form (GSH). GSH is then reacted with DTNB (5,5’-dithiobis-2-nitrobenzoic acid) 
to generate 5-thio-2-nitrobenzoic acid (TNB). The mixed disulphide reaction product 
(GSTNB) is reduced to TNB and GSH, also by glutathione reductase. TNB absorbs at 
405 or 414 nm.  Total glutathione levels are estimated by TNB production. (Trevigen) 
 
 
In summary, increased RPA expression is associated with improved tolerance to 
toxicity and improved NER function under oxidising conditions. Although higher 
levels of RPA appear to be beneficial for the cell, they are also associated with higher 
steady state ROS and possibly lower cellular GSH levels. 
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Chapter 5. Proteomics based method for identifying 
DPCs 
5.1 Introduction 
DNA lesions are well-characterized and the specific mechanisms by which they are 
repaired are generally well understood. DNA-protein crosslinks (DPCs) are an 
exception in this regard and the identities of the cellular proteins that are particularly 
susceptible to crosslinking, the mechanisms of DPC formation and their repair have 
been less thoroughly investigated. 
 
5.1.1 DNA-protein crosslinks  
DPCs involve a covalent linkage between DNA and protein, resulting in a bulky 
lesion. Proteins are generally unreactive with DNA. However, exposure to a range 
of agents such as ultraviolet radiation (UV), ionising radiation, chemotherapeutic 
drugs and various aldehydes can result in DPC formation (reviewed in (Barker et al., 
2005b)). These include crosslinking to DNA directly through free radical formation 
under oxidative stress, or via a chemical, drug or metal ion. Due to associated 
unpredictability of free radical reactions, there is an added level of complexity that a 
particular crosslinking agent can cause multiple types of chemical crosslinks 
between protein and DNA (Tretyakova et al., 2015). 
 
DPCs are particularly detrimental to cells as they sequester and inactivate proteins 
in close proximity to DNA that are likely to be involved in essential DNA metabolic 
processes. In addition, the bulky nature of DPCs can impede DNA repair, block DNA 
replication fork progression in vivo and restrict RNA polymerase movement on the 
transcribed strand (Kuo et al., 2007; Nakano et al., 2012; Yeo et al., 2014). Failure 
to repair DPCs is likely to cause genomic instability. 
 
DPCs can be formed through enzymatic reactions in the cell. The best examples are 
those involving topoisomerases (Chen et al., 2013). Topoisomerase 1 (TOP1) 
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relieves DNA supercoiling by introducing a single strand break and remaining 
covalently attached to DNA until re-ligation of the DNA is complete. TOP2 works by 
introducing double strand breaks. Both TOP1 and 2 can be trapped in this covalent 
reaction intermediate through chemotherapeutic drugs and, interestingly, through 
nearby DNA lesions (Pommier, 2006; Pourquier et al., 1997). Therefore, exposure 
of cells to DNA damaging agents can stabilize these normally transient covalent 
complexes as DPCs.  
 
Non-enzymatic DPCs involve proteins in close proximity to DNA. One of the most 
potent and commonly used crosslinking agents is formaldehyde, as a part of 
chromatin immunoprecipitation assays for DNA-protein interaction studies. It works 
mainly by forming a covalent bond between guanine and nucleophilic amino acid 
residues lysine and cysteine (Lu et al., 2010; Solomon et al., 1988). Mice exposed 
to formaldehyde by inhalation exhibit DPCs, lowered glutathione and higher reactive 
oxygen species (ROS) and malondialdehyde in their bone marrow and other organs 
(Ye et al., 2013). It has even been proposed that number of DPCs can be used as a 
biomarker for occupational exposure to formaldehyde (Shaham et al., 1997). 
 
Production of ROS through cellular redox reactions and oxidative stress conditions 
can result in various types of DNA and protein damage. This altered chemistry can 
result in reactions to occur between DNA and proteins. Oxidation of guanine, 
cytosine or thymine DNA bases, and lysine or tyrosine protein side chains by ROS 
can result in reactions that can cause DPC formation (Tretyakova et al., 2015).  
There are various proposed crosslinking mechanisms, such as hydroxyl radical 
(•OH) mediated abstraction of a methyl group from thymine and its subsequent 
reaction with tyrosine (Dizdaroglu et al., 1989; Tretyakova et al., 2015). 
 
5.1.2 6-Thioguanine and UVA mediated DPCs 
Heat and reducing agent-resistant DPCs are formed when oligopeptides are 
incubated with oligonucleotides containing GSO3, an oxidized form of 6-thioguanine 
(6-TG). Crosslinking can involve free amino groups (arginine, asparagine, glutamine, 
lysine), which are often exposed on the protein surface due to their hydrophilic 
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nature (Gueranger et al., 2011). DPCs are detected when cells containing DNA 6-
TG are exposed to UVA. Preliminary findings indicated that PCNA, MSH2 and XPA 
DNA replication/repair proteins were among those crosslinked by 6-TG+UVA. This 
work underlined the susceptibility of nuclear proteins in close proximity of DNA to 
DPC formation. 
 
Ciprofloxacin, like 6-TG, is a Type II photosensitizer. Unlike 6-TG, it does not become 
covalently embedded in DNA.  Prior to my starting this project, the ability of UV 
photoactivated ciprofloxacin to generate DPCs had not been examined. 
 
5.1.3 Detection of DPCs 
There are several methods by which DPCs generated in cells can be detected. In 
the alkaline elution assay, cell lysates are applied to filters that bind DNA (Fornace 
and Kohn, 1976). Under alkaline conditions, smaller DNA fragments unwind and 
pass through the membrane. Increased DNA elution following protease treatment 
reveals the presence of DPCs. DPCs may also be detected by the change in buoyant 
density in caesium chloride of DNA extracted from cells (Barker et al., 2005a; 
Gueranger et al., 2011; Lipinski, 2011; Subramanian and Furbee, 2001).  In addition, 
the presence of DPCs decreases the yield of DNA from cells treated with a DPC 
inducing agent. Restoration of quantitative DNA recovery by the inclusion of a 
protease step indicates the presence of DPCs.  
 
Crosslinked proteins can be identified from the DNA fraction by fluorescent labelling 
and mass spectrometry (MS) (Shoulkamy et al., 2012; Tretyakova et al., 2015). The 
involvement of specific proteins in DPCs can be revealed by immunoblotting in the 
rapid DNA adduct recovery (RADAR) approach, in which extracts from treated cells 
are applied to nitrocellulose or PVDF (polyvinylidene difluoride) membranes and 
probed with antibodies (Kiianitsa and Maizels, 2013). Each of these methods has 
drawbacks either in the ability to identify the crosslinked species or their quantitation. 
For this reason, I developed an improved and unbiased method for DPC analysis. 
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5.1.4 Mass spectrometry 
In order to study proteins involved in DPCs, Gherezghiher et al. used 1,2,3,4-
Diepoxybutane, a carcinogenic metabolite of 1,3-butadiene found in urban air and 
cigarette smoke, to generate DPCs in human fibrosarcoma cells (Gherezghiher et 
al., 2013). Their method of DPC isolation involved extracting DNA from treated cells 
and subjecting them to neutral thermal hydrolysis to release protein-guanine 
conjugates, which were separated by SDS-PAGE and analysed by MS 
(HPLC−ESI+−MS/MS). They identified around 150 proteins that included histones, 
high mobility group proteins, transcription factors, splicing factors, and tubulins and 
identified the presence of crosslinks between protein cysteine thiols and N-7 guanine. 
The drawback of this approach is that it relies on a chemically modified DNA base 
as the DNA end of the DPCs. 
 
Chromatin enrichment of proteins (ChEP) utilises formaldehyde to form crosslinks 
between DNA and protein and involves resuspending chromatin in sodium dodecyl 
sulphate and urea to remove non-specific interactions before detection by MS 
(Kustatscher et al., 2014). However, the authors recognise that not all contaminating 
proteins are removed in this approach. 
 
The study by Kustatscher et al. involved stable isotope labelling by amino acids in 
cell culture (SILAC) (Kustatscher et al., 2014). SILAC involves growing two 
populations of cells that have been grown in medium supplemented with ‘heavy’ 
amino acid, which includes 2H instead of 1H, 13C instead of 12C, or 15N instead 
of 14N. This results in a mass shift for the proteins from cells grown in heavy medium 
compared to the light version without any other chemical changes. This metabolic 
labelling is stable and complete labelling occurs after five cell doublings, even for 
proteins that do not exhibit a significant turnover. 
 
SILAC allows comparison of proteins from cells that have undergone different 
treatments (reviewed by (Mann, 2006)). An advantage is that cells can be pooled 
together after undergoing a variety of different treatments and any further processing 
can occur without introducing artefacts due to differential handling of samples. Upon 
extraction and analysis by MS, the peptides with the lower and higher masses can 
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be compared as a pair in the mass spectra. If they appear to be in a 1:1 ratio, there 
is no difference between the two proteomes. If there is a difference, due to the mass 
shift, it is possible to identify in which proteome the protein is more or less abundant. 
I therefore developed a SILAC-based approach that provides a more statistically 
rigorous and sensitive method of DPC analysis. 
 
5.1.5 Aims 
My aims at the outset were to: 
- Develop a sensitive and statistically rigorous proteomic method to study 
DPCs following a variety of damaging treatments, 
- Examine the types of proteins involved in DPC formation. 
 
5.2 Results 
5.2.1 UVA-mediated DPC formation in CCRF-CEM cells containing DNA 6-TG 
I measured 6-TG incorporated into the DNA of CCRF-CEM cells grown in medium 
containing 6-TG. Incorporation was concentration dependent and non-linear (Table 
5.1). Inhibition of DNA replication by pre-treatment with hydroxyurea (HU) for 6 hours 
prior to addition of 6-TG reduced incorporation to below detectable levels. 
 
 
Table 5.1: Incorporated 6-TG as a percentage of DNA guanine in CCRF-CEM cells 
Cells were incubated in medium containing 6-TG for 48 h. DNA was extracted and 6-TG 
and guanine measured by HPLC (see Section 2.3.8). Hydroxyurea (HU, 3mM) was 
added 6 hours prior to addition of 6-TG and was present throughout the subsequent 
incubation. 
 
6-TG concentration  
(μM) 
Incorporated 6-TG as a percentage of DNA guanine 
(%) 
0 0 
0.3 0.047 
0.6 0.17 
0.9 0.61 
0.9 + HU <0.001 
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Previous investigations had revealed that the yield of DNA extracted using the 
Wizard (Promega) extraction protocol was reduced if the cells had been treated with 
6-TG and UVA (Gueranger et al., 2011).  The Wizard protocol involves a protein 
precipitation step prior to harvesting the DNA. When cells have proteins covalently 
attached to their DNA, this step can result in the precipitation of these proteins and 
therefore loss of DNA and a decline in the final DNA concentration that is measured. 
Quantitative DNA recovery is restored by the inclusion of a proteinase K digestion 
step before DNA precipitation – implicating DPCs in the DNA losses. 
 
An example of this behaviour is shown in Table 5.2, which reports the increase in 
DNA recovery achieved by including proteinase K digestion during purification of 
DNA from 6-TG+UVA treated CCRF-CEM cells. The modest dose of UVA (50 kJ/m2) 
did not affect DNA recovery whereas 6-TG treatment resulted in significant DNA 
losses that were reversed by proteinase K digestion. The effects of 6-TG and UVA 
were synergistic and treatment with 0.9μM 6-TG+UVA resulted in complete loss of 
extractable DNA. Thus, 6-TG+UVA treatment, and to a lesser extent 6-TG alone, 
induce the formation of DPCs in CCRF-CEM cells.  
 
The dependence of DPC formation on DNA-embedded 6-TG was investigated in two 
ways. Firstly, DNA recovery was measured in 6-TG-treated GM03467 Lesch-Nyhan 
fibroblasts. These cells do not express hypoxanthine-guanine 
phosphoribosyltransferase and cannot salvage 6-TG for DNA incorporation. DNA 
recovery was quantitative and was unaffected by proteinase K digestion in Lesch-
Nyhan cells treated with 6-TG+UVA (Table 5.2). Secondly, CCRF-CEM cells were 
treated with HU prior to and during incubation with 6-TG to prevent DNA replication 
and 6-TG incorporation.  The yield of DNA was again quantitative with or without 
proteinase K digestion.  These findings indicate that 6-TG-induced DPC formation 
requires DNA-embedded 6-TG. 
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Table 5.2: Proteinase K induced increase in DNA recovery 
Cells were treated with 6-TG for 24 hours. CCRF-CEM cells treated with hydroxyurea 
(HU) were incubated with HU for 6 hours prior to 6-TG addition. GM03467 Lesch-Nyhan 
cells are hypoxanthine-guanine phosphoribosyltransferase deficient and cannot 
scavenge 6-TG for DNA incorporation. DNA extracts were made with Wizard (Promega) 
extraction kit and measured by NanoDrop. Results of the paired t-tests comparing each 
treatment to the control sample are shown. ns, not significant (p >0.05); * (p<0.05), ** 
(p<0.01). All values are mean of ≥ 2 independent determinations. 
 
Treatment CCRF-CEM CCRF-CEM with 
3mM HU 
GM03467 Lesch-
Nyhan cells 
No treatment 1.00 1.00 1.01 
50kJ/m2 UVA 1.09 (NS) 1.03 (NS) 1.04 (NS) 
0.3μM 6-TG 1.82* 1.03 (NS) 1.07 (NS) 
0.9μM 6-TG 2.44* 1.04 (NS) 1.09 (NS) 
0.3μM 6-TG + UVA 3.85** 1.01 (NS) 1.02 (NS) 
 
 
DNA 6-TG generates ROS when cells are exposed to UVA. Unincorporated free 6-
TG and its nucleot(s)ides are also a source of ROS upon UVA activation. To 
determine whether DNA 6-TG-derived ROS were required for DPC formation, I 
measured intracellular ROS in CCRF-CEM cells, CCRF-CEM cells treated with HU 
and GM03467 Lesch-Nyhan cells.  
 
Figure 5.1 (A) shows that UVA induces ROS in 6-TG-treated GM03467 Lesch-Nyhan 
cells. Since these cells do not incorporate 6-TG, ROS production can be ascribed to 
free intracellular 6-TG.  Consistent with this view, approximately similar ROS levels 
are generated in UVA-irradiated CCRF-CEM cells treated with 6-TG in the presence 
of HU (Figure 5.1 (B)). Since UVA does not induce detectable DPCs under these 
conditions, it appears that this level of ROS is insufficient for DPC formation in the 
absence of DNA-embedded 6-TG. Incorporated DNA 6-TG makes a major 
contribution to UVA-induced ROS (Figure 5.1 (B), orange line). There is significant 
DPC formation under these conditions, indicating that ROS generated from DNA 6-
TG is a significant contributor to DPC formation. I note, however, that since 6-TG is 
more reactive than canonical DNA bases, the preferential formation of DPCs 
involving DNA 6-TG or its oxidation products is not excluded by these data. 
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A. GM03467 Lesch-Nyhan 
 
B. CCRF-CEM+HU 
 
 
 
Figure 5.1: Intracellular ROS measurements with and without 6-TG incorporation 
(A) GM03467 Lesch-Nyhan cells were treated with indicated doses of 6-TG for 24 hours 
and 50kJ/m2 UVA. (B) CCRF-CEM cells were treated with hydroxyurea (HU) for 6 hours 
prior to 6-TG incubation and maintained in the medium along with 6-TG for 24 hours and 
irradiated with 50kJ/m2 UVA. Cells were all incubated for 20 minutes with 7.5μM CM-
H2DCFDA prior to UVA irradiation and were washed and resuspended in PBS for 
subsequent FACS analysis. The fluorescence intensity (FL1-H log 10) vs frequency 
distribution (counts) is shown. 
 
 
No treatment 
0.3μM 6-TG 
0.9μM 6-TG 
0.9μM 6-TG+UVA 
 
No treatment 
0.9μM 6-TG 
0.9μM 6-TG+HU 
0.9μM 6-TG+UVA+HU 
0.9μM 6-TG+UVA 
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5.2.2 Optimising detection of individual proteins in DPCs 
To investigate DPC formation in CCRF-CEM cells, I devised a method to enrich for 
DPCs. In order to do this, I needed to eliminate proteins that were non-covalently 
associated with DNA. I therefore prepared chromatin and depleted it of non-
covalently associated proteins by high salt (500mM NaCl) washes. Sheared, salt-
washed chromatin was then applied to a Hybond-N+ membrane, which has high 
affinity for DNA. The DNA was crosslinked to the membrane by UVC irradiation 
(Stratalinker). Any remaining non-covalently associated proteins were further 
depleted by extensive washing with 8M urea. Figure 5.2 shows an example of a 
membrane to which chromatin from CCRF-CEM cells treated with 6-TG+UVA had 
been applied. It demonstrates the decrease in background protein levels (SyproRuby 
staining) achieved by the urea wash and shows further that this step did not affect 
the amount of bound DNA (SYBR Green staining).  
 
DNA repair/replication proteins were detected on the urea-washed membranes by 
antibody probes. An example is shown in Figure 5.2. The presence of XPA, PCNA 
and MSH2 in DPCs was confirmed (Gueranger et al., 2011) and I additionally 
detected RPA70, which I focused on extensively in the previous two chapters. 
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Figure 5.2: Detection of DNA-crosslinked proteins 
CCRF-CEM cells were treated with 6-TG and 50 kJ/m
2
 UVA as indicated. Chromatin was 
prepared, washed with 0.5M salt, extensively sheared and UVC-crosslinked to a 
HyBond-N+ membrane. Membranes were washed with 8M urea that was removed by 
rinsing with water.  Protein and DNA on the membrane were detected by staining with 
Sypro Ruby and SYBR Green, respectively. The membrane was probed with antibodies 
against MSH2, PCNA, RPA70 and XPA. 
 
5.2.3 A proteomics method to study DPCs 
Immunodetection of DNA crosslinked proteins on Hybond-N+ membranes is 
insensitive and depends absolutely on the availability of high quality antibodies that 
produce very little or no non-specific staining. These requirements severely limit its 
applicability. I therefore developed a proteomics-based method to identify proteins in 
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DPCs in a comprehensive, statistically rigorous and unbiased way. These 
experiments were carried out in collaboration with Drs. Karin Barnouin and Bram 
Snijders from the Protein Analysis and Proteomics Laboratory at Clare Hall.  
 
The experimental scheme is presented in Figure 5.3. It utilises SILAC, which 
provides an internal control and enables a statistically rigorous comparison of 
samples. CCRF-CEM cells were grown for a week in medium containing heavy or 
light isotopes of arginine and lysine. Full isotopic labelling of proteins was confirmed 
by MS. Samples that have been exposed to exactly the same treatment can be 
labelled in the opposite way with light and heavy labels and compared. If the results 
of the two experiments match each other, it means that two independent experiments 
of the same treatment have resulted in the same outcome. 
 
One half of each heavy and light culture was treated with 0.9μM 6-TG for 24 hours. 
The other half was untreated. Half of each of the resulting four cultures was irradiated 
with UVA (50 kJ/m2) and the other half was unirradiated. Equal numbers of light and 
heavy-labelled cells were mixed (Figure 5.3, table) to generate 16 Mixes of heavy 
and light-labelled cells in 1:1 ratios. Each of these Mixes was then divided into two 
equal aliquots. One half of each was used to prepare salt-washed sheared chromatin 
that was applied to the HyBond-N+ membrane. Following washing with 8M urea, 
membrane-associated proteins were digested with trypsin in situ and the digests 
analysed by MS. This procedure was designed to enrich for DPCs. 
 
A DNA-free whole cell (RIPA) extract was prepared from the other half of each Mix.  
These were separated by SDS-PAGE and digested in-gel with trypsin for subsequent 
MS analysis.  If certain proteins become crosslinked to DNA, there would be a 
selective loss of these proteins in the RIPA extract. This would not only give an 
indication of the impact of DPC formation, resulting in a noticeable decline in overall 
extractable protein, but also would act to validate the results of the chromatin 
experiment.  
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Figure 5.3: Outline of the SILAC analysis 
CCRF-CEM cells were labelled with heavy or light arginine and lysine isotopes and half 
were treated with 0.9μM 6-TG for 24 hours. Half of the cells from each culture were 
irradiated with 50 kJ/m2 UVA and the remaining cells were not irradiated. Cells from each 
of the 8 cultures were mixed in a 1:1 ratio as indicated in the table of mixes. The 16 
mixed samples were then divided into two equal aliquots., From one aliquot, chromatin 
was prepared and applied to a HyBond-N+ membrane for MS analysis. The other aliquot 
was used to prepare a DNA-free whole-cell (RIPA) extract for SDS-PAGE and MS 
analysis. 
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5.2.4 DPC formation by 6-TG+UVA 
In two independent experiments of forward and reverse SILAC labelling, MS analysis 
identified 2611 proteins from Hybond-N+ membrane-bound, DPC enriched samples. 
The analysis of each Mix provides a heavy/light (H/L) ratio. This is a ratio of the 
abundance of heavy and light-labelled proteins in that particular Mix. As an intrinsic 
quality control, mixes of cells that were labelled differently but were otherwise treated 
in exactly the same way were compared. The H/L ratio for these proteomes was 
expected to be 1.0. Deviations from 1.0 (expressed as log2 = 0) reflect the effects of 
treatments.  
 
An example of this intrinsic SILAC control is shown in Figure 5.4. In the Table in 
Figure 5.3, it can be seen that Mixes 1, 6, 11 and 16 contain heavy and light-labelled 
cells that have received identical treatments. Figure 5.4 (A and B) present scatter 
and density plots for Mix 1. The protein abundance is represented as intensity or 
density, which refers to the statistical distribution of a variable. This is plotted as a 
function of H/L ratio. As expected, the H/L ratios for Mix 1 (combined untreated heavy 
and untreated light-labelled cells) cluster symmetrically around the log2 value of 0, 
indicating equal abundance of heavy and light isomers of the proteins and confirming 
that Mix 1 contains an accurate 1:1 ratio of heavy and light-labelled cells. More than 
99.5% of the H/L ratios lie between log2 values of -1 and +1. In analysing the effects 
of treatments, I therefore considered values outside this range (>2 fold enrichment) 
to be a significant response to treatment and a result of DPC formation. As expected, 
the distributions for Mixes 6, 11 and 16 also cluster tightly around log2 values close 
to zero (Figure 5.4 (C-F)). 
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A. Mix 1-Scatter plot 
 
B. Mix 1- Density plot 
 
C. Mix 6 
 
D. Mix 11 
 
E. Mix 16-Scatter plot 
 
F. Mix 16-Density plot 
 
Figure 5.4: SILAC H/L ratios of the control samples 
CCRF-CEM cells were labelled with heavy (H) or light (L) arginine and lysine isotopes 
and treated with 0.9μM 6-TG for 24 hours and irradiated with 50 kJ/m2 UVA as indicated. 
Chromatin extracts were applied on HyBond-N+ membranes, subject to in situ trypsin 
digestion and analysed by MS. Scatterplots of log2 SILAC H/L ratios of the detected 
proteins in each sample vs log10 Intensity (A, C, D and E) or Density (B and F) are 
presented. The H/L values at 5% and 95% of the density distribution are indicated. 
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An increase in H/L ratios indicates that the heavy-labelled cells contain more of a 
particular protein compared to the light-labelled cells. If 6-TG+UVA causes DPC 
formation, we would expect the heavy-labelled cells treated with 6-TG+UVA 
compared to untreated light-labelled cells to result in an increase in the SILAC H/L 
ratio. A decrease in H/L ratios would result from the reverse, if the light-labelled cells 
were treated with 6-TG+UVA and the heavy-labelled cells were left untreated. 
 
Starting with UVA, Mix 2 is a mixture of heavy-labelled cells treated with UVA and 
untreated light-labelled cells. Mix 5 is the reverse-labelled version of Mix 2 that 
comprises UVA-treated light-labelled cells and untreated heavy-labelled cells. The 
distribution/scatter plots for these mixes are presented in Figure 5.5 (A and B for Mix 
2; C and D for Mix 5) . In both cases, there are no changes in the H/L ratio, indicating 
a lack of DPC formation with UVA treatment at this particular dosage. 
 
Mix 3 is a mixture of heavy-labelled cells treated with 6-TG and untreated light-
labelled cells. Mix 9 is the reverse-labelled version of Mix 3 that comprises 6-TG-
treated light-labelled cells and untreated heavy-labelled cells. The distribution/scatter 
plots for these mixes are presented in Figure 5.6 (A and B for Mix 3; C and D for Mix 
9). In each case there is a shift in the H/L ratios, where the ratios increase when 
heavy-labelled cells are treated with 6-TG and decrease when light-labelled cells are 
treated. This is consistent with a 6-TG-mediated enrichment in DNA-associated 
proteins. The effect is small, however, and most of the values fall within -1 and +1 
representing < 2-fold enrichment. 
 
In contrast, 6-TG+UVA (Mixes 4 and 13) caused significant changes in the 
distribution of H/L ratios as seen in Figure 5.7 (A and B for Mix 4; C and D for Mix 
13). In each case there is a highly significant shift in the H/L ratios, where the ratios 
increase when heavy-labelled cells are treated with 6-TG+UVA and decrease when 
light-labelled cells are treated. Most of the ratios fall outside the -1 to +1 range and 
confirm a significant increase in DPC formation. Since UVA on its own did not induce 
significant changes in H/L ratios, the effects of 6-TG and UVA on DPC formation are 
synergistic.  
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A. Mix 2- Scatter plot 
 
B. Mix 2- Density plot 
 
 
 
 
 
 
 
 
 
 
 
 
C. Mix 5- Scatter plot 
 
 
 
D. Mix 5- Density plot 
 
 
 
Figure 5.5: SILAC H/L ratios for UVA treatment  
CCRF-CEM cells were labelled with heavy (H) or light (L) arginine and lysine isotopes 
and irradiated with 50 kJ/m2 UVA as indicated. Chromatin extracts were applied on 
HyBond-N+ membranes, subject to in situ trypsin digestion and analysed by MS. 
Scatterplots of log2 SILAC H/L ratios of the detected proteins in each sample vs log10 
Intensity (A and C) or Density (B and D) are presented. The H/L values at 5% and 95% 
of the density distribution are indicated. 
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A. Mix 3- Scatter plot 
 
B. Mix 3- Density plot 
 
 
 
 
 
 
 
 
 
 
 
 
C. Mix 9- Scatter plot 
 
 
 
D. Mix 9- Density plot 
 
 
 
Figure 5.6: SILAC H/L ratios for 6-TG treatment  
CCRF-CEM cells were labelled with heavy (H) or light (L) arginine and lysine isotopes 
and treated with 0.9μM 6-TG for 24 hours as indicated. Chromatin extracts were applied 
on HyBond-N+ membranes, subject to in situ trypsin digestion and analysed by MS. 
Scatterplots of log2 SILAC H/L ratios of the detected proteins in each sample vs log10 
Intensity (A and C) or Density (B and D) are presented. The H/L values at 5% and 95% 
of the density distribution are indicated. 
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A. Mix 4- Scatter plot 
 
B. Mix 4- Density plot 
 
 
 
 
 
 
 
 
 
 
 
 
C. Mix 13- Scatter plot 
 
 
 
D. Mix 13- Density plot 
  
 
 
Figure 5.7: SILAC H/L ratios for 6-TG+UVA treatment  
CCRF-CEM cells were labelled with heavy (H) or light (L) arginine and lysine isotopes 
and treated with 0.9μM 6-TG for 24 hours and irradiated with 50 kJ/m2 UVA as indicated. 
Chromatin extracts were applied on HyBond-N+ membranes, subject to in situ trypsin 
digestion and analysed by MS. Scatterplots of log2 SILAC H/L ratios of the detected 
proteins in each sample vs log10 Intensity (A and C) or Density (B and D) are presented. 
The H/L values at 5% and 95% of the density distribution are indicated. 
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A. Mix 12- Scatter plot 
 
B. Mix 12- Density plot 
 
 
 
 
 
 
 
 
 
 
 
 
C. Mix 15- Scatter plot 
 
 
 
D. Mix 15- Density plot 
  
 
 
Figure 5.8: SILAC H/L ratios for 6-TG+UVA treatment vs. 6-TG only 
CCRF-CEM cells were labelled with heavy (H) or light (L) arginine and lysine isotopes 
and treated with 0.9μM 6-TG for 24 hours and irradiated with 50 kJ/m2 UVA as indicated. 
Chromatin extracts were applied on HyBond-N+ membranes, subject to in situ trypsin 
digestion and analysed by MS. Scatterplots of log2 SILAC H/L ratios of the detected 
proteins in each sample vs log10 Intensity (A and C) or Density (B and D) are presented. 
The H/L values at 5% and 95% of the density distribution are indicated. 
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This synergy was confirmed in the analysis of Mixes 12 and 15 (Figure 5.8 A and B 
for Mix 12; C and D for Mix 15), which specifically addresses the effect of UVA on 
cells treated with 6-TG. Mix 12 is a mixture of heavy-labelled cells treated with 6-
TG+UVA and light-labelled cells treated with 6-TG. Mix 15 is the reverse-labelled 
version of Mix 12 that comprises 6-TG+UVA treated light-labelled cells and 6-TG 
treated heavy-labelled cells. In the absence of synergy between 6-TG and UVA, the 
log2 H/L ratios when comparing 6-TG and 6-TG+UVA would fall within the -1 to +1 
range, indicating no change. However, there is a highly significant shift in H/L ratios 
confirming that efficient DPC formation requires both 6-TG and UVA and their effects 
are synergistic. 
 
H/L ratio density distributions and scatter plots for analysis of the other mixes are 
presented in the Appendix (Figure 7.1). 
 
Figure 5.9 is an example of an alternative presentation of the SILAC data for DPC 
formation. In it, each treatment is compared to its equivalent reverse label treatment. 
By performing this comparison, I combine data from two completely independent 
experiments to analyse changes in the amount of specific proteins as a result of 
treatment in otherwise untreated cells. In other words, if the effect of a particular 
treatment is reproducible, a comparison of two reverse-labelled mixes should result 
in a correlation.  
 
Figure 5.9 (A) addresses the impact of UVA on DPC formation. It compares the H/L 
ratios of Mix 2 and Mix 5, which represents UVA (H)/No treatment (L) and No 
treatment (H)/UVA (L), respectively. It shows that H/L ratios remain tightly clustered 
around the origin of the scatter plot. This is in agreement with the proteinase K data 
and confirms that 50kJ/m2 UVA does not induce significant DPC formation.  
 
On the other hand, comparison of Mixes 3 and 9 (Figure 5.9 (B)) results in a negative 
correlation, where a majority of the proteins shift to the lower right hand quadrant. 
This shows the effect of 6-TG treatment on membrane-associated protein. The fact 
that 6-TG (H)/ No treatment (L), shows an increase in protein ratios and the reverse 
label results in a decrease, indicates that 6-TG alters the association of proteins with 
DNA in two independent experiments. Even though this effect is reproducible, a 
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majority of the proteins (84 and 93% for Mixes 3 and 9, respectively) still lie within 
the -1 and 1 range. Therefore, we can conclude that 6-TG on its own induces a low 
level of DPC formation. 
 
A similar analysis addressing the effects of 6-TG+UVA treatment is shown in Figure 
5.9 (C). In this case, an increase in protein H/L ratios for 6-TG+UVA (H)/No treatment 
(L), and decrease in ratios for the reverse label results in the majority of proteins 
occupying the lower right hand quadrant of the scatter plot. Most of the ratios lie 
outside the -1 to 1 range of log2 values. In this way, data from two independent 
experiments combine to demonstrate significant DPC formation by 6-TG+UVA. 
 
Synergy between 6-TG and UVA in DPC formation (Figure 5.9 (D)) was 
demonstrated by combining data from Mixes 12 and 15 to specifically address the 
effect of UVA on cells treated with 6-TG. The effect of UVA here clearly differs from 
its effect in non-6-TG treated cells, underlining the photosensitising effect of 6-TG 
and the synergy between 6-TG+UVA in DPC formation.  
 
In conclusion, I have developed a proteomics-based analysis that uses SILAC to 
reveal extensive DPC formation by combined 6-TG+UVA treatment of CCRF-CEM 
cells. It confirms that 6-TG and UVA act synergistically in DPC induction. 6-TG 
treatment induces only a low level of DNA-protein crosslinking and DPCs are not 
detected following exposure to the relatively low dose of UVA used.
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Figure 5.9: Comparison of protein SILAC H/L ratios 
CCRF-CEM cells were labelled with heavy (H) or light (L) arginine and lysine isotopes 
and treated with 0.9μM 6-TG for 24 hours and irradiated with 50 kJ/m2 UVA as indicated. 
Chromatin extracts were applied on HyBond-N+ membranes, subject to in situ trypsin 
digestion and analysed by MS. Scatterplots of log2 SILAC H/L ratios of the detected 
proteins in each Mix is shown. (A) Mix 2 vs Mix 5, (B) Mix 3 vs Mix 9, (C) Mix 4 vs Mix 
13, (D) Mix 12 vs Mix 15. 
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5.2.5 MS analysis of RIPA extracts and changes in protein abundance 
Treatment with 6-TG affects cells in numerous ways. In particular, it significantly 
impairs transcription and possibly translation. Since the cells are treated for 24 hours 
in my experiments, I examined whether 6-TG-mediated impairment of transcription 
and translation might have led to significant decline in protein abundance and 
skewing of crosslinking analysis in 6-TG treated cells. Proteomic analysis of DNA-
free whole cell (RIPA) extracts was carried out to address this possibility. 
 
In Figure 5.10 (A), I compared the chromatin extract Mix 3, which is a mixture of 
heavy-labelled cells treated with 6-TG and light-labelled cells left untreated, with the 
RIPA extract Mix 3 treated in exactly the same way. I have shown that 6-TG results 
in a change in SILAC H/L ratios and in Mix 3 results in an increase in the ratio due 
to some DPC formation. Therefore, the protein density should be moving up along 
the y-axis away from the origin to indicate DPC formation. This is indeed what we 
see in this plot. If 6-TG treatment had an impact on overall protein levels in the cell 
this would show up in the RIPA extract results and cause a shift along the x-axis. In 
this case, there does seem to be a very minor shift left, towards lower ratios. This 
shift almost entirely lies within the -1 to 0 range and is therefore not considered 
significant. Figure 5.10 (B), is the reverse label version of Figure 5.10 (A), and as 
expected the effect of 6-TG is mirrored in this plot. 
 
Figure 5.10 (C and D), show the effect of UVA, which results in protein ratios 
clustered around the origin of the graph. This indicates that UVA does not cause 
DPC formation, nor any change in protein abundance.  
 
In Figure 5.10 (E), I investigated the impact of 6-TG+UVA on DPC formation and 
overall protein abundance. There was again an increase in H/L ratios for the 
chromatin extract to indicate DPC formation, as I have demonstrated previously. 
However, there was also a significant shift left to indicate a decrease in protein 
recovery with treatment. Figure 5.10 (F), is the reverse label version of Figure 5.10 
(E), and as expected the effect of 6-TG+UVA is mirrored in this plot.  
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A 24-hour incubation of cells with 6-TG can inhibit transcription and/or translation 
and can therefore cause changes in protein abundance. If this were the case then 
we should see a similar dramatic shift in the 6-TG only treatment, which we do not. 
 
The analysis did, however, reveal a significant decline in protein recovery when 6-
TG and UVA were combined. Since cell extracts were prepared immediately after 
irradiation, these losses cannot reflect changes in transcription/translation. The 
formation of DPCs is probably a significant contributor to reduced protein recovery 
in this case. In addition, 6-TG+UVA causes widespread protein oxidation that 
negatively impacts protein solubility. Losses through precipitation most likely also 
contribute to diminished protein yields. 
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Figure 5.10: Comparison of SILAC H/L ratios of chromatin and RIPA extracts 
CCRF-CEM cells were labelled with heavy (H) or light (L) arginine and lysine isotopes 
and treated with 0.9μM 6-TG for 24 hours and irradiated with 50 kJ/m2 UVA as indicated. 
Chromatin extracts were applied on HyBond-N+ membranes, subject to in situ trypsin 
digestion and analysed by MS. DNA-free whole-cell (RIPA) extracts were separated by 
SDS-PAGE, trypsin digested in gel and analysed by MS. Scatterplots of log2 SILAC H/L 
ratios of the detected proteins in chromatin and RIPA extracts of identically treated cells 
are shown. 
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5.2.6 Proteins involved in DPCs 
MS analysis identifies which proteins are crosslinked to DNA. To analyse the proteins 
that are most vulnerable to crosslinking, I compiled the H/L ratio values of the upper 
95th percentile (5th percentile if the light-labelled cells are treated) to define the most 
extreme shifts in H/L ratio caused by each treatment. These values were obtained 
by K. Barnouin using density distributions and the ggplot2 data visualization package 
for the statistical programming language, R. The control samples were set to 0. The 
values are summarised in the table in Figure 5.11 (A).  
 
Using these figures, I generated an ideal protein profile plot (Figure 5.11 (A)), that 
represents the expected behaviour of the proteins most vulnerable to crosslinking by 
each treatment. Using Perseus, the software with which the data were analysed, I 
then determined the proteins with the closest match to the ideal profile. In Figure 
5.11 (B), the top 200 closest matches are superimposed in red on the profiles of all 
2611 proteins displayed in grey.  
 
I used Uniprot and Gene Cards to determine protein functions and classify them as 
nuclear/non-nuclear (Figure 5.11 (C)). Among the 200 best fits, 192 are 
predominantly nuclear proteins or can be detected in the nucleus. The three largest 
functional categories are gene expression (31%) and DNA replication/repair (16%), 
followed by cell cycle (11%).  
 
Interestingly, DNA- or RNA- binding proteins were equally represented and together 
accounted for around half of the 200 best fit proteins (Figure 5.11 (D)). Since 6-TG 
can also be incorporated into RNA and photoreactive purine analogues can crosslink 
proteins to RNA when exposed to UVA, it is possible that RNA-protein crosslinks 
contribute to overall nucleic acid-protein crosslinking (Costas et al., 2000). To 
examine this possibility, I measured the RNA content of the chromatin extracts 
applied to the HyBond N+ membrane. Since RNA comprises <2% of the total nucleic 
acids in these extracts, I conclude that RNA-protein crosslinks are unlikely to 
contribute significantly to overall crosslinking. The presence of RNA processing 
proteins most likely represents their presence in DPCs. 
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Figure 5.11: Analysis of proteins most vulnerable to DPC formation 
(A) 95th or 5th percentile heavy/light (H/L) ratios for each treatment are presented in the 
table and plotted in Perseus to form a hypothetical crosslinking profile. (B) The 
crosslinking profile of 200 proteins (red) that most closely match the hypothetical profile 
are superimposed on the profile of all identified proteins (grey). (C) Functional categories 
of the 200 proteins as specified by UniProt. (D) RNA and DNA binding by the 200 
proteins. 
 
 
 
Mix 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
95th or 5th
percentile ratio 0.00 0.52 1.18 2.44 -0.38 0.00 1.20 2.45 -1.04 -0.67 0.00 2.14 -2.62 -2.33 -1.89 0.00
Total=200
31%  Gene expression
16%  DNA repair and replication
11%  Cell cycle
10.5%  Protein processing
9.5%  Signalling
8%  Metabolism
5%  Structural
3.5%  Nuclear transport
2.5%  Chromatin regulation
2%  Translation
1%  Apoptosis Total=200
23%  DNA
24%  RNA
4.5%  Both DNA and RNA
48.5%  Neither DNA or RNA
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5.2.7 DNA crosslinking of DNA repair proteins 
The close proximity of DNA repair proteins to DNA may increase their vulnerability 
to crosslinking. My analysis identified 52 members of a list of 179 DNA repair proteins 
(http://sciencepark.mdanderson.org/labs/wood/dna_repair_genes.html). Figure 5.12 
(A) shows the profiles of these 52 DNA repair proteins. Most, but not all of them 
follow a similar pattern to the hypothetical crosslinking profile in Figure 5.11 (A). I 
selected the proteins that closely matched this profile and found that 30 of the 52 
were a good fit (Figure 5.12 (B)). Some others followed a similar pattern but deviated 
from the ideal profile in one or two of the treatment conditions. In addition, other DNA 
repair proteins were identified that did not change in a treatment-dependent manner.  
 
Consistent with their involvement in DPCs, analysis of RIPA extracts confirmed that 
the majority of the 30 DNA repair proteins were less abundant in cells treated with 6-
TG+UVA (Figure 5.12 (C)). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 5. Proteomics based method for identifying DPCs 
 
148 
 
A 
 
B 
 
C 
 
 
Figure 5.12: Crosslinking of DNA repair proteins 
(A) Log2 SILAC Heavy/Light (H/L) ratio profiles of 52 designated DNA repair proteins 
detected in the analysis. (B) Log2 SILAC H/L ratio profiles of 30 proteins among the 52 
repair proteins that were detected, which closely match the hypothetical crosslinking 
profile. (C) Log2 SILAC H/L ratio profiles for the 30 DNA repair proteins (in red) most 
vulnerable to crosslinking to DNA, superimposed on all identified proteins (grey) from 
DNA-free whole cell (RIPA) extracts. 
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5.2.8 Analysis of individual DNA repair and replication proteins  
I investigated the crosslinking characteristics of individual DNA repair and replication 
proteins.  
 
DNA polymerase d (POLD) is a tetramer, required for DNA repair and replication. 
Three of the subunits, POLD1 (125kDa catalytic), POLD2 (66kDa) and POLD3 
(50kDa), were identified among the 2611 proteins but the smaller 12kDa subunit was 
not. The SILAC H/L ratio profiles of these three proteins is presented in Figure 5.13 
(A-C). POLD1 is almost an exact match to the generic crosslinking profile defined in 
Figure 5.11 (A), confirming its vulnerability to crosslinking. As defined by the profile, 
POLD1 exhibits an altered H/L ratio following 6-TG treatment and a significant 
additional shift after 6-TG+UVA. POLD3 on the other hand appears to be 
predominantly vulnerable to photochemical crosslinking through 6-TG+UVA 
treatment. POLD2 is not a good fit to the expected crosslinking profile and may be 
less susceptible to crosslinking. 
 
The hexameric MCM complex (MCM2-7) is an essential component of DNA 
replication initiation. SILAC H/L ratio profiles of all six of the subunits match the 
expected crosslink profile and are almost perfectly superimposable (Figure 5.13 (D)). 
This suggests that the MCM complex is vulnerable to DPC formation by both 6-TG 
and 6-TG+UVA. 
 
Topoisomerases (TOPs) relieve supercoiling by introducing breaks in the DNA 
during replication and transcription. TOP1, TOP2A and 2B were among the proteins 
identified by the analysis. SILAC H/L profiles of these three proteins appear almost 
identical. They resemble the profile of POLD3 and it appears that TOPs are 
predominantly susceptible to photochemical crosslinking by 6-TG+UVA (Figure 5.13 
(E)). 
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Figure 5.13: DNA crosslinking of individual DNA repair/replication proteins 
Log2 SILAC heavy/light (H/L) ratio profiles of (A) POLD1, (B) POLD2, (C) POLD3, (D) 
MCM2-7 and (E) TOP1, 2A and 2B, in chromatin DPC extracts. 
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Analysis of RIPA extracts confirmed that the three POLD proteins (A), all six MCM 
proteins (B) and the three TOP proteins (C), were present at reduced levels following 
6-TG+UVA treatment (Figure 5.14). This is consistent with selective loss of these 
proteins due to DPC formation.  
 
 
A                                            B                                            C 
 
 
Figure 5.14: Loss of DNA replication/repair proteins in RIPA extracts 
Log2 SILAC heavy/light (H/L) ratio profiles of (A) POLD1, POLD2, POLD3, (B) MCM2-
7 and (C) TOP1, 2A and 2B, in RIPA extracts. 
 
 
5.2.9 DPC formation by ciprofloxacin+UVA 
I also used the SILAC/HyBond-N+ analysis to investigate DPC formation by 
ciprofloxacin+UVA (Cip+UVA). Unlike 6-TG, ciprofloxacin is not covalently 
incorporated into DNA and Cip+UVA-induced DPC formation must therefore involve 
canonical DNA constituents. Thus, Cip+UVA represents a proof of principle for the 
general detection of DPCs by this method.  
 
Heavy and light-labelled CCRF-CEM cells were treated with 500µM ciprofloxacin 
and 50 kJ/m2 UVA. The combination of treatments and the Mixes I prepared are 
presented in Figure 5.15 (A). Subsequent steps in the analysis were identical to 
those described for 6-TG+UVA.  
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Figure 5.15 (B) shows the changes in H/L ratios induced by Cip+UVA. The clustering 
of a majority of the proteins in the lower right hand quadrant of the scatter plot is 
similar to the distribution shift induced by 6-TG+UVA (Figure 5.9 (C)) and indicates 
extensive DPC formation. A total of 2269 crosslinked proteins were detected. The 
number of total DNA and RNA binding proteins in both the ciprofloxacin and 6-TG 
experiments were very similar, indicating that they have similar vulnerabilities to 
crosslinking under both treatment conditions (Figure 5.15 (C)). 
 
I identified 41 DNA repair proteins in the ciprofloxacin experiment compared to 52 
with 6-TG (http://sciencepark.mdanderson.org/labs/wood/dna_repair_genes.html). 
Among these, 29 of them fit the expected profile for DPC induction (no change for 
control Mixes 1 and 4, significant shift for Mixes 2 and 3). The SILAC H/L profile of 
these 29 proteins are presented in green in Figure 5.15 (D), superimposed on all of 
the proteins identified in the experiment in grey.  
 
I compared the types of DNA repair proteins that were crosslinked by 6-TG+UVA 
and with Cip+UVA. The Venn diagram in Figure 5.15 (E) reveals the significant 
overlap in the DNA repair proteins identified in the two experiments (p=	1.125879e-
11, calculated in R). The DNA repair proteins identified by both approaches are listed 
in Table 5.3. 
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Figure 5.15: Ciprofloxacin+UVA mediated DPC formation 
(A) Heavy (H) and light-labelled (L) CCRF-CEM cells were treated with 500µM 
ciprofloxacin (Cip) for 1 hour and UVA (50 kJ/m2) as indicated. Cells were counted and 
mixed at 1:1 ratio as indicated in the table. High salt-washed chromatin extracts were 
applied to a HyBond-N+ membrane. The membrane was washed with 8M Urea and water 
before membrane-associated proteins were digested in situ with trypsin and analysed by 
MS. (B) Scatterplot comparing log2 SILAC H/L ratios of proteins in Mix 2 and Mix 3. (C) 
DNA and RNA binding proteins identified in Cip+UVA (green) and 6-TG+UVA (blue) 
experiments. (D) Log2 SILAC H/L ratio profile plots of all identified proteins (grey) and 
29 DNA repair proteins that are most vulnerable to crosslinking (green). (E) Overlap of 
the 29 DNA repair proteins most vulnerable to crosslinking by Cip+UVA and the 30 
proteins by 6-TG+UVA. 
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Table 5.3: DNA repair proteins identified in DPCs 
DNA repair proteins identified to be most vulnerable to crosslinking by 6-
Thioguanine+UVA and Ciprofloxacin+UVA. (+) indicates crosslinking by the specified 
treatment. 
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5.2.10 Hierarchical clustering and identifying false positives 
Hierarchical clustering was used to identify proteins with similar behaviours. I found 
that it was a useful way to summarise all the data as a conclusion to this chapter. 
This method of analysis also identifies false positives. 
 
The hierarchical clusters for both 6-TG+UVA (A) and Cip+UVA (B) experiments are 
presented in Figure 5.16. By inspection, the majority of the proteins follow the 
crosslinking profile that I described earlier in the chapter. I placed this profile below 
the 6-TG+UVA cluster for reference. For treatments where we anticipate an increase 
in SILAC H/L ratios, for example where heavy-labelled cells are treated with 6-
TG+UVA, those columns in the clusters are mostly red (increase). For treatments 
were we anticipate a decrease in SILAC H/L ratios, for example where light-labelled 
cells are treated with 6-TG+UVA, those columns in the clusters are mostly green 
(decrease). 
 
Some groups of proteins exhibit hardly any change in response to treatment. These 
generate black sections in the heat map (example arrowed in Figure 5.16). I 
concluded that these are false positive proteins and analysed the members of this 
family in 6-TG+UVA treated cells. 
 
The crosslinking profiles of the 114 potential false positive proteins are shown in 
Figure 5.17 (A). They are largely unaffected by treatment and this confirms their false 
positive status. Gene expression is the largest functional group of these false 
positives. There are also numerous factors involved in ribosome biogenesis and 
chromatin regulation (eg. histones) in this group (Figure 5.17 (B)). There is no 
significant difference in the number of DNA and RNA binding proteins identified as 
false positives (Figure 5.17 (C)), compared to the proteins vulnerable to DPC 
formation (Figure 5.11 (D)). 
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Figure 5.16: Heat map of DPC formation 
Hierarchical clustering analysis of SILAC heavy/light (H/L) ratios of (A) 6-TG and (B) 
ciprofloxacin experiments. The general crosslinking profile is under the 6-TG heat map. 
Red indicates an increase and green indicates a decrease in SILAC H/L ratios. Arrow 
indicates family of potential false positive proteins. All clustering was Euclidean.  
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False positives may appear in the analysis because they are particularly high 
abundance proteins and have particularly strong affinity for DNA or for the HyBond-
N+ membrane. These reasons are not mutually exclusive. Among the 114 proteins, I 
identified the highly abundant intermediate filament protein, Vimentin. Histones were 
also present. These proteins are not only highly abundant, but also interact strongly 
with DNA.  
 
The Cip+UVA hierarchical clustering also revealed a family of 68 proteins that were 
unaffected by treatment (Figure 5.16 (B)). This family contained a large group of 
histone proteins. The histones identified are listed in Table 5.4. There is a significant 
overlap between the false positives from the 6-TG+UVA and Cip+UVA analyses.  
 
 
A 
 
B                                                                   C 
 
Figure 5.17: Analysis of false positives 
(A) Log2 SILAC heavy/light (H/L) ratio crosslinking profiles of 114 potential false positive 
proteins. (B) Functional characterization of the 114 proteins using UniProt. (C) DNA and 
RNA binding ability of the proteins. 
 
 
 
 
UVA light (U) 6-TG light (TG)   6-TG/UVA light (TG+U)   Control light (C)
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0
Total=114
31.58%  Gene expression
17.54%  Ribosome biogenesis
13.16%  Chromatin regulation
11.40%  Nuclear transport
9.65%  Signalling
7.02%  Structural
6.14%  Cell Cycle
2.63%  Metabolism
0.88%  Protein processing
Total=114
21.93%  DNA
18.42%  RNA
5.26%  Both DNA and RNA
54.39%  Neither DNA or RNA
Chapter 5. Proteomics based method for identifying DPCs 
 
158 
 
 
Table 5.4: Histones identified in the false positive group 
The gene names and protein names of histones identified in the false positives group of 
both the 6-thioguanine and ciprofloxacin experiments. The overlapping proteins between 
the two experiments are in bold. 
 
 
 
In summary, I have devised a SILAC and proteomics method to investigate DPC 
formation in human cells treated with UVA photosensitisers. The method identified 
over 2000 proteins that were crosslinked by a DNA incorporated photosensitiser (6-
TG) and a DNA embedded/intercalated photosensitiser (ciprofloxacin), underlining 
the versatility of the technique and the different ways by which DPCs can form. The 
proteins most susceptible to DNA crosslinking were those involved in gene 
expression and DNA repair and replication, including RPA. 
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Chapter 6. Discussion 
6.1 Oxidative damage to proteins caused by 6-TG+UVA 
The initial aim of this thesis was to investigate the oxidative damage caused by 6-
thioguanine (6-TG) and UVA (ultraviolet radiation) on proteins involved in DNA repair, 
in particular to study the possible functional impairment of RPA. As the project 
developed, I also examined whether antioxidant allopurinol is able to lower ROS 
levels generated by 6-TG+UVA and alleviate protein damage. 
 
At the outset, it had been shown that 6-TG+UVA generates intracellular ROS, 
particularly singlet oxygen (1O2) (O'Donovan et al., 2005). These findings were 
confirmed, and I was able to show in addition that allopurinol inhibited 1O2 production 
by 6-TG+UVA or UVA treatment. Protection by allopurinol was, however, only partial 
and it was unable to restore untreated steady state ROS levels.  
 
It had previously been shown that allopurinol alleviates DNA damage and improves 
cell survival following antioxidant depletion by 6-TG treatment (Brem and Karran, 
2012). Protection was ascribed to the antioxidant effects of allopurinol rather than its 
ability to inhibit xanthine oxidase (XO), because an alternative XO inhibitor 
(febuxostat) was unable to protect 6-TG-treated cells (Brem and Karran, 2012). Only 
allopurinol was able to scavenge UVA mediated ROS. 
 
The inability of allopurinol to reinstate steady state levels might reflect the different 
reactive oxygen species (ROS) generated by UVA and 6-TG+UVA. Both produce 
not only 1O2 but also superoxide, hydrogen peroxide and, in the presence of a metal 
cation, hydroxyl radicals (See Section 1.2.2). The scavenging ability of allopurinol 
may differ among the different types of ROS. In the case of 6-TG+UVA, it is clear 
from the magnitude of the signal (the x-axis is a logarithmic scale) that substantially 
high levels of ROS are produced that may overwhelm the allopurinol present. 
 
The short half-lives and diffusion distances of ROS make it likely that proteins in 
close proximity to DNA are more vulnerable to oxidation by UVA-activated DNA-
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embedded 6-TG. I found that 6-TG+UVA treatment decreased the recovery in cell 
extracts of three proteins involved in nucleotide excision repair (NER): XPD 
(xeroderma pigmentosum group D), XPA and RPA (replication protein A, RPA70). In 
the case of XPA and RPA70, the protein recovery was restored to apparently normal 
levels by the inclusion of allopurinol.  
 
The decrease in extractable protein is most likely due to protein oxidation. Structural 
changes including protein carbonylation, thiol oxidation or protein-protein 
crosslinking may expose hydrophobic regions that can result in aggregation, 
precipitation and loss during protein extraction. The improved recovery in the 
presence of allopurinol is consistent with an antioxidant effect.  
 
Normal levels of XPD were not recovered by allopurinol inclusion. It is noteworthy 
that XPD contains an iron-sulphur cluster which may make it particularly vulnerable 
to oxidative damage and precipitation. Alternatively, XPD may be vulnerable to a 
particular type of ROS that allopurinol is unable to scavenge (Liu and Huang, 2015). 
 
I also considered chromatinisation as a possible contributor to the lower recovery of 
RPA. 6-TG+UVA induces numerous different DNA lesions and causes replication 
arrest. Photoproducts induced by high doses of UVC also cause double strand 
breaks (DSBs) and stalled replication forks. These lesions recruit RPA to exposed 
single-stranded DNA (ssDNA) regions. My results show that RPA70 recovery 
decreases with time following 6-TG+UVA and UVC treatment and is improved by 
benzonase digestion. By digesting DNA, benzonase releases DNA-bound proteins. 
These results indicate that some RPA70 is most likely recruited to DNA following 6-
TG+UVA (and UVC) treatment and is lost to extraction under relatively low-salt 
conditions. They do not, however, discount the possibility that RPA is also oxidatively 
damaged. Benzonase treatment also releases protein covalently bound to DNA. 
Therefore, these findings do not exclude possible depletion of RPA by DNA-protein 
crosslinking.   
 
6-TG+UVA treatment resulted in a significant loss of ssDNA binding activity. This 
was not observed following UVC treatments that induced similar levels of 
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chromatinisation. These functional assays provide additional support for the 
conclusion that RPA suffers oxidative damage that impairs its function. 
 
An interaction between XPA and RPA is imperative for NER (Jiang et al., 2012; Saijo 
et al., 2011; Tsodikov et al., 2007). 6-TG+UVA treatment abolished this interaction. 
At the lower concentration of 6-TG tested (0.5μM), the chromatinisation is very low, 
suggesting that the complete loss of detectable binding is unlikely to be solely due 
to RPA chromatinisation. The absence of detectable RPA and XPA interaction is 
consistent with damage to RPA, XPA or to both proteins and is also consistent with 
the lower recovery of XPA from 6-TG+UVA treated cells. 
 
One important finding from my work is the formation of higher molecular weight RPA 
species of around 100 and 45-50kDa in cells treated with 6-TG+UVA. This 
modification does not occur in cells treated with 6-TG or with UVA alone. The 
modification is not due to severe DNA damage, stalled replication forks or fork 
collapse as it was not observed in cells treated with high doses of ionising radiation, 
hydroxyurea (HU) or UVC. 
 
The size of the higher molecular weight complexes suggests that they may be 
products of covalent crosslinking between RPA70 and RPA32 (102kDa), and RPA14 
and RPA32 (46kDa). The two prominent bands in the 45-50kDa region are consistent 
with RPA32 and RPA14 crosslinking in two different ways, perhaps through different 
residues, that result in slightly different migrations. Crosslinking is not via disulphide 
links as the complexes were resistant to denaturing conditions in the presence of 
DTT and β-mercaptoethanol. None of the complexes are detected with the RPA70 
and RPA14 antibodies, which may reflect the loss of the epitopes recognised by 
these antibodies through crosslinking or may simply be a result of the quality of the 
antibodies. It is also possible that the crosslinked RPA complexes involve other close 
interacting partners such as PCNA (proliferating cell nuclear antigen) or XPA. 
 
The protein-protein crosslinking appears to be mediated by ROS and was partially 
inhibited by allopurinol. However, the widely-used antioxidants N-acetyl cysteine 
(NAC) and ascorbic acid (AA) were not protective. Depending on the concentration 
and uptake by cells, antioxidants may also act as pro-oxidants. It is possible that 
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NAC and AA were not at the optimal concentration for antioxidant effects. Because 
these antioxidant experiments were equivocal, I sought confirmation of ROS 
involvement by using a different photosensitiser+UVA combination. 
 
Ciprofloxacin is also a UVA photosensitiser that generates ROS. Ciprofloxacin+UVA 
(Cip+UVA) generated modified RPA32 species that were similar to those formed by 
6-TG+UVA. This confirms that ROS are most likely responsible for these RPA32 
modifications. In addition, this indicates that protein-protein crosslink formation does 
not require the photosensitiser to be incorporated into DNA. Ciprofloxacin is not 
incorporated but maintains a close interaction with DNA through DNA intercalation 
(Vilfan et al., 2003). 
 
In summary, upon UVC and 6-TG+UVA treatment, RPA undergoes chromatinisation 
due to the formation of photoproducts and stalled replication forks. In addition to 
chromatinisation, RPA is also damaged, partially by inter-subunit crosslinking of 
RPA32. Impaired ssDNA and XPA binding by RPA can contribute towards loss of 
NER function in cells under oxidizing conditions. RPA is particularly susceptible to 
oxidation and this crosslinking is only one example of the oxidized RPA forms. In the 
next chapter, I investigated this crosslinking further and will discuss other types of 
RPA damage. In addition, I will be describing the impact of RPA overexpression in 
cells under oxidative stress. 
 
 
6.2 Photosensitiser+UVA mediated damage to RPA  
In this chapter, I describe my investigation into the nature and consequences of the 
damage caused to RPA by UVA photosensitising treatments. The photosensitisers 
were: 6-TG, ciprofloxacin, ofloxacin and FICZ (6-formylindolo[3,2-b]carbazole). This 
chapter addressed the impact of RPA overexpression on cell survival and DNA 
damage repair. An essential tool for this investigation was the RPA21 cell line in 
which RPA is modestly (two-fold) overexpressed. 
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RPA21 cells were more resistant than their parental U2OS cells to the toxic effect of 
the three photosensitisers. This indicates that a modest two-fold overexpression of 
RPA confers resistance to the toxicity caused by UVA photosensitising treatments. 
The cytotoxic effect of ofloxacin is more modest compared to ciprofloxacin or 6-TG 
in combination with UVA. All three photosensitiser+UVA combinations inhibited NER 
in U2OS cells. RPA overexpression in RPA21 cells prevented this inhibition. 
 
Both Cip+UVA and 6-TG+UVA can produce replication arresting lesions. Cip+UVA 
can result in the formation of T<>T cyclobutane pyrimidine dimers (CPDs) (Lhiaubet-
Vallet et al., 2009) and cause the chromatinisation of both RPA70 and DDB2 
confirming the presence of NER substrates (DDB2 data in (Guven et al., 2015)). 6-
TG+UVA causes the production of guanine sulfinate (GSO2) and guanine sulfonate 
(GSO3), single-strand and double-strand breaks, DNA-protein crosslinks (DPCs) and 
interstrand crosslinks (ICLs). It is therefore possible that depletion of RPA at stalled 
replication forks caused by 6-TG or ciprofloxacin and UVA can cause replication fork 
collapse and cell death. Exposure to UVC in addition to this damage, imposes 
conflicting demands on the RPA pool (Tsaalbi-Shtylik et al., 2014). In this case, not 
only is RPA demanded primarily at stalled replication forks but it is also taken up by 
regions of NER repair, resulting in depletion of RPA. Therefore, having more 
functional RPA in the cell can alleviate this competition between stalled replication 
forks and photolesions and allow NER to function.  
 
I consider it unlikely that chromatinisation is the only explanation for the effects on 
RPA for the following reasons: Firstly, replication fork collapse occurs exclusively in 
S phase. The almost complete inhibition of NER activity in photosensitiser+UVA 
treated U2OS cells indicate that the NER inhibition cannot be confined to S phase. 
Secondly, the CPDs that are generated by 6-TG+UVA and Cip+UVA are removed 
much less efficiently than the UVC-induced 6,4 Py:Pys (6,4 pyrimidine-pyrimidone 
photoproducts) that were monitored in the NER ELISA. They would not provide 
sufficient competition to inhibit NER (Hwang et al., 1999). In addition, Ofloxacin+UVA 
(Oflx+UVA) is a very weak source of replication blocking photolesions (T<>T CPDs) 
and does not result in RPA chromatinisation (Lhiaubet-Vallet et al., 2009; Peacock 
et al., 2014). Yet, Oflx+UVA is cytotoxic and inhibits NER. Finally, nuclear extracts 
used in the NER assays have a higher level of salt and do not exhibit a decrease in 
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RPA recovery with treatment, yet NER inhibition still occurs in 6-TG+UVA, Cip+UVA 
and Oflx+UVA treated cells (Gueranger et al., 2014; Guven et al., 2015; Peacock et 
al., 2014). This strongly suggests that RPA chromatinisation cannot fully account for 
NER inhibition in photosensitiser+UVA treated cells.  
 
UVA can result in the formation of CPDs, as well as causing ROS production and 
extensive protein oxidation. It has previously been shown that this oxidation 
damages NER proteins and inhibits NER (McAdam et al., 2016). In addition to 
photosensitisers, RPA overexpression also enables U2OS cells to partially 
overcome NER inhibition induced by high dose UVA. Oxidative damage to RPA is 
most likely responsible for this UVA-mediated inhibition of NER. Overexpression of 
RPA means that more undamaged RPA is available for NER. 
 
Higher levels of RPA also appear to increase baseline NER efficiency when cells are 
exposed only to UVC. The two-fold increase in RPA expression resulted in a 
significant increase in the rate of NER. This indicates that RPA levels may be limiting 
in NER at least in U2OS cells and that this limitation is more pronounced when cells 
are exposed to oxidative stress conditions.  
 
Data presented in Chapter 3 established that RPA undergoes oxidative damage to 
form a higher molecular weight complex. These photoproducts were also formed by 
Cip+UVA, as well as Oflx+UVA. This modification is not specific to tumour derived 
cell lines HeLa and U2OS, but is also formed in untransformed human fibroblasts. 
 
The availability of the RPA overexpressing cell line allowed me to investigate the 
nature of the crosslinked RPA products. Immunoprecipitation (IP) confirmed that the 
higher molecular weight species in the treated cells is crosslinked RPA32 and RPA70. 
Considering that RPA70 and RPA32 contain the ssDNA binding sites, crosslinking 
involving these two subunits is predicted to have a detrimental effect on ssDNA 
binding. 
 
According to the crystal structure of the RPA trimerisation core by Bochkareva et al., 
the interaction between the three subunits occurs through DBD-C/DBD-
D/RPA14(Bochkareva et al., 2002). There is a metal cation, zinc, coordinated by four 
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cysteines in the RPA DBD-C domain, which can lower the oxidation potential of 
RPA70 and result in oxidation and crosslinking. However, the structure places the 
Zn away from the trimerisation core, diminishing the possibility of its involvement in 
the crosslinking. The trimerisation is stabilised by amino acids, Tyr599, Tyr602, 
Leu606, Val607, Ile610 and Ala614 of RPA70; Met152, Phe155, Ile159, Leu160, 
Ile163 and Met167 of RPA32; and Leu98, Ala102, Ile105, Phe109 and Phe112 of 
RPA14. The crosslink between RPA70 and RPA32 can therefore be between a 
tyrosine and a methionine. The proposed mechanism for RPA binding suggests that 
when binding short length ssDNA (8-10nt) only DBD-A and B of RPA70 is engaged, 
while long length DNA binding (23-27nt) requires DBD-C and D for tight binding. This 
binding of DBD-C and D requires a conformational adjustment, which may be 
prohibited by the crosslinking and contribute towards the impaired NER in 
photosensitiser+UVA treated cells.  
 
As mentioned previously, the crosslinked portion is a very small fraction of the overall 
RPA32. Interestingly, assays for NER function show that this crosslinked form is 
present in all NER-negative extracts and is not detected in NER-functional extracts 
(NER assay results in (Guven et al., 2015)). It is possible that this crosslinked form 
exerts a dominant negative effect, however, it is more plausible that the crosslinking 
is an indication of widespread RPA damage. 
 
It is also important to address the clearance of heavily oxidised and crosslinked 
proteins from the cell. The proposed mechanism of clearance for proteins that 
experience low levels of oxidation is through the proteasome and for those that are 
heavily oxidised, it is through lysosomal pathways (Kaganovich et al., 2008; Rodgers 
et al., 2002). Crosslinking of proteins may make it difficult for them to fit through the 
channel of the proteasome and therefore deviate to the lysosomal pathway. In order 
to investigate whether crosslinked RPA and PCNA were processed by the 
proteasome, I used two proteasome inhibitors in combination, MG-132 and 
lactacystin. MG-132 is a peptide aldehyde that selectively and reversibly inhibits the 
activity of the 26S proteasome. Lactacystin works by irreversibly modifying specific 
catalytic subunits of the proteasome. Proteasome inhibition prevented the removal 
of PCNA crosslinks, indicating that they are removed through the proteasome. RPA 
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removal appeared to be partially prevented by proteasome inhibition, but a 
substantial proportion of crosslinked RPA was still removed after 24 hours.  
 
PCNA crosslinking can be detected at relatively low UVA doses. My prediction is that 
photosensitising treatments would further exacerbate this damage, resulting in a 
heavily oxidised protein. If this is the case, it is surprising that the crosslinked form 
of PCNA is mainly removed by the proteasome, considering the difficulty of unfolding 
heavily oxidised proteins. It is possible that other than crosslinking PCNA is not as 
heavily oxidised as RPA, which suffers further damage as described below. 
 
RPA is sensitive to oxidation and was identified in a screen for protein carbonyls 
(Peacock et al., 2014). The redox sensitivity of RPA also leaves it vulnerable to thiol 
oxidation (Men et al., 2007; Park et al., 1999). RPA contains 15 cysteines and four 
of them coordinate the zinc finger in DBD-C. This zinc finger is essential for RPA’s 
role in replication but not repair (Lin et al., 1998). These cysteines involved in zinc 
coordination are susceptible to disulphide bond formation, while the remaining 11 
cysteines were shown to be unaffected (Men et al., 2007). In my experiments, 
untreated RPA21 cells exhibited low but detectable levels of Cys-SOH, which is 
formed through cysteine oxidation. This type of modification can work as a redox 
switch to provide allosteric changes within the protein to alter its function, and can 
be reduced to a thiolate anion (Cys-S-) by thioredoxin and glutaredoxin to restore the 
protein to its original state (Groitl and Jakob, 2014; Hall et al., 2009; Winterbourn and 
Hampton, 2008). However, these can also be further and irreversibly oxidised to 
sulfinic and sulfonic acids and can react with other amino groups to generate 
sulfenamide crosslinks. Following Cip+UVA or Oflx+UVA treatments the level of 
oxidised cysteines were considerably higher, indicating significant oxidation of 
RPA32.  
 
In addition to RPA32 oxidation there was also detectable levels of cysteine sulfenate 
at around 100kDa, which may correspond to crosslinked RPA32:RPA70. This 
crosslinked product is a small fraction of the overall RPA32. Therefore, the fact that 
this product was detected in this assay indicates heavy cysteine oxidation of the 
crosslinked complex. This heavy oxidation of cysteines highlights the possibility for 
the oxidation of methionines at the interface of RPA32 and 70, which may contribute 
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to crosslinking, RPA inactivation and NER inhibition. Cysteines that are oxidised 
beyond sulfenate are not actually detected by the BP-1 probe. Therefore, it is likely 
that the cysteine oxidation of proteins following photosensitiser+UVA treatment are 
underestimated. Irreversible thiol oxidations are difficult to study with selective 
tagging due to their chemical inertness. Both sulfinate and sulfonate can be detected 
by mass spectrometry (MS). However, their analysis is complex due to inefficient 
ionisation as a result of their high negative charge and difficulty in distinguishing their 
fragmentation patterns from other post-translational modifications (Murray and Van 
Eyk, 2012). 
 
After studying the oxidising effect of photosensitising drugs, I also investigated 
whether an endogenous photosensitiser (FICZ) was able to cause PCNA and RPA 
crosslinking. FICZ is a UVB photoproduct of tryptophan and absorbs in the UVA 
region of the spectrum. These characteristics make it physiologically very important, 
as tryptophan in human skin cells would be exposed to UVB and UVA at the same 
time from sunlight. FICZ results in the production of intracellular ROS upon UVA 
irradiation and can cause DNA damage (Park et al., 2015). PCNA was oxidised and 
formed inter-subunit crosslinking in a FICZ+UVA concentration dependent manner. 
RPA was not as significantly oxidised and a crosslinked product was only detected 
in the RPA21 cells due to the higher levels of RPA. This indicates that at nanomolar 
concentrations of this endogenous photoproduct, an essential protein involved in 
DNA repair and replication is oxidised and damaged, impeding its function. This can 
contribute to the detrimental effects of physiological exposure to sunlight. 
 
The previous results show that higher expression of RPA seems to have a protective 
response against toxicity and DNA damage under oxidising conditions. It then raises 
the question as to why cells do not generally express higher levels of RPA. It is 
possible that RPA needs to be maintained at a particular concentration to be the 
regulatory factor in DNA replication and repair, as discussed previously (see Section 
3.1.1). However, there may be an additional reason. RPA is particularly susceptible 
to oxidative damage even under steady state conditions. It is possible that having 
higher levels of RPA can result in accumulation of oxidised RPA and put pressure 
on the cell’s antioxidant defences, such as glutathione. This can lower the amount of 
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reduced glutathione in the cell and result in higher overall ROS levels. The sensitivity 
of RPA to oxidation may be the reason why cells do not express higher levels of RPA.  
 
Interestingly, I noted that the steady state ROS levels of RPA21 cells were 
substantially higher than those of U2OS. This stable increase in ROS is unlikely to 
be the result of the construction of RPA21 cells, as transient increases of ROS should 
not persist long after transfection. I considered the possibility that higher levels of 
RPA is permissive for higher ROS levels. RPA16 has an intermediate amount of RPA 
between RPA21 and U2OS (about 1.5-fold higher that U2OS). Its steady state ROS 
levels were intermediate between U2OS and RPA21, and closer to the latter. 
Although this is a very limited comparison, it would be interesting to explore in more 
detail the relationships between RPA expression and endogenous ROS.   
 
This oxidative stress is a reflection of the insufficiency of the cell’s antioxidant 
defences. GSH levels provide an indication of the depletion of antioxidant resources 
as GSH provides reducing equivalents to antioxidant enzymes and is very important 
in the cell’s antioxidant defence. Unfortunately, I was only able to measure the total 
GSH present in the cell and not the oxidised GSSG levels, which limits the 
conclusions that can be drawn from this data. It is interesting that total GSH appears 
to be inversely correlated to ROS and RPA levels in U2OS, RPA16 and RPA21 cells. 
It is possible that some of the oxidised glutathione in RPA16 and RPA21 cells is in a 
form that is not reducible by glutathione reductase and would therefore escape 
detection in this assay. I regard this as an interesting but preliminary observation that 
suggests that accurate determination of reduced:oxidized glutathione ratios in these 
cells might yield important information.  
 
To summarise, increased RPA expression has a protective effect. It improves cell 
survival after DNA damaging treatments as well as under conditions of oxidative 
stress. RPA also appears to be the limiting factor in NER under steady state 
conditions. This raises the question as to why RPA is limiting. I propose that a 
contributing factor to this limitation is the vulnerability of RPA to oxidative damage, 
including thiol oxidation and protein-protein crosslinking. This susceptibility may 
result in higher steady-state utilisation of antioxidant defences and therefore result in 
higher levels of steady state ROS.  
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6.3 Proteomics based method for identifying DPCs 
The aim of this chapter was to develop a statistically rigorous technique to investigate 
the identity of the proteins involved in DPCs. 
 
Initially, confirmation of the synergistic formation of DPCs with 6-TG+UVA was 
obtained through the Wizard (Promega) DNA extraction protocol with an additional 
proteinase K digestion step. This process revealed that 6-TG+UVA and, to a lesser 
extent, 6-TG result in DPC formation. No DPCs were detected after cells were 
exposed to 50kJ/m2 UVA alone. This underlines the synergistic effect of 6-TG+UVA.  
 
The incorporation of 6-TG into DNA was essential for DPC formation. Lesch-Nyhan 
fibroblasts and CCRC-CEM cells that were treated with HU to prevent 6-TG 
incorporation were not susceptive to DPC formation. In terms of ROS production, 
unincorporated 6-TG did not result in any ROS production in GM03467 Lesch-Nyhan 
fibroblasts, while in HU treated CCRF-CEM cells it did. This could be because the 
Lesch-Nyhan cells are HPRT deficient and do not phosphorylate 6-TG to retain it in 
the cell. 6-TG most likely establishes an equilibrium concentration between the 
extracellular and intracellular environment. On the other hand, CCRF-CEM cells 
treated with HU, still phosphorylate and retain 6-TG in the cell, which can generate 
more intracellular ROS. When Lesch-Nyhan cells, and CCRF-CEM cells treated with 
HU, are treated with 6-TG+UVA it results in ROS levels higher than 6-TG on its own 
but lower than incorporated 6-TG+UVA. However, this ROS is insufficient in causing 
crosslinks. Even though there is intracellular ROS detected with unincorporated 6-
TG, it does not mean the ROS is generated in the right location to cause DPCs. 
 
Crosslinks between oligonucleotides containing 6-TG and oligopeptides can occur 
between peptide SH or NH2 and GSO3, which is a good leaving group for nucleophilic 
substitution reactions (Gueranger et al., 2011). In addition, crosslinks can also form 
through a free protein NH2 group and a 6-TG radical cation or a 6-TG thiyl radical 
formed by oxidation of DNA 6-TG (Perrier et al., 2006). These radicals can result in 
a significant number of propagating reactions and damage to nearby DNA and 
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proteins resulting in more DPCs. This data also suggests that reactions between 
protein nucleophiles and oxidised guanine are not contributors to DPC formation by 
6-TG and a majority of the crosslinking occurs through incorporated 6-TG. 
 
I decided to analyse DPC formation by MS. An acknowledged issue with identifying 
proteins involved in DPCs is contamination by non-covalently bound proteins. 
Therefore, the method development aimed at maximising the removal of free DNA 
and free protein to enrich the DNA:protein crosslink fraction. The removal of free 
protein was maximized by performing high salt washes of the chromatin fraction. 
After DNA was immobilized on a filter, extensive washing with urea further depleted 
any proteins not covalently attached to DNA. The analysis of tryptic digests 
effectively excluded any contribution from DNA.  
 
I identified over 2000 cellular proteins that were crosslinked by 6-TG and 6-TG+UVA. 
Using SILAC (stable isotope labelling by amino acids in cell culture), the analysis 
confirmed that the modest UVA dose I used does not cause significant DPC 
formation. As the significance level was set to a conservative log2 value of 1 (2-fold 
enrichment), 6-TG treatment alone was a relatively inefficient crosslinker. On the 
other hand, 6-TG+UVA resulted in a very significant increase in the association of 
proteins with DNA following treatment, highlighting both the contribution of 6-
TG+UVA to DPC formation as well as the synergistic relationship between 6-TG and 
UVA. The formation of ICLs has been demonstrated to require both 6-TG 
incorporation and ROS production (Brem and Karran, 2012). These results suggest 
that it is also a requirement for DPC formation.  SILAC reverse labelling provided a 
statistically rigorous and highly reproducible approach to viewing the effects of 6-TG 
and 6-TG+UVA treatments.  
 
I analysed DNA-free total lysate data to examine whether 6-TG had an overall effect 
on protein recovery. Because 6-TG impairs transcription (and possibly translation) 
during the 24-hour incubation period, underrepresentation of proteins due to 
expression changes might have skewed the crosslinking data. The results show that 
6-TG treatment was not associated with significant changes in protein abundance in 
RIPA extracts, indicating that changes in transcription and translation caused by 6-
TG over the 24-hour incubation did not have a substantial impact on overall protein 
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levels. There was evidence of a decline in protein recovery from 6-TG+UVA cells. 
This cannot be related to changes in transcription or translation as proteins were 
extracted immediately after irradiation. These changes most likely represent the 
effects of DPC formation and protein oxidation. The resulting protein unfolding, 
aggregation and precipitation can decrease overall protein recovery as well as 
possibly impeding the detection of some proteins that are recovered due to heavy 
oxidation. This may explain why the data presents itself as a scatter rather than a 
clear correlation. 
 
The MS analysis revealed that the proteins most vulnerable to crosslinking were 
predominantly nuclear proteins involved in gene expression, DNA replication/repair 
and cell cycle. The proteins involved in these cellular functions are anticipated to 
exist in close proximity to DNA. 
 
Among 179 DNA repair proteins, 52 were detected and 30 of these appeared to be 
crosslinked to DNA. An advantage of this method is that it recognises proteins that 
do not change in a treatment-dependent manner. This facilitates the identification of 
false positives. The information from the RIPA extracts also confirms this depletion 
of DNA repair proteins through either DPC formation or protein oxidation. This can 
contribute towards reduced protein recovery that was identified with DNA repair 
proteins in Chapter 3. In fact, RPA70 was among the 30 proteins that display a 
crosslinking profile. RPA32 and RPA14 were detected but did not appear to be 
crosslinked. This may be because RPA70 is the subunit with the most intimate 
association with DNA.  
 
Investigating individual proteins involved in replication and repair revealed different 
susceptibilities to crosslinking. While POLD1 subunit of DNA polymerase d and the 
MCM proteins were efficiently crosslinked by both 6-TG and 6-TG+UVA, the smaller 
POLD3 and the topoisomerases exhibit mainly photochemical crosslinking 
dependent on 6-TG+UVA. The vulnerability to crosslinking with 6-TG on its own may 
be due to oxidation susceptibilities or the way in which the proteins interact with DNA. 
The MCM complex proteins exhibit almost perfect overlap in their DPC formation. 
This can be a result of the subunits having equal susceptibilities to DPC formation or 
through one subunit crosslinking to DNA and the other subunits forming inter-subunit 
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protein-protein crosslinks. In agreement with the crosslinking data, the whole-cell 
protein abundance of POLD, MCM and TOP proteins were visibly reduced in 6-
TG+UVA treated cells. 
 
After applying this method to studying 6-TG+UVA mediated DPC formation, I 
investigated Cip+UVA mediated crosslinking. DPCs with 6-TG and 6-TG+UVA can 
occur through proteins reacting with 6-TG itself. Ciprofloxacin can be DNA-
intercalated, but because of its lack of incorporation, covalent protein crosslinking 
must occur through canonical DNA constituents (Vilfan et al., 2003). Both DNA 6-TG 
and ciprofloxacin are Type II photosensitisers. 1O2 is most likely a significant 
contributor to DPC formation by both Cip+UVA and 6-TG+UVA.   
 
As a proof of principle, I wanted to test whether this DPC detection method can be 
applied to treatments that result in a reactive centre in DNA, such as 6-TG, as well 
as crosslinking without a DNA incorporated target, such as ciprofloxacin. DPC 
formation by Cip+UVA was extensive and over 2000 DNA-crosslinked proteins were 
identified. This confirms that the method can be applied to different crosslinking 
treatments. The particular DNA repair proteins that were crosslinked by Cip+UVA 
and 6-TG+UVA exhibited significant overlap. This suggests that some DNA repair 
proteins are highly vulnerable to DNA crosslinking and indicates that crosslinking 
under both conditions may be by a similar mechanism. 
 
The analysis clearly identified some false positives. Most of these were gene 
expression, ribosome biosynthesis and chromatin regulation proteins. There was a 
large family of histones in the false positive groups from both 6-TG+UVA and 
Cip+UVA treated cells. Histones and structural proteins like vimentin, which was also 
among the false positives, are highly abundant proteins and this high abundance can 
make them difficult to remove fully from the samples and cause its detection by MS. 
Initially, I anticipated that histones may be particularly prone to crosslinking by 
photosensitising treatments due to their intimate association with DNA. However, it 
appears that histone levels are unchanged with treatment. It may be possible that 
some histone crosslinking is masked by the high abundance and high propensity for 
contamination by histones. 
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There are various proposed ways by which DPCs are repaired including NER, 
homologous recombination (HR), the proteasome and more recently the DPC-
specific protease SPRTN (Barker et al., 2005b; Quievryn and Zhitkovich, 2000; 
Ridpath et al., 2007; Stingele et al., 2015). The difficulty in fully determining which 
pathway is responsible for DPC repair is that most treatments that result in DPC 
formation also result in other forms of DNA damage. In these experiments, I have 
not only identified proteins from NER, HR and Fanconi anaemia pathways forming 
DPCs but it was also previously shown by our lab that NER is inhibited by both 6-
TG+UVA and ciprofloxacin+UVA treatments (Gueranger et al., 2014; Peacock et al., 
2014). Therefore, potential repair by these pathways may be impeded by DPC 
formation and by the other damaging effects of these oxidizing treatments. It would 
be interesting to use the method described here to investigate changes in protein 
composition of DPCs over time and examine their repair. 
 
There have been other methods used to identify proteins involved in DPCs. 
Formaldehyde induced DPCs have been investigated by chromatin enrichment of 
proteins (ChEP) (Kliszczak et al., 2011). Biotinylated oligonucleotides have been 
used to investigate crosslinking by a specific subsets of proteins (Mittler et al., 2009). 
In addition, in vivo labelling of DNA by DNA polymerases, on-bead digestion of 
immunoprecipitated crosslinked proteins and immunoprecipitation of tri-methylated 
histone 3 to investigate the heterochromatin proteome are other methods that have 
been developed (Byrum et al., 2012; Mohammed et al., 2016; Soldi and Bonaldi, 
2014). Most of these methods have a labelling step to quantify the crosslinking. 
However, to my knowledge, enrichment of DPCs using a Hybond-N+ membrane and 
analysis of these proteins by SILAC-LC-MS/MS is a new, statistically rigorous and 
versatile method in the identification of DPCs. 
 
In summary, I have devised a sensitive and highly informative proteomics based 
method to investigate DPC formation in human cells treated with UVA 
photosensitisers. The method identified over 2000 proteins many involved in 
essential processes such as gene expression, DNA repair and replication that can 
become crosslinked to DNA under acute oxidative stress conditions. 
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6.4 Conclusions 
ROS production by UVA photosensitisers can lead to protein losses through 
oxidation and precipitation. RPA is particularly susceptible to oxidation by inter-
subunit protein crosslinking, thiol oxidation and crosslinking to DNA. RPA has a 
crucial role in all aspects of DNA metabolism that involves a ssDNA intermediate, 
including DNA replication, recombination, repair, telomere maintenance and DNA 
damage response. RPA was identified as the limiting factor for NER and is the key 
target for inactivation in cells treated with 6-TG+UVA. Oxidation of RPA results in 
impaired ssDNA and XPA binding. This can contribute towards loss of NER function 
in cells under oxidizing conditions. Increased RPA expression improves cell survival 
and NER function after DNA damaging treatments as well as under conditions of 
oxidative stress.  
 
I have also devised a SILAC and proteomics based method to investigate DPC 
formation in human cells treated with UVA photosensitisers. The method identified 
over 2000 proteins crosslinked to DNA by 6-TG and 6-TG+UVA or Cip+UVA 
treatment-mediated photochemical production of ROS. The proteins most vulnerable 
to crosslinking were those involved in gene expression, DNA repair and replication. 
RPA70 was among this group of susceptible proteins. 
 
The experiments described in this thesis were aimed to reflect an amplified version 
of the clinical impact of photosensitising medications and potentially mimic long term 
effects. As the source of genetic information, DNA has received a majority of the 
attention as a target of damage by ROS compared to protein oxidation, due to the 
ease of replacement of oxidised proteins by protein turnover. However, oxidation of 
DNA repair proteins and the resulting impaired removal of DNA damage connects 
these two fields. This thesis has contributed some evidence to support the 
detrimental impact of protein oxidation to cellular viability and genomic integrity. 
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Chapter 7. Appendix 
A. Mix 7- Scatter plot 
 
B. Mix 7- Density plot 
 
 
C. Mix 8- Scatter plot 
 
D. Mix 8- Density plot 
 
 
 
E. Mix 10- Scatter plot 
 
F. Mix 10- Density plot 
 
 
 
G. Mix 14- Scatter plot 
 
H. Mix 14- Density plot 
 
Figure 7.1: The effects of the different treatments on DPC formation 
CCRF-CEM cells were labelled with heavy (H) or light (L) arginine and lysine isotopes 
and treated with 0.9μM 6-TG for 24 hours and irradiated with 50 kJ/m2 UVA as indicated. 
Chromatin extracts were applied on HyBond-N+ membranes, subject to in situ trypsin 
digestion and analysed by MS. Scatterplots of log2 SILAC H/L ratios of the detected 
proteins in each sample vs log10 Intensity (A, C, E and G) or Density (B, D, F and H) 
are presented. The H/L values at 5% and 95% of the density distribution are indicated. 
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